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ABSTRACT

This dissertation focuses on three key aspects in health IT management: (1) Complexities in the
collection of health data in electronic health record (EHR) systems and the use of EHR data in research, (2)
Complexities of collaboration between physicians and AI for improving healthcare delivery, and (3)
Complexities of workflows and collaborations between healthcare organization (HCO) staff during the
delivery of care. The first dissertation essay (Chapter 1) examines the key data quality issues that arise in
recorded health information in EHR systems, provides quality thresholds that the data needs to meet for
mitigating errors and increasing reproducibility of downstream research. The essay finally provides
remedial actions that can be taken to enhance quality of EHR data. The second dissertation essay (Chapter
2), examines the challenge of collaboration between human experts and AI in order to increase the quality
of care provided. The essay looks at this problem from the lens of task complexity where it first maps the
various elements that can impact the complexity of an information processing task in HCOs. The essay then
builds a framework the helps reduce the identified elements of task complexity to increase performance in
such tasks by using complementary strengths of human-experts and AIs. The third essay (Chapter 3) studies
complex and dynamic workflows in HCOs and investigates the impacts of workload and collaborations
between HCO staff on inefficiencies and delays in healthcare delivery. The essay further investigates the
impacts of these inefficiencies and delays on the quality of care (QoC) provided by the HCO to its patients.
The essay develops a new methodology for studying dynamic and complex workflows in HCOs, provide
insights into the factors that play a role in inefficient workflows and their impacts key QoC metrics.
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CHAPTER ONE:
ELECTRONIC HEALTH RECORDS IN IS RESEARCH: QUALITY ISSUES, ESSENTIAL
THRESHOLDS AND REMEDIAL ACTIONS1

1.1. Abstract
The increase in adoption of Electronic Health Record (EHR) systems by healthcare organizations has led
to the proliferation of the use of EHR as a secondary data source in both IS and supporting fields. It is
imperative that EHR data is exploited appropriately, which would lead to high quality results and enhanced
reproducibility. However, the quality of the EHR data being used can vary significantly and can have
repercussions for research outcomes. In this paper, we first discuss four major data quality issues present
in EHR data. These issues are: (a) non-standard coding schemes, (b) missing data, (c) inconsistencies and
(d) aggregation and augmentation of EHR data. Then, we discuss quality thresholds that need to be met in
order to avoid the negative impacts of quality issues. Lastly, we discuss some remedial actions that
researchers can take to enhance the quality of EHR data to meet the quality thresholds. The discussed issues,
thresholds and remedial actions can also apply to a much wider set of data sources when used as secondary
data in research.
1.2. Introduction
Due to recent advances in healthcare technologies and changes in policies put forth by governments (i.e.
HITECH Act2), the use of Electronic Health Records (EHR) in healthcare organizations (HCOs) has seen
a dramatic increase in the past decade (I. R. Bardhan & Thouin, 2013). This increased use of EHR systems

1This

chapter was published in Decision Support Systems, Volume 126, Jetley, G., Zhang, H., Electronic Health Records in IS
Research: Quality Issues, Essential Thresholds and Remedial Actions, 113137, Copyright Elsevier (2019).
https://doi.org/10.1016/j.dss.2019.113137
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has led to the capture of massive amounts of patient data, opening avenues for its utilization as a secondary
data source in research. In information systems (IS), we have seen EHR data used for research in hospital
workflow, disease management, clinical decision support systems and patient centric care, among others
(Gupta & Sharda, 2013; Johnson, Zheng, & Padman, 2014; van Valkenhoef, Tervonen, Zwinkels, de Brock,
& Hillege, 2013). While there is great emphasis given to the modeling tasks in studies employing EHR
data, the data quality is often not discussed in detail in research involving EHR data in IS. Like most types
of observational data, EHR data can suffer from quality issues such as inaccuracy and missing values, which
lead to issues downstream in research. Therefore, the use of EHR data in IS research needs more welldefined quality thresholds.
Marsden and Pingry (2018) pointed out the seven elements, what, when, where, how, which and
why, that need to be addressed for the accuracy and validity of the data being used and reproducibility of
the research being conducted. In many situations, EHR data can fail to address these W’s due to data quality
issues such as the presence of missing data and logical contradictions. EHR data used in IS literature
(Rector, 1999; Sen, Al Kawam, & Datta, 2019; Walczak & Velanovich, 2018) can be from various
components of the system (audit, laboratory, radiology, pharmacy, clinical physician order entry (CPOE)
system, clinical texts/notes and administrative components) and can suffer from quality issues ranging from
missing data to issues in medical coding schemes used to record the data. These issues have repercussions
for the reproducibility of the research as well as the accuracy of the findings. In this paper, we provide a
compelling case for cautious use of EHR data in IS research by: (1) discussing four major data quality
issues when using EHR data, (2) providing quality thresholds to address each issue and (3) discussing some
remedial actions to improve the quality of EHR data to meet the quality thresholds.
The rest of the paper is organized as follows. In §1.3, we provide a brief overview of EHR systems
and the use of EHR data in research. In §1.4, we discuss four major data quality issues in EHR data. In
§1.5, we discuss the data quality thresholds that need to be met. In §1.6, we discuss the remedial actions
that can help meet the quality thresholds. Concluding remarks are presented in §1.7.

2

1.3. Electronic Health Records and Research
In the past decade, we have seen a widespread adoption of EHR systems. In 2011, 84% of hospital
emergency departments (EDs) and 73% of outpatient departments (OPDs) used at least a basic EHR
system3. Modern EHR systems include multiple components such as clinical notes and laboratory results.
EHR systems typically record clinical information of patients visiting the institution in a longitudinal
format. However, EHR systems don’t capture the history of the patients across HCOs. Even inside an HCO,
there can be disparate systems that do not interact with the main EHR system and/or may record data that
is in different medical coding schemes or in different data formats (i.e. structured or unstructured data).
Moreover, EHR systems capture data for clinical purposes, not for research, which makes the recording
less careful than that for research purposes (Weiner & Embi, 2009).
In the field of IS, EHR data has been used for research on clinical decision support systems (Yet et
al., 2013; Zhuang, Wilkin, & Ceglowski, 2013) and quality of care improvements (I. Bardhan, Oh, Zheng,
& Kirksey, 2014) among many other research topics. However, most research using EHR data focuses more
on the development of methods or the research findings and less on supplying details on the quality issues
that existed in the EHR data and how those issues were resolved. In this paper, we will provide a systematic
discussion about major quality issues, quality thresholds and remedial actions for the usage of EHR data in
IS research.
1.4. EHR Data Quality Issues
In this section, we will cover four main EHR data quality issues, namely: (1) non-standard medical coding
schemes, (2) missing data, (3) representational and semantic inconsistency and (4) aggregated and
augmented EHR data. For each data quality issue, we are going to briefly describe the data quality issue
with some typical examples, its negative outcomes, impacted W’s and common causes.

3
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1.4.1. Non-Standard Medical Coding Schemes
One of the major data quality issues with the use of EHR data in research is linked to the use of medical
coding schemes (Laur, #237, & March, 2011; Millar, 2016). In general, coding schemes are used to describe
and define the data, which involves assigning raw observations into categories representing particular
themes or topics based on similarities or differences between the observations. Based on the scheme being
used, data can be coded quite differently than in other schemes. Naturally, having multiple coding schemes
can introduce data quality issues such as incorrectness and impreciseness.

Brief Description:
Negative Outcomes:
EHR data attributes recorded in multiple Incorrectness and impreciseness concerns.
medical coding schemes, no medical coding
scheme or a combination of the two.
W’s Impacted:
What is being recorded and which coding
Typical Examples:
scheme was used to record the data.
Patient condition of back pain being coded
interchangeably within the same attribute as: Common Causes:
(a) “724.5” using International Classification Changes in the EHR system provider,
of Diseases, 9th revision, coding scheme (See evolutionary changes in the coding schemes
Appx. A); (b) “T-D2100” and “F-A26000” and recording in free-form text.
using the Systematized Nomenclature of
Medicine coding scheme (See Appx. A) or; (c)
“Back Pain” using free-form textual input (no
coding scheme).
Figure 1.1: Overview of Data Quality Issue due to Non-Standard Coding Schemes

Similarly, medical coding involves the conversion of concepts such as medical conditions
(diagnosis) and services (procedures) to predefined codes (medical coding schemes) (Yan, Fung, Dy, &
Rosales, 2010). There are a variety of medical coding schemes available worldwide and the use of a medical
coding scheme can not only vary between EHR datasets (guided by factors such as EHR provider, etc.), but
also within EHR datasets. Having a data attribute coded in multiple coding schemes, no coding scheme or
a combination of both (Campbell et al., 1997; Codd, 1981) can create data quality issues if not dealt with
appropriately. For example, the recording of patient diagnosis in free-form text (no coding scheme) can
4

introduce incorrectness due to coding errors and impreciseness due to the lack of rigorous definitions
(González Bernaldo de Quirós, Otero, & Luna, 2018; Laur et al., 2011). Figure 1.1 provides an overview
of the key elements of this data quality issue.
1.4.2. Missing Data
The second major data quality issue in EHR data is linked to missing attributes, missing data within
attributes and longitudinal truncations for observations. Completeness of data is described as the presence
of the complete truth regarding an observation being present in the data (Weiskopf & Weng, 2013). Missing
attributes, missing data within attributes and longitudinal truncation of observations hinder the data from
providing the complete truth about the affected observations. For example, if we have missing date and
time information for a medication prescription to a patient, it is hard to establish the truth about when the
prescription was given and if the patient is still on the medication. EHR data can suffer from truncation
when there is unobserved data before the start, during or after the end of the observation period for a patient
in the EHR dataset (Hazelbag, Klungel, van Staa, de Boer, & Groenwold, 2015). For example, missing
information on disease diagnosis and associated timestamps for a patient transferring from another facility
is often not recorded in EHR datasets.
Incompleteness in EHR data can introduce data quality issues such as the ambiguity due to missing
values which may lead to bias in conclusions and a large amount of missing values in the data which may
lead to insufficient data for analysis (Beaulieu-Jones et al., 2018). Figure 1.2 lists the key elements of this
data quality issue.

5

Brief Description:
Negative Outcomes:
Missing values in data attributes and Ambiguity, sufficiency and inaccuracy
missing longitudinal information for concerns.
observations.
W’s Impacted:
Typical Examples:
What is and isn’t recorded in the data; When the
Missing diagnosis date for a patient data was recorded; Where was the data not
diagnosis or missing historical diagnosis recorded; How was the data recorded and why
information for a patient being transferred are there missing values.
from another facility.
Common Causes:
Receiving care at multiple HCOs, refusal to
provide information, data recording failure and
attributes relevance only in certain situations
Figure 1.2: Overview of Data Quality Issue due to Missing Data

1.4.3. Representational and Semantic Inconsistency
The third major data quality issue is inconsistency. Weiskopf and Weng (Weiskopf & Weng, 2013) describe
consistency as the agreement in data attributes, where two or more attributes recording the same information
for an observation should have the same values (also known as representational consistency) (Heinrich,
Klier, Schiller, & Wagner, 2018) and the information regarding observations contained in the attributes
should be logically sound (also known as semantic consistency) (Heinrich et al., 2018; Weiskopf & Weng,
2013).
Representational consistency is violated when there is variation in data due to multiple formats,
units, granularities and measurement protocols (Botsis, Hartvigsen, Chen, & Weng, 2010; Kahn, Raebel,
Glanz, Riedlinger, & Steiner, 2012). For example, inconsistencies can occur when having weights of
patients recorded in both pounds and kilograms or using both a 3-point and a 5-point Likert scale to record
pain levels (Feder, 2018). Semantic consistency is violated when the data has logical contradictions
(Heinrich et al., 2018) such as records of hospital visits by a deceased patient. Having representational
and/or semantic inconsistency in data can lead to issues such as implausibility (Heinrich et al., 2018;
Weiskopf & Weng, 2013) of data due to logical contradictions, which can be related to lab reports being

6

outside of the range of plausible values for a human being. Figure 1.3 provides an overview of this data
quality issue.

Brief Description:
Contradictory information in EHR data such
as mismatch between two attributes that
record the same data or logical errors in the
recorded data. Variation in measurement
protocols, granularities, scales, etc. for
recording a single attribute.
Typical Examples:
Mismatch between the diagnosis dates
recorded in two separate tables for a patient,
a diagnosis recorded after death of patient,
weight being recorded in pounds and
kilograms.

Negative Outcomes:
Incorrectness and inaccuracy concerns.
W’s Impacted:
What is being recorded, when was it recorded,
how was the data recorded and which
instruments and protocols were used in
recording the data.
Common Causes:
Changes in EHR system providers, phased
rollout of the EHR system, data entry as free
form text and change in procedure protocols

Figure 1.3: Overview of Data Quality Issue due to Representational and Semantic Inconsistency

1.4.4. Data Aggregation and Augmentation
With the scarcity of EHR data sources coupled with the need for larger sample sizes or a richer set of
attributes , it is not uncommon for the researchers to aggregate data from multiple sites and augment data
with more/transformed attributes from multiple information sources (Gong & Kang, 2016). Data
aggregation is a process of combining information from multiple sources for the purpose of creating a larger
dataset, for example, aggregating patient information (i.e. demographics, disease diagnosis, medication
prescriptions, etc.) from multiple small EHR datasets to form one large dataset. Data augmentation, on the
other hand, is the process of enriching the data with external information or manipulating the data in order
to make it easier to analyze (Tanner & Wong, 1987), for example, augmenting the drug prescriptions
recorded in an EHR dataset by including a new attribute for active drug ingredients sourced from an external
dataset.

7

Brief Description:
EHR dataset that is being aggregated or
external information that is being used to
augment the EHR data having the first three
data quality issues.
Typical Examples:
Aggregating multiple EHR datasets together
which have attributes recorded in different
formats. Augmenting EHR dataset with
external data on a common attribute which
is formatted differently in both.

Negative Outcomes:
Incorrectness,
impreciseness,
ambiguity,
sufficiency, and inaccuracy concerns.
W’s Impacted:
All W’s in §1.4.1 – §1.4.3.
Common Causes:
Presence of the first three data quality issues in
individual or aggregated and/or augmented
dataset(s).

Figure 1.4: Overview of Data Quality Issue due to Aggregation and Augmentation of EHR data

Data in individual and disparate EHR systems can be very heterogeneous with respect to the
medical coding schemes being used, missing values in the data, inconsistencies in the data and the reasons
for data collection (van der Lei, 1991). For example, aggregation of multiple EHR datasets holding patient
information will be challenging because of the existence of multiple formats of patient information. This
will be the case even if the EHR datasets and external datasets used for augmentation are free of the quality
issues individually. Figure 1.4 provides an overview of this data quality issue.
1.5. Quality Thresholds
In this section, we discuss data quality thresholds for EHR data being used for research in IS and supporting
disciplines. The thresholds we discuss in this section correspond to the four data quality issues discussed in
§1.4.
1.5.1. Formal Medical Coding Schemes
Data quality thresholds for the non-standard coding scheme issue have been extensively covered in previous
literature (Ariosto et al., 2018; Laur et al., 2011; March, Laura, & Lantos, 2004). The Office of the National
Coordinator for Health Information Technology4 (ONC) recommends the use of standard medical coding
schemes for recorded information (i.e. patient diagnosis, procedures, etc.) and having limited free-form text

4

ONC is the organization overseeing the efforts of nationwide migration to EHR systems within HCOs in the US.

8

fields in the data (Guide, 2013) to reduce potential data quality issues. For example, the International
Classification of Diseases, 9th and 10th revisions, clinical modification5 (ICD9-CM and ICD10-CM),
maintained by the World Health Organization, is a popular coding standard for recording disease diagnosis
and medical procedures in EHR systems across the world (Laur et al., 2011). This coding standard is also
heavily used in health informatics research and IS (I. Bardhan et al., 2014; Bertsimas et al., 2008).
Definitions for the most commonly used coding schemes for recording diagnosis, medications and
laboratory reports are provided in Appx. A. For more details on most globally recognized coding schemes,
please see (U.S. National Library of Medicine, 2019, May 6).
Using EHR data that follows formal medical coding schemes used in previous literature and
recommended by agencies such as ONC will not only help increase the reproducibility of the research but
also significantly reduce the quality issues that arise due to the presence of non-standard medical coding
schemes (Weiskopf & Weng, 2013). Thus, the first threshold that EHR data needs to meet in order to avoid
the negative impacts of the presence of non-standard coding schemes is:
Threshold 1: EHR data used for research should follow formal medical coding schemes.
EHR data meeting Threshold 1 precisely describes and defines what is being recorded in the data according
to the coding scheme used. This threshold also increases the accuracy and removes ambiguity in the data
due to the lack of free-form text entry.
1.5.2. Completeness
The second data quality threshold we discuss is concerned with the presence of missing data, which has
been heavily discussed in previous literature (Beaulieu-Jones et al., 2018; Guide, 2013). Literature tackling
the issue of missing data in EHR datasets used in research points out the negative consequences of missing
data. These consequences include the inability of running certain analytical methods because of missing
data, reduced power due to a larger proportion of missing data and bias in the study outcomes due to
systematic underlying reasons for the missing data or misinterpretation of the missing value (Allison, 2001;

5

https://www.who.int/health-topics/international-classification-of-diseases
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Beaulieu-Jones et al., 2018; Wells, Chagin, Nowacki, & Kattan, 2013). Most literature that use EHR data
for research drops the observations that have missing values or plausible longitudinal truncations to avoid
the reparations of this data quality issue (I. Bardhan et al., 2014; Yet et al., 2013). Thus, following previous
literature on missing data in EHR datasets, we suggest that the second threshold that good quality EHR data
needs to meet is:
Threshold 2: EHR data used for research should have no missing values in key attributes; no
longitudinal truncation in observations for temporal/trajectory analysis; no ambiguity for missing data
in non-key attributes.
EHR data that meets Threshold 2 reduces the negative consequences of missing data such as bias
(Allison, 2001; Beaulieu-Jones et al., 2018; Wells et al., 2013) and thus increases the data accuracy and
study reproducibility.
1.5.3. Representational and Semantic Consistency
The third data quality threshold that EHR data needs to meet is the representational and semantic
consistency of the EHR dataset being used in research. Consistency in EHR data is another data quality
threshold that has been extensively discussed in the field of health informatics (Weiskopf & Weng, 2013).
Researchers should only have data corresponding to observations which are consistent before using the data
in any study, as inconsistencies can lead to bias and other negative repercussions (Bayley et al., 2013).
The ONC suggests that good quality EHR data needs to be consistent and suggests several ways to
ensure representational and semantic consistency, such as standardized formats, field definitions and
reference ranges (Guide, 2013). Literature also suggests that inconsistencies between and within EHR data
attributes pose serious problems for the effective use of EHR data in research (Botsis et al., 2010). The
majority of researchers using EHR data perform careful deletion of inconsistent data such as data outside
the range of a particular therapeutic range (Yet et al., 2013) to avoid the negative consequences of the
presence of inconsistencies. Thus, we suggest:
Threshold 3: EHR data being used in research must be representationally and semantically consistent.
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EHR data that meets Threshold 3 improves the correctness in EHR data because of consistency in formats
and increases the plausibility of data by not having any contradictions in the EHR data.
1.5.4. Accurate Aggregation and Augmentation
Researchers should be extremely careful in how they aggregate and augment the datasets as it can lead to
all the data quality issues discussed in §1.4.1 – §1.4.3. Thresholds 1, 2 and 3 are all applicable when
researchers are aggregating multiple EHR datasets. Meeting these thresholds is critical as the coding
schemes, missing values, and representational and semantic inconsistencies between datasets can differ
even more than within EHR datasets (Hirschtick, 2006). Moreover, even if the EHR datasets are free of
quality issues individually, the act of aggregation itself can introduce the above data quality issues. Hence,
we suggest the following threshold when using multisite data for aggregation and external data for
augmentation:
Threshold 4.a: When aggregating EHR data or augmenting EHR data with external data, the first three
thresholds for data quality must be met for each individual and the aggregated/augmented dataset.
Additionally, augmentation of EHR data with external data sources brings about additional challenges and
issues. Common attributes used for matching EHR and external data which are not in the same coding
scheme or which have different units/formats of recording contributes to the complexity of using EHR
datasets for secondary research (Cowie et al., 2017). We suggest one additional threshold for data
augmentation:
Threshold 4.b: When augmenting EHR data with an external data source, the matching between the two
data sources should be done on common attributes recorded using the same coding scheme or in the
same format.
Aggregated and augmented EHR data meeting the above thresholds will resolve all the issues that
the other thresholds help with.
1.6. Remedial Actions for Meeting Lower Thresholds
In this section, we discuss some methods and techniques which researchers can exploit to meet the lower
thresholds when there are one or more data quality issues (§4) present in their EHR data. Table 1.1 lists
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some methods and techniques that can be used to increase the quality of EHR data while still allowing
researchers to keep most of the observations and attributes present in their dataset(s). It should be noted
that all the remedial actions mentioned in this section should only be performed under the supervision of
medical professionals and experts.
To achieve Threshold 1 when there are multiple coding schemes present in an attribute, researchers
can exploit external mappings6 for conversion between coding schemes (Bodenreider, 2004). For example,
Metathesaurus7 provides mappings between over 200 medical coding schemes. Researchers can exploit
methods in the field of natural language processing (NLP) to convert free-form text to a formal medical
coding scheme (Weiskopf & Weng, 2013; Xu et al., 2004). Researchers can also take the help of healthcare
professionals to manually convert to a formal medical coding scheme (March et al., 2004), however, this
may be very resource intensive.
To meet Threshold 2 when there is missing information in the EHR data, researchers can exploit
information sources that are not traditionally used in research such as clinical notes which house patient
information in an unstructured format. NLP tools and techniques such as The SPECILIST Lexicon (Browne
et al., 2018) provided by UMLS can be used to selectively extract missing information in a well-documented
fashion. These conversion methods, however, are not 100% accurate and need supervision by healthcare
professionals and experts (Botsis et al., 2010). Information from the clinical notes can also be manually
extracted, however, as with any manually conducted technique, it can be very resource intensive. External
sources of information such as national cancer registries (Botsis et al., 2010; Gho et al., 2018) can be used
to fill in missing information such as cancer diagnosis. In the case where the missing data in not retrievable
from either clinical notes or external data sources, deletion techniques can be used (Yet et al., 2013).

6

Most of these mappings between coding schemes are also available for free through resources such as united
medical language system (UMLS), maintained by U.S. National Library of Medicine.
7
https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/index.html
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Table 1.1: Remedial Actions to meet Lower Thresholds for EHR Data Quality
Threshold

Remedial Action(s)

1

(a) When multiple coding schemes are present in a single attribute, external mappings
between coding schemes can be used to convert the attribute to a single coding scheme
(Aronson, 2001; Bodenreider, 2004; Millar, 2016).
(b) When free-form text is present in attributes: (1) natural language processing (NLP)
techniques can be used to convert to a formal coding scheme (Botsis et al., 2010; Laur et
al., 2011; Weiskopf & Weng, 2013; Xu, Anderson, Grann, & Friedman, 2004) or (2)
manual mapping of free-form text to a formal coding scheme can be performed (March et
al., 2004).

2

(a) When additional patient information is present in the form of free-form text such as
clinical notes, researchers can use: (1) information extraction techniques (Browne,
McCray, & Srinivasan, 2018) and (2) manual information extraction to fill in missing
values (Browne et al., 2018; Savova et al., 2012).
(b) External data sources such as clinical registries can be exploited to fill in missing
patient information (Botsis et al., 2010; Gho et al., 2018).
(c) If (a) and (b) cannot be used, careful deletion using appropriate techniques can be
employed (Spaulding, Furukawa, Raghu, & Vinze, 2013; Yet et al., 2013).

3

Manual intervention by healthcare professionals or deletion techniques to resolve
representational and semantic inconsistencies (Yet et al., 2013).

4.a

Performing the remedial actions for Thresholds 1, 2 & 3 on individual and
aggregated/augmented datasets.

4.b

(a) Mappings between coding schemes can be used to convert the common attributes
used for augmentation to a single coding scheme (Aronson, 2001).
(b) Careful deletion of observations that are not augmented properly (Spaulding et al.,
2013) .

To meet Threshold 3, representational inconsistencies such as multiple formats, measures,
granularities and recording procedures in attributes and semantic inconsistencies like contradictory data can
be resolved with the help of healthcare experts using manual intervention. If the inconsistencies in certain
attributes cannot be resolved or if the inconsistencies are too numerous to be resolved manually, then careful
deletion of those observations can be performed with a healthcare professional’s guidance (Yet et al., 2013).
To make EHR data meet Threshold 4.a when aggregating and/or augmenting EHR data, researchers
can repeat the remedial actions for Thresholds 1, 2 and 3 on each individual and aggregated/augmented
dataset(s). Additionally, to meet Threshold 4.b when augmenting EHR data with an external dataset,
researchers can use mappings between medical coding schemes to convert the common attributes used for
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augmentation to a single coding scheme. Careful deletion of observations that were not augmented properly
is another option that researchers can use.
1.7. Conclusions
In this paper, we discuss four major data quality issues that arise when EHR data is used in research. We
first discuss how these issues impact data quality in terms of the identifiability of the seven W’s (Marsden
& Pingry, 2018). Next, we provide researchers with four data quality thresholds that EHR data needs to
meet when being used for research. We also investigate some remedial actions that researchers can employ
to make the EHR data meet the quality thresholds.
The issues, thresholds and remedial actions presented in this paper are by no means comprehensive
and there are likely to be more issues that can impact EHR data quality when used for research purposes.
These EHR data quality thresholds will not only apply to research in IS, but other disciplines as well, and
produce more reliable results and help in curtailing the reproducibility crisis in the healthcare research
(Collins & Tabak, 2014). Though we focus solely on EHR data in this article, the scope of implications is
much wider, as EHR data is used across industries and research streams. The four issues, thresholds and
remedial actions that we discuss in this paper can apply to a wider variety of observational data for IS
research.
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CHAPTER TWO:
COLLABORATIVE INTELLIGENCE IN HEALTHCARE: A FRAMEWORK FOR
AUGMENTING COMPLEX TASKS WITH PHYSICIAN AND ARTIFICIAL INTELLIGENCE
FUSION

2.1. Abstract
Strategic use of information and development of new information management pipelines play a critical role
in performance of healthcare organizations, however, there is a clear lack of guidelines for modifying these
tasks. In this research, we present a framework for improving performance in complex healthcare tasks. We
first leverage literature on task complexity to identify elements impacting information processing task’s
complexity. Next, we develop an index to help estimate impact of an intervention (human or AI driven) on
task’s complexity. The goal is to identify intervention(s), before they are developed or employed, that have
the greatest impact on reducing task complexity and thus, can have the greatest chance of increasing
performance. Using the help of two healthcare professionals and a unique EHR dataset, we show that the
framework can help identify the best interventions for improving performance. Additionally, we find that
using interventions based on advanced AI don’t always increase performance, iterative interventions
increase performance, however, the interventions with greatest decrease in task complexity have greatest
impact on increasing performance and use of both human and AI interventions may reduce the amount of
interventions required, thereby reducing human-expert’s involvement. We also discuss theoretical and
practical contributions of the research.
2.2. Introduction
In healthcare organizations (HCOs), the IT management capabilities (information management capabilities,
process management capabilities) and the human capital (i.e. physician’s intellect, autonomy, expertise and
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domain knowledge) play critical roles in patient outcomes, HCOs performance, and in maintaining
competitive advantage (Braithwaite et al. 2009; Karahanna et al. 2019; Lawler et al. 2011; Mithas et al.
2011; Sittig and Singh 2015). Research suggests that a firm’s information management capabilities, such
as the ability to develop appropriate information management processes for the purpose of providing
accurate, dependable and timely information to key stakeholders, is of great importance when it comes to
its downstream impacts on firm performance (Marchand et al. 2000; Mithas et al. 2011). Additionally, the
know-how to maintain, develop and experiment with ITs to improve business and clinical processes and to
integrate new technologies into existing processes are critical components that impact HCOs digital
advantage (Karahanna et al. 2019; Paré and Trudel 2007). Therefore, strategic use and exploitation of
information is key in increasing firm performance and maintaining competitive advantage.
However, healthcare delivery is a challenging and complex task which involves the routine
interaction of patients, physicians and the healthcare IT ecosystem translating to challenges in development
of appropriate information management pipelines that provide accurate, reliable and timely information.
With the recent advent, advancement and proliferation of research in Artificial Intelligence (AIs), the
healthcare industry has seen a steady increase in the development of algorithms for diagnosis, prescription,
drug surveillance, readmission prediction and disease prevention tasks among others (Castaneda et al. 2015;
Connolly and Magowan 2018; Fraccaro et al. 2015; Garg et al. 2005; Samuel et al. 2017; Sim et al. 2017).
While there have been advancements in the development of AI based systems, it has not translated into
such systems being actively deployed in clinical practices (Panch et al. 2018). One of the reasons for the
low adoption of AI based systems in HCOs is the lack of context and structure on how and where to modify
existing information processes8. Another reason is that the complexity of certain tasks can make it very
challenging for AI dominant or human dominant processes to provide accurate, reliable and timely
information on their own.

8

https://www.mckinsey.com/featured-insights/artificial-intelligence/ai-adoption-advances-but-foundational-barriersremain

21

In clinical settings, a physician’s incapacity to handle task complexities such as analyzing large
feature spaces, large numbers of records and time pressure create an opening for AIs. This which can
alleviate the impacts of such complexities on humans by performing tasks that are cognitively demanding,
time consuming, repetitive and structured. The performance of these AI based systems has been slowly
increasing, reaching near human level performance on a few tasks such as malignant tumor detection and
prediction using clinical images such as x-ray images (Bahadure et al. 2017; Cheng et al. 2016; Pereira et
al. 2016). However, AIs are not suitable to perform all tasks that humans can face problems in performing
effectively and efficiently as AIs are also susceptible to the impacts of task complexities. Even tasks that
are prime candidates to be performed by supervised machine learning methods can pose difficulties such
as NP-hard problems, causality, interpretability and small to no training samples (Brynjolfsson and Mitchell
2017; Holzinger et al. 2017).
In this research, we propose a framework that will help develop and modify existing information
processes in HCOs with the goal of increasing performance on tasks that neither humans nor AIs are
currently efficient at performing. The framework draws literature on task complexity to decompose an
information processing task into subprocesses and explores the key elements that impact a task’s
complexity and, in turn, performance on the task. The framework provides guidance on what
modification(s) (interventions) in the system might help in the reduction of task complexity and also
improve performance. Specifically, we built a framework for developing collaborative processes involving
humans and AIs for increasing performance in tasks where AIs or humans don’t perform well on their own.
The framework, which is grounded in task complexity literature, will help guide organizations to build
more effective solutions to problems and tasks which can help in deciding the tasks and subtasks where
human interventions or domination is necessary. It will also help in tasks and subtasks where AI domination
can yield better performance. The framework will help organizations manage humans and AIs in complex
processes, integrate these solutions into its key processes and develop and maintain these information
management processes to maintain competitive advantage (Mithas et al. 2011).
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Using literature on task complexity and task performance stemming from Wood’s (1986) and
Campbell’s (1988) work, we identified a comprehensive list of elements that contribute towards task
complexity in information processing tasks. Each information processing task is broken down into subtasks
and then we map each element of task complexity to these subtasks. The elements that impact the task’s
complexity along with the evaluation of each intervention (modification) in the task, together, describe the
CI framework for increasing task performance on complex information processing tasks by using
appropriate humans and AIs interventions.
We evaluated the framework by applying it to perform a complex information processing task,
namely adverse drug reaction (ADR) detection in EHR databases using a unique EHR dataset spanning 10
years and involving two physicians. We evaluated the framework from multiple angles and answered the
following questions: (a) how useful is the CI framework in evaluating and choosing human and AI
interventions which can produce the greatest increase in performance in complex tasks, (b) what is the role
of using greater number of interventions as compared to using interventions that have the greatest decrease
in task complexity, and (c) what role does using human interventions, AI interventions and a combination
of both play in increasing task performance in AI dominated and human dominated complex tasks.
The evaluations of the CI framework reveal several important insights. First, we find evidence that
the CI framework can help in improving task performance by guiding the choice of interventions to use.
Second, we find that using interventions that cause the greatest decrease in task complexity also have the
greatest impact on increasing the task performance. Additionally, iterative (multiple) interventions also
increase task performance, however, the presence of interventions that cause the greatest decrease in task
complexity still plays a role in the increased performance. Third, using interventions involving more
advanced AIs not always led to an increase in task performance. Fourth, human dominated, and AI
dominated tasks, both benefit from using collaborations of human and AI interventions. Using more
advanced AIs reduce the need for more human interventions in human dominated tasks which reduces
expert’s workload and opens opportunities for researchers to develop more advanced AIs that can further
help reduce the human inputs and open the path to full automata.
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This research makes several important contributions to theory and practice. First, the framework of
collaborative intelligence between humans and machines extends current literature on task complexity and
performance outcomes in complex tasks. The paper develops a framework of collaboration between humans
and AIs that helps in increasing task performance in jobs that are too complex for humans and AIs to
perform on their own. The framework shows how certain elements of task complexity can be tackled by
either humans or AIs to lower the overall complexity of the task and increase performance. Second, this is
one of the first studies to show through evaluations that task performance of physicians can be increased
by collaboration with AIs. Third, the framework provides generalized guidance that practitioners can follow
to develop their own information processing and knowledge extraction processes. Fourth, by using the
framework, we found a clinically significant finding which can be used as a hypothesis to be tested in
clinical trials.
2.3. Background
2.3.1. Task Complexity
In the past three decades, there have been multiple definitions of task complexity and perspectives of
viewing it. Liu and Li (2012) categorized them into three perspectives, namely, structuralist, resource and
interaction perspectives. From the structuralist perspective, task complexity is broadly defined as the
construct of how the characteristics of the task impacts the cognitive load on the task performer (Gill and
Murphy 2011). According to the resource perspective, task complexity is defined in terms of the amount of
resources required to perform the task where more complex tasks will require a greater investment of
resources such as cognitive ability, attention, memory and physical resources. In the interaction perspective,
task complexity is not only the characteristics of the task but the combination or interaction of task
characteristics and the task performer. This comprises of not only what is required to perform the task and
the load the task places on the performer but also who is performing the task. Thus, the structuralist and
resource perspectives are concerned objective task complexities while the interaction viewpoint is
concerned with subjective task complexity. Objective task complexities are linked to the task and do not
interact with the task performers characteristics, subjective task complexities are dependent on the
24

interaction of both the task and task performers characteristics where this interaction occurs at all
information processing stages (Bonner 1994; Liu and Li 2012). While the three perspectives reveal the
elements contributing towards task complexities and their impacts when humans are performing tasks,
research has not addressed the impacts of these elements of task complexities on AIs and how humans and
AIs can work together to mitigate these complexities by complementing each other’s strengths.
There have been multiple models of task complexity proposed in literature. Bonner’s (1994) model
is one of the most well widely used models of task complexity. Bonner split the elements of task complexity
into three categories, namely, input, processing and output categories which relate well to most information
processing tasks undertaken in organizations.
The amount of complexity a task suffers from is a fundamental way to discriminate tasks. Tasks
that allow for higher levels of decision latitude and autonomy are regarded being more complex (Kohn and
Schooler 1983). These tasks that are more complex may have multifaceted requirements such as the need
for combining various sources of knowledge together and a more involved thought process to perform the
task (Farr 1990). As the tasks such as making coffee, assembling electronics or recording standard clinical
markers during a patient visit are less complex due to the presence of standard protocols that can be followed
to realize them. On the other hand, tasks such as prescribing medications to patients with comorbidities and
strategic decision making in organizations are particularly complexity as these decisions are plagued by
time constraints, dynamicity, ambiguity, etc. Tasks that are subject to complexities are the focus of this
study and where the CI framework can help practitioners in designing ideal processes using both human
experts and AIs.
2.3.2. Information Management Capabilities and Development of New HITs
Research has found that organizational performance is not only influenced by the management of its IT
infrastructure (which is the foundation) but more so by its information management capabilities (Mithas et
al. 2011). The information management is referring to (a) the processes for extracting accurate, timely and
reliable information which is relevant to users and stakeholders or (b) the modification of the infrastructure
for new business needs; which play an important role in the firm’s ability to modify and build their
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organizational capabilities and influencing firm’s performance. To gain advantage, organizations must
advance their information processing capabilities and focus on the utilization of information (Cotteleer and
Bendoly 2006; Davenport and Linder 1994; Davenport and Prusak 1998; Mithas et al. 2011).
Further, an HCOs cultural capital which includes the knowledge resources and capabilities for the
development of new health information technologies (HITs), modifications to existing HITs and how the
HITs can help the HCO in its clinical and business processes (Karahanna et al. 2019). Research has shown
that an HCOs cultural capital can help overcome its organizational knowledge barriers which reflect the
integration of new HITs in existing clinical and business processes and redesigning of existing processes,
and its technological knowledge barriers that reflect the knowledge resources for selection of appropriate
HITs (Karahanna et al. 2019; Paré and Trudel 2007).
2.4. Collaborative Intelligence Framework
This section presents and describes the collaborative intelligence framework. First, we discuss the
framework context. Second, the collaborative intelligence framework is described, which comprises of two
phases: framework building and framework operationalization. In the framework building phase, we first
draw literature on task complexity and task performance to identify the elements of task complexity that
can impact human-experts and AIs (Table 2.1). Next, we describe the process of assessing the impact of
human-expert and AI interventions on the identified elements of task complexity.
In the framework operationalization phase, we illustrate the deployment of the framework for
increasing performance in complex information processing tasks. We show an instantiation of the
framework to a complex information processing task that is commonplace in healthcare research and HCOs.
This instantiation elucidates how the deployment of the framework will take place and how the framework
can reduce (or eliminate) the current problems in the processes.
2.4.1. Framework Context
The CI framework focuses on improving information management and processing tasks undertaken in
HCOs. The CI framework helps in improving the performance in information management and processing
tasks in HCOs. These tasks are not performed by humans, AIs or a combination of both at an acceptable
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level of performance. Such complex tasks are commonplace in medicine and involve problems such as
adverse drug reaction (ADR) detection, drug-drug interaction detection, rare disease treatment and
detection, drug development and drug effectiveness evaluations. There are several elements that make these
tasks complex for humans and AIs. Elements such as rarity in labeled data, very high dimensional data,
assessing causality from the results and even the number of components in the process increases the
complexity of such tasks. The CI framework focuses on the impacts of task complexity on a process and
leverages previous literature on task complexity in order to provide a guideline for assessing the impacts of
changes and modifications in process on the complexity of the task and, in turn, the performance.
The framework uses Bonner’s (1994) model of task complexity and divides the information
management and processing tasks into three phases: (1) data collection and pre-processing phase, (2)
information processing, pattern recognition and information extraction phase and (3) knowledge and
insights extraction phase. These three phases also relate very well to most tasks in HCOs that involve the
use of AIs.
The CI framework involves human-experts and AIs complementing each other’s strengths in
mitigating elements of task complexity when performing complex tasks. Here, human-experts denote
humans with expertise in a particular job, trade or profession, where they use their experiences, training,
expertise and domain knowledge to perform tasks that other humans might find challenging. AI is a loose
term which is commonly used to denote machine learning and data mining algorithms. AIs in the CI
framework denote algorithms and techniques from supervised, unsupervised and reinforcement machine
learning domains which also include statistical techniques. Here, the algorithms and techniques can differ
from each other in terms of the tasks they can be applied to (prediction, clustering, search and retrieval,
NLP, anomaly detection, etc.) and in terms of their efficiency and predictive power.
Thus, the focus of the CI framework will be to solve: (1) information processing tasks (2) that are
substantially complex, (3) which cannot be fully automated with AI with reliable and accurate results and
(4) cannot be fully performed by human experts with speed and reliability. For example, among many tasks
that physicians perform in healthcare organizations, treating ailments by prescribing proper medications is
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one of the primary tasks, both in an outpatient and inpatient setting. This is a complex task because of the
intersection of the rising number of patient cases with comorbidities, multiple medications to treat them
and introduction of new medications only having been tested in small scale clinical trials. This complex
task creates a multitude of problems of which the most concerning are ADRs which are extremely common
place in healthcare and yet also preventable. While attempts have been made at automating most of this
type of information processing task, the entire task cannot be fully automated.
2.4.2. Framework Development
The elements that impact task complexity play a central role in the CI framework. We argue that the
performance on complex tasks can be improved by reducing the negative impacts of elements of task
complexity by systematically augmenting complex tasks with human-expert or AI interventions. Here,
interventions refer to the augmentations made to a task by introducing new modifications to the current
process with the goal of improving performance.
The interventions can be performed by humans in terms of enhancing the process with their domain
knowledge, experience, expertise or abilities. The interventions can also be performed by AIs by modifying
or introducing new methods or algorithms in the process. All interventions are designed with the goal of
improving task performance, however, not all interventions will impact the elements of task complexity
equally. Interventions can reduce, increase or even have no impact (in totality) on the task complexity of a
task. In the CI framework, the interventions are chosen based on the impact of these elements of task
complexities on human experts and AIs. As the tasks or processes that can be modified using the CI
framework include subprocesses which are either AI dominated (computation, processing, etc.) or human
dominated (knowledge extraction, data cleaning, etc.), the entire task or process can be a collaboration of
humans and AIs performing multiple subtasks or processes.
The CI framework aims at modifying the collaboration between humans and AIs in complex tasks
and processes to increase performance by introducing interventions through systematic augmentations.
Thus, systematic augmentation refers to the precise allocation of human or AI interventions which would
yield the greatest decrease in the elements of task complexity and thus positively impacting task
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performance. In systematically augmented tasks using the CI framework, AIs or human-experts are chosen
to intervene in particular subtasks or subprocesses in order to mitigate the elements contributing towards
task complexity impacting the task.
In the next two sections, we first identify the elements of task complexity that impact information
management and processing tasks. Then, we develop a method of gauging the impacts of human-experts’
and/or AI interventions (collaboration configurations) on the elements of task complexity to help in
deciding which interventions and/or mediations are best for systematic augmentation.
2.4.2.1. Framework Development I: Identifying the Elements of Task Complexity and Their
Impacts on Task Performance
While both human-experts and AIs are susceptible to certain elements impacting task complexity, these
elements can contrast between them. There is a great potential for human-experts and AIs to complement
each other for overall reduction of task complexity. We note that the elements of task complexity that have
been described in this research have been used and discussed in previous literature, however, there is no
research that has segmented them to the three phases of complex tasks and evaluated the impact of each
element of task complexity on both human-experts and AIs. We emphasize the importance of evaluating
the impacts of these elements of task complexities on both humans and AIs as literature has already started
to assess and contend a variety of computational agents against humans and the distinction between human
and AIs will become weaker in the coming years in terms of performing tasks. Thus, evaluating the impacts
of the elements of task complexity on AIs which has traditionally been only reserved for human task
performers is very important.
Table 2.1 provides a comprehensive overview and descriptions of the elements of task complexity
that have been investigated in previous literature. We investigate these elements in the CI framework and
how they can influence the performance for human-experts vs. AIs. Based on the task or the process that is
built using the CI framework, a subset of the task complexity elements described in Table 2.1 can be
applicable. For example, a process which uses EHR access logs data for abnormal EHR records access
detection (Zhang et al. 2013) may not focus on the data quality element of task complexity as the EHR
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access logs data is fairly regular and available in standard format. On the other hand, detection of adverse
drug reaction (ADR) signals using social media (twitter, etc.) and EHR outpatient and billing data will be
impacted by the data quality element of task complexity (Jetley and Zhang 2019).
While the elements of task complexity in Table 2.1 may have a negative or positive impact on the
task performance, the level of impact on performance will vary depending if a human or an AI is involved
in the process. For example, if a task is suffering from high computational complexity, the impact on the
task performance will be high and negative if a human is being asked to process the information rather than
an AI. As the impact of computational complexity on AIs will be dependent on the type of AI (for some,
the impact is high and for others, the impact is low), the expectation will be medium. Thus, the element of
task complexity will have a negative impact on task performance and will be high when a human is highly
involved in the process and medium on AIs in expectation. Thus Table 2.1 also presents the impacts of the
elements of task complexity on performance depending on the involvement of human or AI in the process.
Apart from some exceptions, most of the literature on task complexity has focused on the elements impact
on performance of tasks performed by humans, however, by using logical reasoning, we extend these to
their impacts on tasks performed by AIs. These impacts on task performance will be leveraged in the next
section where we gauge the impact of the changes made to a process by introducing human-expert and AI
interventions on the overall task complexity.
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Table 2.1: Elements of Task Complexity Impacting Information Processing Tasks

Subtask Type

Elements of Task
Complexity and Task
Difficulty

Description

References

Input information diversity has been identified as a
fundamental element task complexity. It is the number of
dissimilar elements in the data such as numerical, textual,
coding schemes, etc. The task complexity will increase as
the diversity and heterogeneity in data elements to be
pre-processed increases. This element can result in
problems of data integration and data fusion.

(Driver and Streufert 1969; Gardner
1990; Ham et al. 2011; Holzinger
2014b; Liu and Li 2012; Schroder
et al. 1967; Schwab and Cummings
1976; Shameer et al. 2018; Smith
and Buchholz 1991; Wickens et al.
2015)

Phase 1:
Data Collection
& PreProcessing

Heterogeneity of data ;
Diversity of input

Phase 1:
Data Collection
& PreProcessing

Uncertainty of the data
quality ; Inaccurate data
; Inconsistent data ;
Missing data ;
Incomplete data ; False
data ; Mismatch;
Compatibility

Data quality issues such as inaccuracy and unreliability
can result in increase in uncertainty of outputs derived
from downstream processes. To resolve these issues,
more complex actions need to be taken in the preprocessing and integration phases which lead to increase
in the task complexity. This complexity element is
particularly difficult for AIs as automated solutions fail
or are difficult to design due to incompleteness of
ontologies.

(Bonner 1994; Greitzer 2005;
Holzinger 2014b; Jetley and Zhang
2019; Liu and Li 2012; O'Donnell
and Johnson 2001; Steinmann 1976;
Wickens 1991; Wood 1986; Zhao
1994)

Change over time ; Rate
of Change

Rate of change is another fundamental element of task
complexity. A task with fluctuations in the rate of
information arrival will require task performer to adapt to
and track the new information which will make the task
performer expend additional attention and thus increase
the complexity of the task.

(Campbell 1988; Driver and
Streufert 1969; Holzinger 2014b;
Huntley 1972; Li and Wieringa
2000; Liu and Li 2012; Schroder et
al. 1967)

Phase 1:
Data Collection
& PreProcessing
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Impact if
Human is
Involved in
Process

Impact if AI
is Involved
in Process

Low –
Negative

High –
Negative

Medium –
Negative

High –
Negative

High –
Negative

Medium –
Negative

Table 2.1 (Continued)
Feature dimensions ;
Pattern recognition in
>3 dimensions ; Feature
selection

Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Large number
of
observations

Input Quantity ; Number of Observations

Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Rare Events ;
Training
Examples
Constraints

The number of dimensions of data relevant to an
information processing task or the number of pertinent
elements for arriving to a solution in complex problem
are elements that impact task complexity. These elements
of task complexity can cause scaling and mapping
problems in IAs. However, these elements have a higher
negative impact on human’s ability to recognize patterns
as the dimensions become greater than 3. This
complexity elements makes manual analysis of clinical
data near impossible as most biomedical data is present
in very high dimensions. Information overload is an
outcome of these elements which increases task
complexity.
Number of observations and elements is a fundamental
element of task complexity. Its impact on task
performance is inverted-U shaped. Too much information
(elements) may lead to increased attention and mental
requirements leading problems of information overload
in humans. This would also lead to increased
computation and processing time in AIs. However, this
element would impact humans more than machines and
the optimal point in the inverted-U would be shifted
towards "more observations" for AI than humanexperts.Too little information (elements) may not be
enough for task performer (human or AI) to effectively
recognize patterns and make effective decisions.
However, humans are good at learning from few
examples and AIs fail at such tasks as they require a large
number of training examples to detect patterns.
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(Akil et al. 2011; Baccarini 1996;
Berghel 1997; Bonner 1994;
Campbell 1988; Dugas et al. 2002;
Funke 2010; Holzinger 2012;
Holzinger 2014a; Holzinger 2014b;
Holzinger et al. 2007; Holzinger
and Jurisica 2014; Holzinger et al.
2017; Holzinger et al. 2011; Liu and
Li 2012; Noone et al. 1998; Rouse
and Rouse 1979; Shameer et al.
2018; Simnett 1996; Wickens et al.
2015; Williams 1999; Wood 1986)
(Baccarini 1996; Bonner 1994;
Driver and Streufert 1969;
Holzinger et al. 2017; Liu and Li
2012; Rouse and Rouse 1979;
Simnett 1996; Williams 1999;
Wood 1986)

High –
Negative

Low –
Negative

High –
Negative

Medium –
Negative

Low –
Negative

High –
Negative

Table 2.1 (Continued)
Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Computational
Complexity ; Problem
Size

This element of task complexity is closely related to
input quantity and feature dimensions. This element of
task complexity has been used for assessment of software
complexity and is defined in terms of the minimum
theoretical size of the problem space. Many types of AIs
are not good at dealing with exponential search spaces
and NP-hard/complete problems. This increases
computation time for arriving to an optimum solution and
increases task complexity.

(Bennett et al. 1993; Gill and Hicks
2006; Holzinger et al. 2017;
Papadimitriou 2003)

Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Lack of Contextual
Information ; Creativity
; Unstructured Problem
Solving ; Ambiguity;
clarity; specification;
structuredness ; unrepetitiveness

Unstructured problem solving is an element of task
complexity that influences the judgement and cognitive
effort required by the task performer. AIs in general
cannot perform tasks without set structure and contextual
information. Without a a-priori rules and steps, AIs face
problems in completing tasks due to lack of "creativity".
Humans on the other hand deal with "creative" problems
on a regular basis but are still impacted by this element of
task complexity.

(Abdolmohammadi and Wright
1987; Bonner 1994; Braarud and
Kirwan 2010; Bui and Sivasankaran
1990; Byström and Järvelin 1995;
De Koning et al. 2008; Harvey and
Koubek 1998; Harvey and Koubek
2000; Holzinger et al. 2017;
Jonassen 2000; Lazzara et al. 2010;
Liu and Li 2012; Mascha and Miller
2010; McDaniel 1990; Nadkarni
and Gupta 2007)

Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Component Complexity
; Number of acts ;
Number of metaoperations ; Number of
procedures ; Number of
sub-tasks

Component complexity is one of the fundamental
elements contributing towards complexity. This element
refers to the non-redundant, non-repeating acts or
procedures that are needed to be performed in a process
or task. Here, the distinct steps in the information
processing add to task complexity.

(Campbell 1988; Darisipudi 2006;
Endsley 2003; Harvey and Koubek
1998; Liu and Li 2012; Speier
2006; Wood 1986; Xu et al. 2009;
Xu et al. 2008; Zhang et al. 2009;
Zhao 1994)
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High –
Negative

Medium –
Negative

Medium –
Negative

High –
Negative

High –
Negative

Low –
Negative

Table 2.1 (Continued)
Phase 2:
Information
processing,
Pattern
Recognition &
Information
Extraction

Coordinative
Complexity ; Number of
solutions ; Number of
paths ; Number of pathgoal connections ;
Number of path-goal
multiplicity

The Coordination (or the lack of) needed between
processes and subtasks that make up the component
complexity has been established as another fundamental
element of task complexity where the complexity
increases as the amount of coordination needed between
acts increases. A longer the sequence of coordination and
dependence relates to higher complexity.

(Bonner 1994; Campbell 1988;
Harvey and Koubek 1998; Harvey
and Koubek 2000; Lazzara et al.
2010; Liu and Li 2012; Wood 1986)

Phase 3:
Knowledge and
Insights
Extraction

Expandability of
Results ; Interpretability
; Causality

In information processing tasks that are heavily regulated
and have legal and privacy aspects (new European
General Data Protection Regulations (GDPR)), there is
an inherent need for the results from the information
processing phase to be converted to knowledge via a
transparent process. This need for transparency in how
the processed information was converted into
knowledge/insight exerts higher cognitive demand on the
task performer than for tasks that don't require causal
statements. Humans are generally great at unstructured
and creative problem solving such as a diagnosis without
being able to exactly explain how they arrived at the
results. This problem is exuberated in AIs as more
complex algorithms (involving multiple interactions and
non-linearity) generally give better results and more
parsimonious algorithms (linear) give more interpretable
yet less accurate results.

(Holzinger et al. 2017; Liu and Li
2012; Pich et al. 2002)
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High –
Negative

Low –
Negative

Medium –
Negative

High –
Negative

Table 2.1 (Continued)
Phase 3:
Knowledge and
Insights
Extraction

Uncertainty /
Inaccuracy of Results

The degree of uncertainty is an element of task
complexity which refers to the confidence in the results
acquired/retrieved/supplied. Higher unpredictability or
confidence in the results leads to greater amount of task
complexity for knowledge extraction. Here, humanexperts can perform well in tasks where the output has a
great deal of uncertainty attached to it by using their
domain knowledge and experience. Algorithms, lacking
domain knowledge, experience and most of the times,
additional sources of information don't perform well if
the output has a great deal of uncertainty / variance
attached to certain learned patterns in the processing
phase.

(Bui and Sivasankaran 1990;
Byström 1999; Byström and
Järvelin 1995; Campbell 1988; Daft
and Macintosh 1981; Hackman and
McGrath 1970; Harvey and Koubek
1998; Harvey and Koubek 2000;
Simnett and Trotman 1989; Wood
1986)

(Braarud and Kirwan 2010;
Cummings et al. 2010; Hendy et al.
1997; Liu and Li 2012; Molloy and
Parasuraman 1996; Xiao et al.
1996)
(Bonner 1994; Campbell 1988;
Harvey and Koubek 1998; Harvey
and Koubek 2000; Lazzara et al.
2010; Liu and Li 2012; Payne 1976)

Phase 3:
Knowledge and
Insights
Extraction

Time Pressure ;
Throughput ;
Simultaneity ;
Concurrency

Time pressure and concurrency are elements that impact
task complexity by creating challenges such as
coordination in execution of subtasks and information
load.

Phase 3:
Knowledge and
Insights
Extraction

Number of Alternative
Solutions ; Redundancy
of Solutions ; Quantity
of Solution Paths

Number of solutions and redundancy of solution paths is
an element of task complexity where a lower number of
current solutions or paths to a solution increases the
complexity of the task. As the number of paths increases,
the task complexity reduces due to redundant paths. The
solutions or paths can be viewed as the characteristic of
the outputs.
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Medium –
Negative

High –
Negative

High –
Negative

Low –
Negative

Medium –
Positive

Medium –
Positive

2.4.2.2. Framework Development II: Assessing Impacts of Human and AI Collaboration
Configurations on Elements of Task Complexity
In this section, we describe human-expert and AI interventions, and how they impact the elements of task
complexity in a process. We also define a score to gauge the amount of task complexity that is added or
reduced due to using different interventions, thereby modifying the human and AI collaborations in a
process.
A human-expert’s intervention can be as simple as a one-time intervention or more involved such
as continued interventions in a process in an iterative fashion. A one-time intervention will involve
proposed changes by experts to the current process based on the expert’s domain knowledge. For example,
a human-expert can be involved in feature building and feature selection in Phase 1 (data preprocessing) of
an information processing task. The expert would have substantial knowledge about the entire task so as to
make valuable contributions in building and selecting features with which the downstream processes will
better work with. Such an intervention will be ideal for cases where the human-experts time is valuable and
a rare resource (i.e. healthcare professionals). A more involved intervention will involve a human expert
interacting with the process in an iterative fashion where the interaction will stop based on some decision
rules or continue indefinitely. For example, an expert in a specific disease or condition can be routinely
consulted to check the accuracy of an ADR detection model for classifying a drug-disease pair as ADRs
for non-ADR. Such an intervention will, however, require substantial time investment by the healthcareexpert in the process over several iterations. An AI intervention can be the employment of different types
of algorithms and modifications of the algorithms in a process. Here, an algorithm can replace a previous
algorithm/human for performing specific subtasks in the process or be used to provide extra functionality
by being employed between subtasks already present.
Due to different types of interventions, their impacts on the elements of task complexity can also
be different. For example, the human-expert intervention of feature building or feature selection will impact
the elements of task complexity in Phase 2 (Uncertainty of Results, Component Complexity, Computational
Complexity) and in Phase 3 (Interpretability), while the human intervention on noise reduction will impact
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the elements of task complexity in Phase 1 (Inaccurate Data), Phase 2 (Input Quantity, Computational
Complexity, Component Complexity) and Phase 3 (Uncertainty of Results). Further, there may be a single
or a combination of different human-expert or AI interventions that may be applied to a process for the goal
of gains in performance. We define a particular set of human-expert and AI interventions out of all potential
interventions as a collaboration configuration.
As making modifications to a process can be a challenging task with different interventions making
different amounts of impact on the performance of the task, it is critical to know what the potential of an
intervention will be for increasing the performance of a task by reducing the elements of task complexities.
The CI framework uses a metric, inspired from previous literature on task complexity, to gauge the impact
of an intervention on the elements of task complexity. Previous research on task complexity has shown that
the reduction in complexity increases task performance. As complexity is something that cannot be
objectively measured, we use a simple index of total positive or negative impacts on the elements of task
complexity, which is motivated by Wood’s (1986) measures of task complexities. This technique is also
used by Brynjolfsson and Mitchell (2017) in their rubric for determining if a task is fit for AI to perform.
Particularly, we define the Complexity Reduction Composite (CRC) Score for each collaboration
configuration as:

𝐶𝑜𝑚𝑝𝑙𝑒𝑥𝑖𝑡𝑦 𝑅𝑒𝑑𝑢𝑐𝑡𝑖𝑜𝑛 𝐶𝑜𝑚𝑝𝑜𝑠𝑖𝑡𝑒 (𝐶𝑅𝐶) 𝑆𝑐𝑜𝑟𝑒 = ∑ Δ 𝐸𝑜𝑇𝐶𝑖
𝑖

Where Δ 𝐸𝑜𝑇𝐶𝑖 is the impact of the human expert intervention or AI mediation on the ith element
of task complexity. Here, if the intervention or mediation has a positive impact on (reduces) the ith element
of task complexity, Δ 𝐸𝑜𝑇𝐶𝑖 = −1. If the intervention or mediation has a negative impact on (increases)
the ith element of task complexity, Δ 𝐸𝑜𝑇𝐶𝑖 = +1. Lastly, if the intervention or mediation has no impact
on the ith element of task complexity, Δ 𝐸𝑜𝑇𝐶𝑖 = 0. Thus, the CRC score will indicate the total change in
the elements of task complexity and a lower CRC score relates to more elements of task complexity being
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reduced by the collaboration configuration. Even though the CRC score will not indicate amount of increase
or decrease within each element of task complexity, the CRC score described above is satisfactory and
appropriate as the focus of the framework is on manipulating the elements of task complexity to increase
the performance in the task. Using the CRC Score, the impacts of different collaboration configurations on
task complexity can be assessed prior implementation and appropriate processes can be designed.
2.4.3. Operationalizing the Framework
A visual representation of the implementation of the CI framework to modify a process is presented in
Figure 1.1. It illustrates how human-expert and AI interventions can be implemented in different phases of
an information management and processing task. Table 2.1, along with the CRC score, can be used as a
guideline for judging the impact of an intervention on the elements of task complexity.
2.4.3.1. Instantiation of CI Framework to Complex Tasks in HCOs
In this section, we make modifications via human-expert and AI interventions in a complex task/process in
healthcare delivery using the CI framework to decrease the task complexity and increase performance.
Adverse Drug Reaction Detection: In the last decade, EHR systems have become widely used in
healthcare facilities with almost three fourths using at least a basic EHR system (Adler-Milstein et al. 2015).
This adoption of EHR has led to the capture and analysis of massive amounts of health-related data for
millions of patients in a longitudinal format (Murdoch and Detsky 2013). Analysis of EHR records is being
performed to aid in discovering occurrence of ADRs, drug discovery, to study new uses of medications and
for phenotype-genotype associations (Kohane 2011; Xu et al. 2015; Yao et al. 2011). These types of
research are conducted with the help of advanced and specialized computer algorithms that have either been
adopted from other fields or have been specifically designed for the unique research domain.
For this instantiation, we use the task of novel ADR detection, also known as the practice of
Pharmacovigilance9 (PhV). In the area of PhV, studies are conducted to detect ADRs mainly using
spontaneous reporting systems (SRS) in the drug post approval phase but recently studies are being

9

https://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/
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conducted using EHR systems and also non-traditional sources of health information such as microblogs
(Bian et al. 2012). Traditional clinical research can be very expensive and time consuming and has a low
success rate (Wells 1999). PhV on EHR systems can be a cheap and fast way to reduce the costs of clinical
research and can also detect ADRs which would otherwise go unnoticed. It is also a very effective way to
get results which would warrant additional clinical research about the suspect ADRs. For a detailed
overview of some of the state-of-the-art ADR detection algorithms and their pros and cons, please see the
Framework Evaluation section.
Current Limitations of ADR Detection Algorithms: While the Bayesian PhV methods have been shown
to perform better than other methods (Ahmed et al. 2009) they are not immune to complexity and are still
not able to reduce the false discovery rate (FDR) to the point that they can be fully automated. More types
of constraints grounded in domain knowledge are needed to reduce the complexity of the problem in
addition to what the Bayesian methods impose in the data mining process to further reduce the FDR to an
acceptable level. Moreover, due to complexities arising from the problem of data quality in EHR records
such as inconsistencies, missing data and non-standard coding schemes (Jetley and Zhang 2019), these
methods may face automation problems and complexities arising from the problems of data quantity in
smaller EHR systems. More complex methods designed to work on large scale datasets generally fail and
simpler methods have generally poorer performance. We evaluate the CI framework in such a scenario and
evaluate the framework’s impacts on task performance, which is the detection of ADR signals, by reducing
task complexities by human expert interventions in the ADR detection process. We also evaluate the CI
framework where human-experts play a dominating role in the ADR detection process and see the impacts
of using simple to more complex AIs on task performance.
CI Framework Instantiation: Figure 1.1 presents a simple conjectural instantiation of the CI framework
where an existing task of ADR detection is modified. The existing task is to classify known ADRs and to
review potential ADRs that may have occurred in the HCO by using EHR data. The series of actions
represent the current continuous detection of ADRs process in an HCO. In this conjectural instantiation, a
total of two human-expert and AI interventions are evaluated for their positive or negative impacts on the
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elements of task complexity that are impacting the ADR detection process. The goal is to find the
collaboration configuration that will positively impact the greatest number of elements of task complexity
(i.e. lowest CRC Score), leading to the greatest decrease in task complexity and thus increasing the

Phase 1

performance on the task which is to accurately classify drug-disease pairs as an ADR or non-ADR.

Data
Collection

Data
Cleaning

Data
Preprocessi #1 #2
ng

Phase 2

Anomaly
Detection

ADR Signal
Present

#1

ADR Signal
Not Present

Unknown
ADR

Known ADR

Human-Expert Interventions
#1: Coding Scheme
Conversion
#2: Feature Building
AI Mediations
#1: More complex anomaly
detection AI
#2: Relevant Literature
Search and Retrieval

#2

Phase 3

Manual
Review by
HumanExpert

ADR

Non-ADR

Figure 2.1: Redesign of a Typical Adverse Drug Reaction Detection and Surveillance Task using CI
Framework
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2.5. Framework Evaluation
The CI framework is evaluated on a real-world task of ADR detection in EHR databases. The evaluation is
done by employing several types of state-of-the-art AIs for ADR detection, each with their pros and cons.
The AIs are paired with two physicians whose task is to detect ADR signals in an EHR dataset. The signals
can range from previously discovered and verified ADR signals and new and undiscovered ADR signals.
For the detection of previously discovered and verified ADRs in EHR database, the human-expert and AI
interactions are simple and the physician interventions in the ADR detection process are minimal with no
knowledge extraction phase as the ADR signals have already been verified by other experts. For the
detection of previously undiscovered ADR signals, the physician involvement and interventions in the ADR
detection process is higher with a knowledge extraction phase where the detected signals are verified. The
first two evaluations concern the known ADR detection problem and the third evaluation concerns the
unknown ADR detection problem. The expected results are that the human expert interventions, which have
a greater reduction in task complexity of the ADR detection process using the CI framework, will have a
higher task performance. Additionally, the collaboration of more advanced AIs with human experts should
also show a higher task performance as the combination will reduce more elements of task complexities.
2.5.1. Data
The evaluation of the CI framework is performed using a unique EHR dataset from a healthcare facility in
eastern United States which includes 10 years of patient data and an ADR dataset containing drug-disease
pairs. The details on the EHR and ADR datasets are provided below.
2.5.1.1. EHR Dataset
The EHR data used in the evaluation of the CI framework comes from an EHR system that collected
diagnoses, prescriptions and clinical notes on 48,650 patients who visited the healthcare facility between
the years 2004 and 2014. The dataset contained information on drug prescriptions (Rx), history of disease
diagnoses (Dx), patient demographics and clinical notes written by the physicians. The notes contain
unstructured information on medical history, family history and clinical markers such as weight, blood
pressure, etc. along with diagnosis and prescription information. The EHR system in the healthcare facility
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was implemented incrementally which led to some of the data points being better populated than others. If
data under study was absent from a patient record, that patient was not included in the study. At the end,
17,414 patient records were used from the EHR dataset. A summary of the EHR dataset is provided in
Table 2.2.

Table 2.2: Descriptive Statistics for EHR Dataset
Variables
Patients
Diagnosis Codes (UMLS)
Diagnosis Codes (ICD9)
Prescriptions
Drug-Disease Pairs (UMLS) | ICD9CM)
Drug-Disease Pairs (ICD9CM)

N
17,414
1,660
2,124
2,744
110,843
153,789

Mean
NA
3.31
3.77
11.21
47.02
55.32

Std. Dev.
NA
2.29
2.85
9.81
69.85
88.04

Min.
NA
1
1
1
1
1

Max.
NA
21
27
80
1071
1,326

2.5.1.2. Adverse Drug Reactions Dataset
In this study, we use a dataset of drugs and diagnosis codes which have been labeled as ADRs. The first
source is called PharmGKB Offsides dataset (Tatonetti et al. 2012). The dataset contains ADRs and side
effects which are not listed on the drug labels. The dataset is processed from FDA adverse Event Reporting
System called FAERS. The dataset contains 1,332 different medications and 10,097 different diagnosis
codes (in UMLS). We used an external dataset from UMLS Metathesaurus (Aronson 2001) to convert the
UMLS codes to ICD9CM codes which are used in the experiments. There are a total of 438,801 ADRs
listed in the dataset. Each ADR pair is also accompanied by the number of spontaneous reports in FAERS
that are associated with that pair, which is the number of times that ADR has been reported to FDA. As
most spontaneous reports represent noise resulting from confounding, co-prescribing, protopathic bias and
co-morbidities (Zorych et al. 2011), the ADR pairs that have been reported under 200 times to the FDA
were removed from the dataset to reduce such noise. Because the dataset only contains positive ADR
signals, negative ADR signals were created using the drugs and diagnosis that are present in the dataset but
are not labeled as ADRs in accordance with previous studies.
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2.5.2. ADR Detection Algorithms
For the detection of Known ADRs and novel potential ADR signals in the EHR, we use ADR detection
algorithms which are the most widely used methods for ADR detection in literature (Zorych et al. 2011)
and by pharmaceutical manufacturers and regulators. The most frequently used and state-of-the-art
algorithms (based on disproportionality analysis) can be classified into two groups: (a) simple (and
interpretable) algorithms and (b) complex (and black-box) algorithms. The simple ADR detection
algorithms we use in the evaluations are reporting ratios (RR), proportional reporting ratios (PRR) (Evans
et al. 2001; Zorych et al. 2011) and reporting odds ratios (ROR/OR). These algorithms are also used by the
European Medicines Agency - EduraVigilence (Caster et al. 2010). The complex state-of-the-art ADR
detection algorithms we use in the evaluations are empirical Bayesian geometric mean – multi-item gamma
Poisson shrinker (EBGM-GPS) (DuMouchel 1999; Fram et al. 2003; Zorych et al. 2011), and Bayesian
Confidence Propagation Neural Network (BCPNN) (Bate 2007). The EBGM-GPS is utilized by FDA for
their post-approval drug surveillance efforts and we use the same in this research.
The simple and complex algorithms are similar in the sense that they all covert higher dimensional
data in prescriptions and diagnosis into two dimensional contingency tables, and then rank the drug disease
pairs in order of their potential of being an ADR. All these methods have arbitrary thresholds for the
generated signals and the decision rules are not defined. Although all these methods build contingency
tables in the beginning, their strengths in identification of potential signals are from constraining the
selection of signals that are highly ranked (strong ADRs). The techniques used by these methods in ranking
of the different contingency tables is where the algorithms differ from each other.
2.5.2.1. Simple ADR Detection Algorithms
RR, PRR and OR are frequentist methods which use the ratios of patients that were prescribed a drug and
were subsequently diagnosed with a disease against the expected number of such occurrences. The RR,
PRR and OR are each defined as:
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𝑅𝑒𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 (𝑅𝑅) =

𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 |𝐷𝑟𝑢𝑔)
𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠)

𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛𝑎𝑙 𝑅𝑒𝑝𝑜𝑟𝑡𝑖𝑛𝑔 𝑅𝑎𝑡𝑖𝑜 (𝑃𝑅𝑅) =

𝑂𝑑𝑑𝑠 𝑅𝑎𝑡𝑖𝑜 (𝑂𝑅) =

𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝐷𝑟𝑢𝑔)
𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝑁𝑜𝑡𝐷𝑟𝑢𝑔)

𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 |𝐷𝑟𝑢𝑔)⁄𝑃(𝑁𝑜𝑡𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝐷𝑟𝑢𝑔)
𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝑁𝑜𝑡𝐷𝑟𝑢𝑔)⁄𝑃(𝑁𝑜𝑡𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝑁𝑜𝑡𝐷𝑟𝑢𝑔)

Thus, these methods provide a higher score for the medications that have a higher probability of
causing a particular disease than the ones that are probabilistically independent of each other. While these
methods have low computational complexity and are easily implemented, they suffer from problems of
sampling variability (Ahmed et al. 2009; Zorych et al. 2011) which arises from small values of
𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝐷𝑟𝑢𝑔) leading to higher uncertainty about the true measure of association, despite the fact
that the total number of reports are often large.
2.5.2.2. Complex ADR Detection Algorithms
There have been namely two approaches proposed which resolve the issues of sampling variability in RR,
PRR and OR methods. These are also heavily implemented by large pharmaceutical manufacturers and
regulators. These methods take a Bayesian approach to the problem. The EBGM-GPS algorithm employs
large-scale Bayesian shrinkage on the generated contingency tables to shrink the signals generated from
tables with very small values in 𝑃(𝐷𝑖𝑎𝑔𝑛𝑜𝑠𝑖𝑠 | 𝐷𝑟𝑢𝑔) or low number of records in 𝑛𝑖𝑗 (the number of
records with the drug preceding the diagnosis. e.g. 𝑛𝑖𝑗 = 1 𝑜𝑟 2). The shrinkage applied to the signals
generated from tables that larger values of 𝑛𝑖𝑗 (e.g. 𝑛𝑖𝑗 = 50) will see little to no shrinkage, thus
circumventing the problems of sampling variability. The EBGM-GPS algorithm does this by:
The EBGM-GPS algorithm assumes

𝑛𝑖𝑗 |𝜆𝑖𝑗 ~ 𝑷𝒏(𝜆𝑖𝑗 𝐸𝑖𝑗 )
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where 𝑖 is a particular drug and 𝑗 is a particular diagnosis. 𝑷𝒏(. ) is a Poisson distribution and 𝐸𝑖𝑗 is the
expected number of records in 𝑛𝑖𝑗 assuming independence between 𝑖′𝑠 and 𝑗′𝑠. 𝐸𝑖𝑗 thus

𝐸𝑖𝑗 =

𝑛𝑖 ∗ 𝑛𝑗
𝑛𝑅

Where 𝑛𝑅 is the 𝑛𝑖𝑗 ’s that are not equal to the total number of records. The main goal is to estimate
𝜆𝑖𝑗 which is assumed to arise from a mixture distribution of two Gamma distributions:

̂ 𝑮𝒂(𝛼
𝜆𝑖𝑗 ~ 𝑤
̂ 𝑮𝒂(𝛼
̂1 , 𝛽̂1 ) + (1 − 𝑤)
̂2 , 𝛽̂2 )

Where the five hyperparameters

̂1 , 𝛼
̂
̂ = (𝑤
𝜽
̂ ,𝛼
̂1 , 𝛽
̂,
2 𝛽3 )

are derived by an empirical Bayes approach. The summary statistics that are reported are the Empirical
Bayes Geometric Mean (EBGM) and the fifth percentile of the posterior distribution (EB05) (Ahmed et al.
2009; DuMouchel 1999).
As noted in the Framework Operationalization section, even the state-of-the-art ADR detection algorithms
are not immune to complexity and are still not able to reduce the false discovery rate (FDR) to the point
that they can be fully automated. More types of constraints grounded in domain knowledge are needed to
reduce the complexity of the problem in addition to what the Bayesian methods impose in the data mining
process to further reduce the FDR to an acceptable level.
2.5.3. Evaluation Methodology and Results
We evaluate the CI framework by using three evaluation designs, each testing the efficacy of the CI
framework from different perspectives. In Evaluation 1, we study if the CI framework can increase the
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accuracy of detection of previously identified (known) ADRs in an EHR database by combining different
human-expert and AI interventions to decrease the overall task complexity. Additionally, we study if a
higher reduction in complexity by intervention(s) provide any added advantage over other intervention(s).
In Evaluation 2, we study the same scenario as Evaluation 1, however, we examine the impact of
intervention(s) when the task is impacted by exogenous increase in task complexity. This scenario mimics
a real-world scenario where the task complexity can increase through time. In Evaluation 3, we study the
impact of reduction in task complexities through interventions on an unstructured task of detection of novel
ADRs in an EHR database.
2.5.3.1. Evaluation 1: Performance on Detection of Known ADR Signals
In this evaluation, we study if the CI framework can improve current ADR detection methods ability to
detect known ADRs inside EHR databases in a drug surveillance setting. The task is an AI dominated task
where the bulk of the work is done by an algorithm and humans play a supporting role. Using the
framework, we first evaluate the contribution of each intervention by human-expert on task complexity and
then we study the impacts of different intervention combinations on the performance of the task. On the AI
side, we use simple and state-of-the-art ADR detection methods which are commonly used for ADR
detection. We employ human interventions recommended by physicians (using their domain knowledge)
for the purpose of improving the ADR detection rate.
Interventions and Impacts on Elements of Task Complexity: As part of the human expert interventions
in the framework, we limit the scope of this evaluation to simple interventions in order to accurately gauge
the changes in task performance by human-expert (physician) recommended interventions impacting the
elements of task complexities at different phases of the ADR detection process. The interventions
considered in this evaluation and the elements of task complexity they impact are presented in Table 2.3
which also reports the CRC scores for each of the three interventions made the physicians. While all the
interventions are theoretically designed to help increase the detection of known ADR signals, we can
observe that only one of the human-expert intervention results in an overall reduction in the elements of
task complexity. The evaluation will combine the human-expert’s interventions in the evaluated framework
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designs ranging from a single intervention to all the interventions combined. For the AI interventions, we
use four different types of AIs ranging from simple to state-of-the-art ADR detection methods used in
literature and the healthcare industry.

Table 2.3: Human-Expert Interventions in Evaluation 1
Human-Expert’s
Interventions

Description

Impacts on Elements of Task Complexity

CRC Score

Thresholds for
Observations
(T)

Thresholds for Drug-Diagnosis Pairs:
•
Minimum Rx → Dx = 1, 5, 10

Phase 1:
•
Inaccurate Data – Reduced
Phase 2:
•
Input Quantity – Reduced
•
Computational Complexity – Reduced
•
Component Complexity – Increased

Phase 1:
•
-1
Phase 2:
•
-1
CRC Score:
•
-2

Controlling for
Toxicity
(C)

Stratification:
•
Toxicity of the prescriptions which
is the number of prescriptions
before the disease is diagnosed.

Phase 2:
•
Computational Complexity – Increased
•
Component Complexity – Increased

Human Expert
Recommendation
(ER)

Diagnosis Coding Scheme
Conversion:
•
UMLS CUI IDs → ICD9CM (1 to
M mappings)

Phase 1:
•
Inaccurate Data – Increased
Phase 2:
•
Component Complexity – Increased

Phase 2:
•
+2
CRC Score:
•
+2
Phase 1:
•
+1
Phase 2:
•
+1
CRC Score:
•
+2

Measure of Task Performance: The performance of the above human-expert and AI interventions is
gauged by the detection rate of the known ADR signals using the receiver operating characteristic (ROC)
area under the curve (AUC). The PharmGKB ADR dataset provides the case ADR signals, however, there
is an absence of control ADR signals. To obtain the control ADR signals, we adopt a strategy used in
previous research and mark random drug disease pairs as controls. While this is not an optimum technique
because of the non-comprehensive nature of these datasets that can potentially introduce controls which are
cases, the technique will allow for testing the efficacy of the CI framework for mass detection of ADRs in
an EHR dataset.

47

Table 2.4 ADR Detection Accuracies
Human-Expert
Intervention
Baseline

C

T

ER

T+C

C + ER

T + ER

T + C + ER

CRC Score (Human-Expert
Intervention)
NA
NA
NA
NA
+2
+2
+2
+2
-2
-2
-2
-2
+2
+2
+2
+2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
+2 ; +2
+2 ; +2
+2 ; +2
+2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2

AI Intervention
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)

AUC
0.58
0.58
0.57
0.53
0.63
0.62
0.59
0.53
0.6 ; 0.64 ; 0.67
0.6 ; 0.65 ; 0.69
0.6 ; 0.64 ; 0.68
0.56 ; 0.62 ; 0.67
0.57
0.57
0.55
0.51
0.67 ; 0.76 ; 0.84
0.67 ; 0.76 ; 0.85
0.66 ; 0.74 ; 0.83
0.6 ; 0.69 ; 0.83
0.62
0.62
0.58
0.52
0.61 ; 0.62 ; 0.64
0.6 ; 0.61 ; 0.64
0.59 ; 0.61 ; 0.63
0.56 ; 0.58 ; 0.6
0.72 ; 0.72 ; 0.9
0.71 ; 0.72 ; 0.9
0.68 ; 0.7 ; 0.9
0.59 ; 0.66 ; 0.9

Results: The results from Evaluation 1 are reported in Table 2.4. The rows represent the human-expert
interventions defined and presented in Table 2.3. The baseline represents the current methodology used for
mass drug surveillance and ADR detection in the industry. We can see that in general, all humaninterventions being tested perform better than the baseline which is no human-expert intervention. We can
also see that the performance increases as the amount of human-expert interventions also increases.
Interestingly, we observe that the highest performing models all have the (T) intervention in them. On
average, the presence of (T) intervention increased the AUC of highest performing ADR detection model
by 19% (p < 0.05). We also see that combining interventions together also increases task performance,
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however, the increase in performance is dependent on (a) the number of interventions and (b) the presence
of (T) intervention.
2.5.3.2. Evaluation 2: Impacts of Exogenous Increase in Complexity
In this evaluation, we study the impact of human-expert and AI interventions in processes where the task
complexity is increasing exogenous to the interventions. This evaluation is conducted to further explore the
results from Evaluation 1. Such a scenario is commonplace in HCOs where the data size is continuously
growing over time which is exogenous to the interventions. As EHR databases are longitudinal in nature
and accumulate information on patients visiting the facility over several years, we will test the interventions
from Evaluation 1 over three timeframes, each representing an increasing number of observations, patients,
diagnosis codes and prescriptions. This evaluation will show if the use of more advanced AI is helpful in
situations where the complexity is higher due to having more data to process or the model fit is better
because of the type of contingency tables generated as a result of the data and the ADR signals.
Results: The results of Evaluation 2 are presented in Table 2.5. On observing the performance of
interventions as t increases, we see a steady drop in performance in most models and interventions. The
increase in complexity as a result of having additional data to analyze (as t increases) reduces the task
performance for most interventions. Furthermore, we see similar results as in Evaluation 1 for the use of
intervention (T) and the increase in human expert’s interventions resulting in increased task performance.
Figure 2.2 presents the AUCs from Table 2.5 averaged over different human-expert interventions. In Figure
2.2, we can clearly see that the AUCs for AI interventions involving more advanced AI (EBGM-GPS and
EBGM-GPS (0.05)) are less susceptible to exogenous increases in complexity (increases in t) and are in
fact more stable than the AUCs for AI interventions involving simple AI (RR and PRR). However, their
performance is still lower than that of simple AI.
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Table 2.5: Known ADR Detection Accuracies with Increasing Complexity

Human-Expert
Intervention

Baseline

C

T

ER

T+C

C + ER

T + ER

T + C + ER

AI Mediation

CRC Score
(Human-Expert
Intervention)

AUC (t = 8)

AUC (t = 9)

AUC (t = 10)

RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)
RR
PRR
EBGM-GPS
EBGM-GPS (0.05)

NA
NA
NA
NA
+2
+2
+2
+2
-2
-2
-2
-2
+2
+2
+2
+2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
+2 ; +2
+2 ; +2
+2 ; +2
+2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2
-2 ; +2 ; +2

0.62
0.62
0.6
0.55
0.73
0.73
0.64
0.53
0.63 ; 0.7 ; 0.7
0.63 ; 0.71 ; 0.72
0.62 ; 0.69 ; 0.69
0.57 ; 0.65 ; 0.67
0.61
0.61
0.59
0.54
0.77 ; 0.89 ; NA
0.77 ; 0.89 ; NA
0.72 ; 0.88 ; NA
0.61 ; 0.85 ; NA
0.63
0.62
0.58
0.51
0.64 ; 0.71 ; 0.67
0.64 ; 0.72 ; 0.67
0.63 ; 0.7 ; 0.64
0.58 ; 0.67 ; 0.58
0.75 ; 0.79 ; 0.89
0.74 ; 0.8 ; 0.9
0.72 ; 0.78 ; 0.87
0.64 ; 0.71 ; 0.84

0.6
0.6
0.58
0.54
0.63
0.62
0.59
0.53
0.62 ; 0.64 ; 0.69
0.62 ; 0.64 ; 0.7
0.61 ; 0.64 ; 0.69
0.56 ; 0.61 ; 0.67
0.59
0.58
0.57
0.52
0.69 ; 0.78 ; 0.88
0.69 ; 0.78 ; 0.89
0.67 ; 0.76 ; 0.88
0.62 ; 0.72 ; 0.85
0.62
0.62
0.58
0.52
0.63 ; 0.63 ; 0.67
0.63 ; 0.63 ; 0.67
0.61 ; 0.61 ; 0.65
0.57 ; 0.58 ; 0.62
0.73 ; 0.74 ; 0.91
0.73 ; 0.73 ; 0.91
0.71 ; 0.72 ; 0.91
0.62 ; 0.66 ; 0.91

0.58
0.58
0.57
0.53
0.63
0.62
0.59
0.53
0.6 ; 0.64 ; 0.67
0.6 ; 0.65 ; 0.69
0.6 ; 0.64 ; 0.68
0.56 ; 0.62 ; 0.67
0.57
0.57
0.55
0.51
0.67 ; 0.76 ; 0.84
0.67 ; 0.76 ; 0.85
0.66 ; 0.74 ; 0.83
0.6 ; 0.69 ; 0.83
0.62
0.62
0.58
0.52
0.61 ; 0.62 ; 0.64
0.6 ; 0.61 ; 0.64
0.59 ; 0.61 ; 0.63
0.56 ; 0.58 ; 0.6
0.72 ; 0.72 ; 0.9
0.71 ; 0.72 ; 0.9
0.68 ; 0.7 ; 0.9
0.59 ; 0.66 ; 0.9
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AUC (t = 8)

AUC (t = 9)

AUC (t = 10)

AUC (Averaged Over AI Mediations)
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0.7

0.65

0.6

0.55
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EBGM
Human-expert Interventions

EBGM (0.05)

Figure 2.2: Known ADRs Detection AUC at Different Time Periods (averaged over Human-Expert
Interventions)

2.5.3.3. Evaluation 3: Performance on Novel ADR Detection
In this evaluation, we test the CI Framework for detection of new ADR signals. Through this evaluation,
we will test the efficacy of the framework to improve performance on processes that are highly unstructured,
dominated by human-experts and commonly performed in clinical settings whose outcomes can have
impacts on the patient care and HCOs overall performance. This evaluation represents a real-world case
study of detection of ADR signals which are medical research driven and for medical hypothesis generation
purposes. It also emphasizes the knowledge extraction phase (Phase 3) as this phase was ignored in the
Evaluations 1 and 2. This also makes this evaluation more unstructured in nature where the process is
human-expert dominated and AIs play a supporting role.
Evaluation 3 is a retrospective analysis of the implementation of AI interventions to increase
performance in a human-expert dominated task. For the evaluation, a case study is first conducted with the
help of physicians to detect and validate new potential ADR signals from an EHR dataset using very simple
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statistical techniques for ADR signal generation. After the end of the case study, we retrospectively
investigate the impacts of using more advanced AI (as the AI interventions) on the task performance.
Specifically, the evaluation is designed as follows: First, a case study (see Appendix A) is
conducted with the help of two physicians and a simple AI of their choice (ADR detection with Odds
Ratios) to find new potential ADRs in an EHR database that are associated to the expertise of the physicians.
The potential ADR signals revealed by the analysis are manually reviewed for their potential to be true
positive signals. The physicians used clinical literature, clinical notes and statistical techniques to for the
validation. The entire process involved multiple human-expert interventions which are listed in Table 2.6.
The case study found a potential ADR signal of Lipophilic Beta-Blockers (LBB), in particular Metoprolol
(Generic Name), and subsequent diagnosis of Parkinson’s disease (PD). Next, we retrospectively employ
AI interventions to see if a reduction in elements of task complexity by the AI interventions could have led
to the LBB and PD ADR signal being marked as having the most potential to be a true ADR, thereby
reducing the number of signals to be manually reviewed by the physicians.
Interventions and Impacts on Elements of Task Complexity: The study is split into three phases where
each phase is a collection of sequential interactions between the physicians and the algorithm outputs. Prior
to Phase 1, the need for data preprocessing was recognized by the physicians from the experiences on
working with the EHR dataset to reduce the amount of noise in the dataset. Phase 1 describes the data
preprocessing efforts put in by the physicians to reduce the amount of noise in the dataset. Phase 2 describes
a series of actions taken by the physicians in order to obtain accurate ADR signals from the algorithm.
Phase 3 describes an in-depth ADR signal validation analysis of detected potential ADR signals which
correspond to the physician’s expertise. The human-expert interventions by the physicians in the case study
are described in Table 2.6. The interventions are listed in the order they were implemented.
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Table 2.6: Description of Physician (Human-Expert) Interventions
Physician
Intervention
1
2

3

4.b

6

7

8
9

Phase 1: Data
Preprocessing
Phase 1: Data
Preprocessing
Phase 2: ADR Signal
Detection

4.a

5

Phase

Phase 2: ADR Signal
Detection
Phase 2: ADR Signal
Detection
Phase 3: ADR Signal
Validation &
Confounding Checks
Phase 3: ADR Signal
Validation &
Confounding Checks
Phase 1: Data
Preprocessing

Phase 2: ADR Signal
Detection
Phase 2: ADR Signal
Detection

Description
Diagnosis Coding Scheme Conversion:
UMLS CUI IDs → ICD9CM (1 to M mappings)
Medication Perspiration Grouping:
Grouped Drug Brands with their Generics. (M to 1
mappings)
Thresholds for Prescriptions:
Minimum 4 Rx’s before Dx
Minimum 1 Year between 1st Rx and Dx
Maximum 1 Year between last Rx and Dx
Thresholds for Drug-Diagnosis Pairs:
Minimum Rx → Dx = 2
Maximum Rx = 200
Thresholds for Drug-Diagnosis Pairs:
Minimum Rx → Dx = 4
Maximum Rx = 200
Reducing the Type of Signals to Analyze:
Hereditary and Degenerative Diseases of the Central
Nervous System (ICD9 330 to 337) was studied in detail
per the expertise of the physicians
Manual Removal of False Positive Signals and Validation of Most
Likely True Positive Signals
Supplementary Information Retrieval:
Using information retrieval techniques,
physician/clinical notes were mined to retrieve
additional patient prescriptions and diagnosis
information.
Manual Drug Category Grouping
Confounding Checks

CRC
Score
+2
+2

-2

-2

-2

NA

NA

NA

NA
NA

For the AI interventions, we use four different ADR algorithms in Phase 2. The algorithms and
their CRC scores are listed in Table 2.7. The same strategy is used to derive the complexity composite score
used in Evaluations 1 and 2 to identify the change in the elements of task complexity due to each
intervention by the physicians.
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Table 2.7: Description of AI Interventions
AI
Intervention

Phase

Description

Phase 2: ADR
Signal Detection

Using RR instead of OR

B

Phase 2: ADR
Signal Detection

Using PRR instead of OR

C

Phase 2: ADR
Signal Detection

Using EBGM-GPS instead of OR

D

Phase 2: ADR
Signal Detection

Using EBGM-GPS (0.05) instead
of OR

A

Impacts on Elements of Task
Complexity

CRC
Score
NA

No Impacts as RR and PRR are
computationally very similar to OR.
NA
Phase 2:
•
Computational Complexity –
Increased
Phase 3:
•
Uncertainty of Results –
Reduced

0

0

Measure of Task Performance: The CI Framework is evaluated based on the increase in task performance.
As the case study followed a sequential interaction of physicians with an algorithm, we will calculate the
reduction in task complexity by both physicians and AIs, and what are the sequential impact of the
interactions on the detection of novel-ADR signals. While the case study was performed using very simple
algorithms such as search and retrieval tools (REGEX, etc.) and Odds Ratios for ADR signal detection, we
check if modifying the process with AI interventions would have made the task of manual validation by the
physicians easier. For this, we use two metrics: (1) the rank of LBB-PD signal in all the detected signals,
where a higher rank would correspond to a higher signal strength and sooner it is manually analyzed, and
(2) the total number of signals where a lower total number corresponds the less signals that may need a
manual review. This evaluation is retrospective in nature as the series of human expert and AI interactions
have already been performed, however, we also evaluate the relative change in performance.
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Table 2.8: Results from Evaluation 3
HumanExpert
Intervention

Number of Potential ADR Signals for PD

Metoprolol → PD ADR Signal Ranked
by Signal Strength
EBGMEBGMRR
PRR
GPS
GPS
(0.05)

CRC
Score

RR
(>1)

PRR
(>1)

EBGMGPS (>1)

EBGMGPS (0.05)
(>0.5)

1

190

190

186

179

107

99

10

4

+2

1+2

192

192

196

186

107

99

10

4

+2 ; +2

1+ 2 + 3

72

72

72

75

30

27

1

1

1 + 2 + 3 + 4a

25

25

25

28

6

6

1

1

1 + 2 + 3 + 4b

8

8

8

9

1

1

1

1

+2 ; +2 ;
-2
+2 ; +2 ;
-2 ; -2
+2 ; +2 ;
-2 ; -2

Results: The detailed case study is presented in Appendix A which also details the steps taken by the
physicians to validate the ADR signal as a strong potential ADR signal. These steps correspond to the
Interventions 5 to 9 by the physicians. Table 2.8 presents the evaluation results from physician interventions
1 to 4.b and AI interventions. On viewing the rank metric in Table 2.8, we can see that at between humanexpert interventions 1 and 2, the rank of LBB-PD signal is not changed for all AI interventions, however,
we see a dramatic difference in the rank of LBB-PD signal in simple vs. advanced AI. Simple AI (RR and
PRR) rank the signal at 107/190 and 99/190 and advanced AI (EBGM-GPS and EBGM-GPS (0.05)) rank
the signal at 10/186 and 4/179. By the third human-expert intervention, we see that the advanced AIs rank
LBB-PD as the strongest ADR signal, however, it takes two more human-expert interventions for the simple
AI to also reach the same conclusion. On viewing the number of potential signals metric in Table 2.8, we
can see that AI interventions did not help in the reduction of the total number of signals that needed to be
manually verified, however, we see that the human-expert interventions with the lowest CRC scores
substantially reduced the number of signals. We also find that the combination of physician intervention
and more advanced AI methods (EBGM-GPS) detect the potential ADR signal in a lower number of
physician interventions than the less advanced AI methods (RR and PRR) which potentially reduces the
effort of introducing additional interventions.
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2.6. Discussion and Conclusions
2.6.1. Discussion
From the three evaluations, we gain several important insights. First, interventions with largest reduction
in CRC scores improve the task performance more than interventions with lower decreases (or increases)
in CRC scores. We find that the interventions which produced the most decrease in the elements of task
complexity played a major role in increasing task performance when compared to other interventions. Thus,
to increase performance in a task, interventions can be chosen that produce the highest decrease in
complexity of the task.
Second, iterative (multiple) interventions also positively impact task performance. From all three
evaluations, we find that iterative interventions in a task produce a positive change in performance. The
results tell us that using the CI framework, we can effectively judge the potential impacts an intervention
can make and the potential benefits of combining interventions together.
Third, interventions involving the use of more advanced AI may not always beat simple AI in terms
of increasing task performance. From evaluations 1 and 2, we find that AI interventions, which involved
the use of simple and more complex AIs, did not increase performance when more advanced AIs were used.
Overall, we see that the domain knowledge of the human-expert played a critical role in increasing the task
performance while the modification of AI in the process didn’t lead to much change in task performance.
The decrease in performance when using more advanced AI might indicate the fit of the model to the
problem or the dataset as the more advanced models have been only tested on larger datasets and not a
medium sized dataset that we’re using in this analysis. It also indicates the decrease in performance as the
models become more complex. Additionally, the decrease in performance indicates that the models are not
a good fit for the ADR that are being detected as these models are specifically designed to shrink the ADR
signal strength for Rx-Dx pairs with low number of observations or rare diseases.
Fourth, human-intensive tasks and AI intensive tasks, both benefit from collaborations between
human and AI interventions. Results from Evaluation 3 suggest that the interventions with the highest
reduction in task complexity results in performance increases. Additionally, the stacking human-expert and
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AI interventions also increased task performance and this impact was greater than only using human-expert
interventions suggesting that collaborative interventions might be more beneficial than only using humanexpert or AI based interventions. The use of more advanced AIs reduces the amount of human-expert
interventions thereby reducing the amount of inputs needed by human-experts and the involvement of the
human expert in the data pre-processing and processing phases results in efficiency gains as it not only
reduces the complexity in Phase 1 and 3 but also reduces the human experts workload in interpretation
phase (Phase 3).
2.6.2. Conclusions and Limitations
In this research, we present a unique framework to help manage and modify information processing and
management tasks in HCOs in order to increase task performance. The framework leverages literature from
task complexity to help guide practitioners on what modifications, whether involving humans, AI or both,
might help in increasing the performance on task. We evaluate the framework on two common types of
information processing tasks performed in HCOs.
This research makes several contributions to literature. The framework of collaborative intelligence
between humans and AIs extends current literature on task complexity and performance outcomes. The
paper develops a framework that helps in management of information processing tasks in HCOs involving
a collaboration of humans and AI to positively influence the overall complexity of the task and thereby
positively impacting the final task performance and task outcomes. This framework can be applied to a
variety of tasks where the task complexity is high, and both machines and humans can contribute towards
reducing the task complexity.
This research has several practical implications that span numerous industries including healthcare.
The collaborative intelligence framework can be easily generalized to a lot of complex tasks where
modifications using humans and AIs can address task related complexities and increase performance.
Besides healthcare, most information processing tasks where nether humans nor AIs are particularly
efficient or effective, such as anomaly detection and fraud detection, can benefit greatly from this
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framework. These tasks, much like the problem of ADR detection are not easy problems to solve by
machines or humans by themselves.
The study has several limitations. First, the composite reduction in complexity (CRC) score used
in the framework only provides a high-level impact on elements of task complexity. It ignores the amount
of change in the particular elements of task complexity which may be helpful in explaining some of the
nuances of the results we obtained in the evaluations. Second, the evaluations were performed on one
specific task, i.e., ADR detection which is a challenging anomaly detection task, however, evaluating the
framework with more healthcare applications and testing more advanced AI interventions (advanced
machine learning algorithms) can be more helpful.
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CHAPTER THREE:
THE IMPACTS OF INEFFICIENCIES AND DELAYS DURING INPATIENT STAYS ON
QUALITY OF CARE AND THE FACTORS THAT IMPACT INEFFICIENCIES

3.1. Abstract
The impacts of delays and inefficiencies prior to the admission of patients to a service department has been
investigated by multiple studies. However, the impacts of delays and inefficiencies during a patient’s stay
in a HCO has only been sparsely studied. In this chapter, we investigate the impacts of inefficiencies and
delays on quality of care metric – length of stay (LOS). We first investigate the impacts of delays and
inefficiencies during a patient’s stay on the patient’s length of stay in the HCO. We also study the factors
that can impact these delays and inefficiencies. We find that delays and inefficiencies during a patient’s
stay can decrease the LOS of patients suggesting an early discharge or a speed up effect. Additionally, we
find that this effect is U-shaped suggesting that this effect is decreasing as inefficiencies stack up. We also
find that the delays on day one impact more specialized service departments (i.e. neurosurgery and
hematology) while more general departments (i.e. general medicine) are not impacted by them. On
investigating the factors that may play a role in increasing or decreasing inefficiencies and delays, we find
that a higher collaboration between staff in more specialized departments decrease the probability of
experiencing delays and inefficiencies while general service departments don’t show this effect.
Additionally, the workload on the same day or hour in specialized departments increases efficiency. We
also find a cascade effect where previous delays and inefficiencies increase the probability of experiencing
more delays and efficiencies in the future. This effect is very prominent in general service departments. We
also discuss the implication and contributions of this research.
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3.2. Introduction
The Centers for Medicare and Medicaid Services (CMS) list the length of stay (LOS) as one of the measures
of the quality of care (QoC) provided by healthcare organizations (HCO) to a patient and is part of Hospital
Value-Based Purchasing plan or the pay-for-performance program. The shift to value-based care modifies
the reimbursements hospitals receive based on their performance score which is a function of LOS and
other factors such as 30-day mortality rates for specific services. This change in reimbursement
methodology has led researchers to find the potential causes that may impact a patient’s length of stay.
Factors such as delays at the time of admission (Chan et al. 2016), off-service placement (Song et al. 2019)
and nuances of admission to step-down units (Chan et al. 2019) have been found to be causally related to
longer LOS with factors such as insufficient bed capacity, operational inefficiencies, patient demand
variations (McManus et al. 2003) at the heart of the problem.
While these factors account for the conditions at the time of or prior to admission, the impact of
the conditions and events that take place during the stay on LOS can be just as vital. As the quality of care
(QoC) provided to patients can be impacted by inefficiencies in care provided by hospital staff, operational
inefficiencies or capacity limitations, variations in these factors during the stay of the patient can amplify
or mitigate the conditions present at the time of admission. The staff members providing care to patients
and the environment they are working in can have substantial variation per day and even per hour which
can aggravate or mitigate inefficiencies in service during the stay of the patient. Specifically, variations in
the workload in hospital service departments, the collaboration and informal communication between staff
providing care to patients, the experience of staff in the hospital and in using the technology in the HCO as
well as the user job or role of the staff member (i.e. physician, nurse, resident, etc.) can lead to inefficiencies
in the care provided. These inefficiencies, taking place at a micro level during a patient stay, can aggregate
to put patients at risk of delays in treatment, treatment errors and lower QoC.
While the potential impacts of these factors on QoC can be substantial, due to lack of research, it
is still not clear what potential factors may drive these inefficiencies during the stay of patients and what
are downstream impacts of these inefficiencies during a patient’s stay on the QoC provided. In this research,
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we try to fill this gap in research by answering the following research questions: (1) What are the impacts
of inefficiencies and delays during an inpatient stay on the LOS of patients? and (2) To what extant do
staff and department associated factors such as collaboration between hospital staff, workload, experience
and staff roles create inefficiencies and delays in PCPs?
In order to answer these research questions, we first estimate inefficiencies and delays during
inpatient stays. To do so, we utilize a large dataset of EHR system access logs for inpatients in a large
teaching hospital. We use the dataset to learn access patterns in the HCO by service department using a
dynamic Bayesian network (DBN) and use the learned model to estimate if a transition was efficient or
inefficient. As focusing on individual departments is crucial in understanding how delays and inefficiencies
within those cells cause adverse outcomes in terms of length of stay (LOS) and other QoC metrics (Chan
et al. 2016), we learn these access patterns individually per service departments. Next, we use two stage
least squares instrumental variable approach to estimate the impact of these inefficiencies and delays during
an inpatient stay on a patients LOS. Using a fixed-effects logit estimator, we further estimate how staff and
department associated factors such as the collaboration, workload, experience and staff roles increase or
decrease such inefficiencies and delays.
Our main findings suggest that (1) the average inefficiencies and delays occurring in the entire stay
of patients have a negative relationship with the LOS, (2) however, this relationship is curvilinear with a
U-shape. This suggests that delays and inefficiencies during a patient stay can lead to early discharge which
previous research has found to have negative impacts on mortality and readmission. Further, (3) we find
that the inefficiencies and delays that take place on the day of admission show heterogeneous effects
depending on the service department the patient is admitted to. These heterogenous effects can be explained
by the service department being specialized (i.e. neurosurgery) or general (i.e. general medicine).
Specialized service departments are impacted by first day delays and inefficiencies while general service
departments don’t show this effect.
Next, on investigating the factors that impact workflow inefficiencies and delays, we find that (5)
for specialized departments, the collaboration between the hospital staff plays a significant role in
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decreasing the probability of experiencing inefficiencies and delays. General service departments don’t
show this impact suggesting that a collaborative environment between hospital staff may only benefit
specialized services. (6) We also find that increases in a user’s experience in working in the HCO (as well
as their experience in using the EHR system) decreases the probability of experiencing inefficiencies and
delays. This effect is most prominent in general service departments which suggests that highly experienced
staff are more likely to increase efficiency in general service departments. (7) Additionally, for specialized
service departments, we find that high workload during the hour (or the same day) decreases the probability
of inefficiencies and delays suggesting increased efficiency under higher workload. This effect is not
prominent in general service departments. (8) However, the impact of having a high workload in the
previous day has heterogonous impacts as it either increases the probability of experiencing inefficiencies
and delays for specialized service departments or has no impact on general service departments. Lastly, we
find that (9) not all staff members in different service departments handle high workload in the say way
with the role of the staff member being resident or nurse moderating this effect.
3.2.1. Relevant Background
3.2.1.1. Delays in Receiving Care
The impact of delays on QoC metrics have received significant attention by researchers in the past two
decades. The impacts of delays in a patient receiving care has been shown to increase patient’s length of
stay. Multiple studies have studied delays from the perspective of admission and their consequences.
Notably, Chan et al. (2016) study the impact of boarding delays experienced by patients being transferred
to ICU from the emergency department (ED). Their study investigates the impact of boarding delays on a
patient’s LOS in ICU where they attribute the delays to congestion in the hospital. The study operationalizes
delays as being continuous in nature (minutes) in which they measure the time taken between the admit
order and the physical admission to ICU. They use the business of the inpatient units at the time of
admission as an instrumental variable to handle the endogeneity in their measure of boarding delay. They
empirically find that an additional hour of boarding delay can increase ICU LOS by 11.37% - 38.21%. This
result is a contrast from studies such as KC and Terwiesch (2012) which found that higher congestion in
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ICU units can exhibit a speedup effect where the LOS of the patients decreases due to early discharges.
Luca et al. (2004) studied delays as time to treatment for Acute Myocardial Infarction (AMI) from the time
of first symptom onset to the time to treatment administration (first balloon inflation) and were interested
in studying the mortality of patients. Yankovic et al. (2010) studied delays as the impact of ambulance
diversion time on mortality of patients with AMI and operationalized delays as diversion rate measured on
the scale of minutes. Chalfin et al. (2007) studied the delay in admission from ED to ICU and used 6 hours
as the cutoff point for dichotomizing boarding time between delay (≥ 6 hrs.) and no delay (< 6 hrs.).
All the above studies only investigate the delays at the beginning of the inpatient stay, while the
delays and inefficiencies taking place while the patients are being cared for during their stay are not
investigated. In this study, we focus on investigating the impact of inefficiencies and delays in care during
a patient’s stay. We also investigate multiple specifications of inefficiencies and delays and consider them
as being continuous (minutes) or binary (yes/no). We consider multiple HCO departments in our study to
investigate the variable nature of impacts of delays during the patient stay. In addition, we study the impacts
of delays at a granular scale where the delays in receiving care are at an EHR user level where these users
are heterogonous. We capture this heterogeneity with various variables including their roles and their
collaboration patterns with other users. This also allows us to also investigate the contribution of different
HCO staff members including nurses, residents and physicians on exuberating or mitigating delays. Our
study also investigates the impacts of delays in more heterogenous HCO departments including
neurosurgery, hematology and obstetrics among others.
3.2.1.1.1. Inefficiency and Delay Estimation
Only a handful of studies come close to our notion of delays as inefficiencies during an inpatient stay. Chan
et al. (2008) study the impacts of delays in defibrillation during an in-hospital cardiac arrest on the mortality
of the patient. They operationalize delays as time difference (in minutes) between recognized cardiac arrest
and the defibrillation administration and their expected time difference is 2 minutes which is informed by
expert guidelines. Chen et al. (2015a) study workflow inefficiencies during an inpatient stay. They
categorize inefficiencies as the transitions between pairs of EHR users (based on their reasons for accesses
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which is almost perfectly correlated to their roles) which have a long average transition duration between
them with high or low variance between PCPs. They used 100 hours as the mean and removed some of the
main reasons such as Physician-CPOE, Residence, Patient Care Staff Nurse from their analysis due to their
method being overwhelmed by the abundance of these access types in the PCPs.
We estimate unusually long transitions between EHR users using similar data, however, we
estimate the long or delayed transitions at a much more granular scale where the estimate is at user level
instead of access reason level. Our estimation of long transitions between users takes a more nuanced
approach by not only allowing the estimation of long transitions to vary by different users but also allowing
the estimates to vary by latent factors not observed in the data directly. We analyze all users working in an
HCO service department and estimate a transition between two users. Our estimates of transition times thus
account for user level heterogeneity making the estimates more precise. Additionally, we let transition times
between two users to vary depending on when in the PCP was the access made, the sequence of accesses
that came before it and other latent factors that may govern this transition.
For flagging transitions as inefficient or efficient, instead of using a global mean (Chen et al.
2015a), we use individual level estimates and variances to differentiate between efficient and inefficient
workflow transitions. We operationalize inefficiencies and delays as a continuous variable which takes on
the value of the difference between the access by an EHR user and expected time plus a threshold. The
threshold allows for some buffer or cushion between observed and expected transition times. This threshold
(which is the standard deviation of the estimate) acts as a region around the expected access time in which
the access is within a reasonable amount of time. Here, we operationalize inefficient and delayed accesses
as 0 when the access was in a reasonable amount of time from the expected access time and a value greater
than 0 when the access is beyond the estimated reasonable access time. As the expected access differences
between hospital staff working on an inpatient case can vary greatly by staff heterogeneity in terms of their
roles, working styles with other staff and shifts as well as when during a patient’s stay was the access
recorded.
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3.2.1.2. Workload
In addition to studying the impacts of delays, multiple studies have investigated the impact of workload and
congestion on the LOS of patients and in-turn their risk of readmission and mortality. (Kc and Terwiesch
2009; Kc and Terwiesch 2012) study the impacts of workload and congestion on ICU LOS where they find
that higher workload can result in shorter LOS of patients to reduce the occupancy levels in the ICU
(speedup effect). This is in contrast to the findings of Chan et al. (2016) who find that delay in boarding to
ICU from ED can increase LOS, where they attribute boarding delays to higher congestion in inpatient
unites. KC and Terwiesch (2012) also find that the reduction in LOS (speedup effect) due to higher
congestion comes at the cost of increased readmission rates and higher chances of mortality of patients.
From the HCO staff perspective, they find that longer periods of speedup and high workload load
(overwork) leads also decrease the service rates (increase the LOS), however. They define load as the
number of patients admitted (for cardiothoracic surgery) normalized by the total bed capacity. This speedup
effect has also been studied by other researchers. Berry Jaeker and Tucker (2017) study the impacts of
occupancy levels on LOS of patients. They find that increases in occupancy levels lead to longer LOS for
patients until a tipping point where any additional occupancy levels lead to shorter LOS as patients are
discharged early due to congestion. This curvilinear relationship between occupancy and workload on LOS
is attributed to workload-related saturation effect where speedup is no longer effective strategy by
employees for overcoming workload.
While workload can be attributed to the percentage of beds occupied in a unit, the number of HCO
staff working in the unit gives a more nuanced view of the workload experienced by employees. Moreover,
this workload will vary from hour to hour and day to day during the patients LOS. Unlike previous work,
we define workload as the total patients in the unit divided by the total number of active EHR users in the
same unit. Our measure not only controls for occupancy level but also the workload experienced by the
staff working in a specific hour of a day.
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3.2.1.3. HCO Staff Collaboration Patterns and Experience
HCOs are highly dynamic in nature, where there are routine interactions between teams of physicians,
nurses, residents and other support and technical staff as the HCO staff is expected to act in a collaborative
and coordinative manner (Corrigan 2005; Kohn et al. 2000). Research has found that the interactions of
HCO staff such as physicians and nurses can play a critical role in patient outcomes (Benike and Clark
2013) and organizations also support increased collaboration between HCO staff in order to increase
efficiency and improve patient outcomes (Alert 2008). However, due to the dynamicity of such
collaborations in HCOs, traditional approaches to map these collaborations and interactions such as
pairwise relationships become infeasible due to the scale of modern HCOs. However, with the advancement
and wide use of clinical information systems, it has become possible to automatically construct these
interactions using systems used in HCOs. EHR systems provide audit logs for EHR accesses by HCO staff.
Under the HIPAA security rule, these logs are maintained by HCOs for over 6 years (USDHHS 2003).
Previous research had used such logs to learn EHR user behavior and also conduct anomaly detection on
the learned behaviors for flagging deviations (Zhang et al. 2013). Malin et al. (2011) used such logs to learn
patterns that summarize how EHR users collaborate with each other. They constructed probabilistic rules
from EHR access logs based on co-accesses on a patient’s record. These rules signify user interactions and
collaboration patters in the HCO. They used a combination of social network analysis with association rules
to construct such a measure and used it study predefined policies and unknown staff behaviors in an HCO.
They also find that the behaviors earned at the service department level offer greater stability over time.
In our study, we also want to study the impacts of collaboration between HCO staff on
ineffectiveness and delays in PCPs and its subsequent impact of LOS. However, unlike previous studies
measuring the collaboration between HCO staff, we study this collaboration at a more granular scale. While
multiple HCO staff members can work on a single PCP, it is not necessarily the case that a user whose role
demands access to the EHR records towards the end of the PCP interacts with and is impacted by the users
in the beginning of the PCP. As we are studying interactions at a more granular scale, we study such
collaborations at a granular scale as well where we measure the collaborations between users that have
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access on the same PCP and the access is within a reasonable distance from the previous and future accesses.
This will allow us to generate collaboration patterns that are at a more granular level where the user to user
collaborations are learned. This also is a more feasible approach given that we want to study this
collaboration impacts on the inefficiencies that take place at an access level and their downstream impacts
on LOS.
In addition to the collaboration between HCO staff being known to impact patient outcomes,
research as also studied the impacts of physician experience on performance. Kc and Staats (2012) study
the impacts of physician’s experience in performing minimally invasive cardiac surgeries and other cardiac
procedures on mortality of patients. We on the other hand study the impacts of experience in working in
the HCO and the experience in using the EHR system present in the HCO. This is regardless of the staff
being a physicians, resident or nurse.
3.3. Empirical Measurements
In this section, first present the abstract modeling of EHR access logs. Next, we present the details of the
construction of measures for workflow delays, staff collaboration, staff experience, service workload and
staff role categories.
3.3.1. Abstract Modeling of EHR Access Logs in EHR Systems
Using EHR access logs present in EHR systems, we define a Patient Care Pathway (PCP) sequence as the
sequence of EHR accesses by HCO staff for a patient’s stay in the HCO. More formally, we can construct
Patient Care Pathway (PCP) sequences using the tuple: (𝑃𝑆, 𝐴1:𝑀
1:𝐿 ) where 𝑃𝑆 ∈ {𝑃𝑆1 , 𝑃𝑆2 , … , 𝑃𝑆𝑃 } is a set
1:𝑀 1:𝑀
1:𝑀
of P unique patient stays in the HCO and 𝐴1:𝑀
1:𝑁 ∈ {𝐴1 , 𝐴1 , … , 𝐴𝑁 } are the N EHR accesses to the

patient’s EHR record during the stay. Here, each EHR access has M attributes which are recorded in the
EHR logs data. Some examples of attributes are EHR user’s ID (𝑈𝐼𝐷), time stamp of access (t), user’s role
assignment in EHR system, patient’s service department, patient’s demographics, etc.
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3.3.2. Estimating Long Transitions Times Between Users and Modeling Dynamic Workflows
3.3.2.1. Dynamic Bayesian Networks
Bayesian networks (BN), probabilistic graphical models (PGM) and directed acyclic graphs (DAG) are
compact and approximate representations of complex distributions (Pearl 2009) achieved by introducing a
dependency structure between the variables of interest. This dependency structure is key in using the chain
rule of probability theory to decompose the joint distribution of the variables into a series of conditional
distributions. The dependency structure is also represented in a graphical form where the nodes of the graph
represent the random variables and the edges of the graph represent the probabilistic dependency structure.
Much like hidden Markov models (HMMs), DBNs can represent stochastic processes using DAGs.
However unlike HMMs and HMM variants, DBNs have an irregular and problem specific structure
(Murphy 2012). In DBNs, the network structure depends on the problem being studied and thus the
dependency between the random variables both within a time slice and between time slices must be
specified with the problem in mind. This bespoke structure allows DBNs to exploit the strengths of both
BNs and HMMs when studying complex stochastic phenomena. The bespoke structure of DBNs can also
make the exact inference task more difficult as the complexity of the network increases (in certain
structures, the hidden nodes become correlated over time (Koller et al. 2009). However, there are ways to
combat this by using approximate inference algorithms.
3.3.2.2. Network Structure
For capturing and analyzing dynamic workflow patterns in HCOs, we model a DBN based on capturing the
latent processes that govern the observed workflow patterns and the transition times. The structure of the
DBN is kept conservative with respect to the random variables introduced and dependency structure
between them to make the structure applicable to a wide range of problem domains. The structure can be
made more complex with minimum changes in the inference tasks.
The objective is to model the underlying mechanism governing the observed transitions between
hospital staff for each inpatient encounter sequence and the consequential transition times from the previous
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event to the new one. To model this mechanism, we build a Dynamic Bayesian Network (DBN) that would
incorporate the observed sequences of events.
For capturing the dynamic workflow patterns in HCOs, we want to model (1) the underlying
mechanism governing the observed transitions between hospital staff for a given inpatient patient encounter
and (2) the resultant transition times. The model of underlying transition structure between users can be
thought of in terms of an HMM where the underlying mechanism is represented by latent variables and the
transition structure is represented as a Markov transition matrix. Here, the state of the underlying
mechanism governs the probability of observing an access by a user given the past state of the underlying
mechanism. In other words, the user access behavior for a patient sequence will be dependent on the state
of the underlying mechanism.
An example of the states of the underlying mechanism will be the job designations of the users and
an example of the state evolution will be how the users with specific job descriptions work together. The
state evolution in this example will essentially encompass the collaborations between users given their job
descriptions. The latent mechanism will not only encompass this mechanism but will most likely be a
combination of several unobserved latent mechanisms in a sparse representation. We discuss a method for
capturing the underlying transition mechanism which don’t follow a strict Markov structure in Section 3.4.
To model the observed transition times between user accesses, we assume the possibility of another
latent mechanism that is dependent on the observed user access and the state of the latent mechanism in
previous time slice. The resultant observed transition time difference between previous time slice and
current time slice is dependent on this latent mechanism. This latent mechanism allows for variability in
the observed transition time given the sequence of user accesses and not just the pair of user accesses.
3.3.2.3. Model of HCO Workflow Between EHR Users
We consider each event in a patient care pathway (PCP) sequence as a time slice. For a given patients’
inpatient stay, we define the PCP as the sequence of events associated with that patient encounter. This
represents the virtual representation of the PCP in the HCO for a service (Chen et al. 2015b; Zhang et al.
2013). For each event, we model observed user IDs as a discrete variable UIDi. With the time stamp (t)
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associated with each event, we model the logged transition time, 𝑇𝑖−1,𝑖 from event in time slice i-1 to i as
the logged difference between the two timestamps. Although the service time can be different from the
transition time, we use it as an approximation of the actual service time, and this is modeled as Gaussian.
We also model the unobserved hidden Markov chain 𝑆 1 to have finite states. This will capture the latent
mechanism that governs user to user transitions. This is helpful in two ways: First, the latent Markov chain
will capture the mechanism for user to user transition at an abstract level which would allow us to make
inferences on this mechanism later. Second, it will limit the number of parameters that need to be estimated.
We follow a similar approach for modeling the latent mechanism 𝑆 2 that governs the observed transition
2
times between events. Note that 𝑆𝑖2 will depend on both 𝑆𝑖−1
and 𝑈𝐼𝐷𝑖 . This structure captures the transition

time as a mixed Gaussian. A graphical representation of the model is provided in Figure 3.1.
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Figure 3.1: A DBN model for PCPs (Grey Nodes are Observed & White Nodes are Unobserved ;
Round Nodes are Multinomial & Square Nodes are Gaussian)
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3.3.2.4. DBN Parameter Learning, Hidden State Sequence Inference and Estimation of Expected
Transition Times
As our DBN model is partially observed (i.e. 𝑆 1 and 𝑆 2 are not observed), we can learn the parameters of
the DBN by employing expectation maximization (EM). The parameters to be learnt are: 𝑃(𝑆11 ), 𝑃(𝑆𝑖1 |𝑆𝑖1 ),
2
𝑃(𝑈𝐼𝐷𝑖 |𝑆𝑖1 ), 𝑃(𝑆12 |𝑈𝐼𝐷1 ), 𝑃(𝑆𝑖2 |𝑈𝐼𝐷𝑖 , 𝑆𝑖−1
), 𝑃(𝑇0,1 |𝑆12) and 𝑃(𝑇𝑖−1,𝑖 |𝑆𝑖2 ). To estimate these parameters,

we used EM with a maximum of 50 iterations with 90% of the PCP sequences in each HCO service
department. For selecting the model with the right number of states for the two hidden Markov chains 𝑆 1
and 𝑆 2 , we estimated several DBNs with increasing number of hidden states. Because the two latent chains
are conditionally independent of each other (d-separated (Pearl 2009)), we estimated the models by varying
the number of states of one latent chain and keeping the number of states = 10 for the other chain. Figure
3.2 – Panel A and Panel B report the log-likelihoods for each of the models at each iteration. We can see
that all model log-likelihoods stabilized before the 50th iteration.
After the EM iterations are complete, we compare the computed log-likelihoods scores of each of
the models at the last EM iteration to gauge the best number of hidden states for each latent chain. We select
the number of states based an elbow plot. Similar method is used in text mining literature for selecting the
optimum number of topics for a topic model. Using the elbow rule (Figure 3.2 – Panel C), we can see that
the model Log likelihood fit increases at diminishing rate as the states increases and then select the number
of hidden states equal to 10 for 𝑆 1 and 15 for 𝑆 2 . The intuition behind this method is that we want to select
the most parsimonious number of states for the model that fits the data well in comparison to more complex
models with higher number of hidden states. In the heuristically most optimum model, for latent chains 𝑆 1 ,
we select the optimum number of states to be equal to 10 and for latent chains 𝑆 2 , we choose the optimum
number of hidden states to be equal to 15.
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Panel B: Model Log Likelihoods at each EM iteration
with different number of hidden states in 𝓢𝟐

Panel A: Model Log Likelihoods at each EM iteration
with different number of hidden states in 𝓢𝟏
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Panel C: Model Log Likelihoods at last EM iteration with different number of hidden states in 𝓢𝟏 and 𝓢𝟐

Figure 3.2: Number of Hidden States Selection using DBN Model Log Likelihood

After we have learnt the parameters of the DBN model using EM, we have the task of inferring the
hidden state sequences 𝑆 1 and 𝑆 2 . We use smoothing to infer the hidden state sequences where the task is
to compute the belief state 𝑃(𝑆𝑖2 , 𝑆𝑖1 | 𝑈𝐼𝐷1:𝑁 , 𝑇0,1:𝑁−1,𝑁 ) in an offline setting, given all of the evidence
(observations) from the PCP sequence, 𝑈𝐼𝐷1:𝑁 and 𝑇0,1:𝑁−1,𝑁 . Here, our uncertainty regarding the inferred
state sequences will greatly reduce by conditioning on past and future data for each PCP sequence. We use
Junction Tree algorithm (Murphy 2012) for exact inference of the hidden state sequences. If the inference
task was to be performed in an online setting (i.e. inferring the state sequences while the PCP sequence is
ongoing), filtering can be performed where the conditioning is only done of past and present data for each
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PCP sequence. Similarly, predictions regarding the future states can also be made for a prediction horizon
in an online setting using past data.
After the parameters in the DBN have been learnt using EM and we have inferred the hidden state
sequences using smoothing (Junction Tree), we can estimate the expected logged transaction time, 𝑇𝑖,𝑖+1 ,
between two subsequent EHR users, 𝑈𝐼𝐷𝑖 and 𝑈𝐼𝐷𝑖+1 . This transition time can be estimated by:

2
𝑃(𝑇𝑖,𝑖+1 |𝑈𝐼𝐷𝑖 , 𝑈𝐼𝐷𝑖+1 ) = ∑ ∑ 𝑃(𝑇𝑖,𝑖+1 , 𝑆𝑖+1
, 𝑆𝑖2 | 𝑈𝐼𝐷𝑖 , 𝑈𝐼𝐷𝑖+1)
2
𝑆𝑖2 𝑆𝑖+1

2
2
= ∑ ∑ 𝑃(𝑇𝑖,𝑖+1 | 𝑆𝑖+1
) 𝑃(𝑆𝑖+1
|𝑆𝑖2 , 𝑈𝐼𝐷𝑖+1 ) 𝑃(𝑆𝑖2 )
2
𝑆𝑖2 𝑆𝑖+1

where, 𝑃(𝑆𝑖2 ) is the smoothed belief state at i’th time point in a PCP sequence obtained from the Junction
2
Tree algorithm. In the DBN, 𝑃(𝑇𝑖,𝑖+1|𝑆𝑖+1
) is modeled as a Gaussian, 𝑃(𝑇𝑖,𝑖+1 ) ~ 𝒩(𝜇̂ , 𝜎̂ 2 ). If we consider
2
𝑃(𝑆𝑖+1
) as a prior with k = 15 states, then, 𝑃(𝑇𝑖,𝑖+1 ) is a mixed Gaussian (i.e. mixture of 15 Gaussians).

For estimates in time scale, we can convert the estimated Gaussian, 𝑃(𝑇𝑖,𝑖+1 ) given by

𝑇𝑖,𝑖+1 | 𝑈𝐼𝐷𝑖 , 𝑈𝐼𝐷𝑖+1 ~ 𝒩(𝜇̂ , 𝜎̂ 2 )

where,

𝜇̂ = Ε [𝑇𝑖,𝑖+1 |𝑈𝐼𝐷𝑖 , 𝑈𝐼𝐷𝑖+1 ] = ∑ 𝜋𝑘 𝜇𝑘
𝑘

𝜎̂ 2 = Ε [ (𝑇𝑖,𝑖+1 | 𝑈𝐼𝐷𝑖 , 𝑈𝐼𝐷𝑖+1 ) − 𝜇̂ )2 ] = ∑ 𝜋𝑘 (𝜇𝑘 2 + 𝜎𝑘2 ) − 𝜇̂ 2
𝑘

back to Log Normal distribution. The original time (as recorded in the dataset) follows a log-normal
distribution with mean 𝜇̃ and variance 𝜎̃ 2 , where
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1 2

𝜇̃ = 𝑒 𝜇̂ + 2 𝜎̂
2

2

𝜎̃ 2 = 𝑒 2 𝜇̂ + 𝜎̂ (𝑒 𝜎̂ − 1)

3.3.2.5. Estimation Performance Checks
We evaluate the performance of the model in estimating the transition times in the 90% of PCP sequences
that it was trained on and in the 10% held out PCP sequences. The results are presented in Table 3.1 and
we can see that the mean error in estimation is quite small and the DBN is accurately estimating the
transition time between two users in a PCP given the UID of current accesses and state of latent variable
𝑆 2 of previous and current access.
The estimates from the DBN are precise because we allow the estimates to be governed by the
latent state sequence 𝑆 2 in a PCP. This allows the estimates of transition times between two users to vary
by when the accesses are seen in a PCP (i.e. the estimated transition time between two users in a PCP can
be different depending on whether the accesses were in the beginning, middle or end of the PCP).

Table 3.1: Estimation and Prediction Performance of DBN Model
Service
Department
Neurosurgery

Training (90%)

Mean Point Estimate Error
( log(Seconds) )
0.73

Mean Point Estimate Error
(Minutes)
0.035

Neurosurgery

Testing (10%)

5.3

3.34

Hematology

Training (90%)

0.36

0.024

Hematology

Testing (10%)

4.37

1.32

General Medicine

Training (90%)

0.05

0.017

General Medicine

Testing (10%)

3.38

0.49

Data

3.3.2.6. Delayed Transitions
To get an estimate of transitions between users that are experiencing delays, we compare the observed time
difference between two users in a patient sequence with the estimated transition times using 𝜇̂ and 𝜎̂ 2 .
Specifically, we flag long transitions (workflow delays) as accesses that fall outside of 𝜇̂ + 𝜎̂ 2 . The
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estimation is in logged time scale as we want to be more precise with estimates that involve shorter
transitions between users such as within an hour or a few hours than longer transitions such as sparse
accesses in the evening and overnight. To estimate the delay time in minutes and seconds, we convert the
flagged transitions using exp(𝑇𝑖,𝑖+1 ) − 𝜇̃. Here, exp(𝑇𝑖,𝑖+1 ) represents the transition time in the actual time
scale recorded in the dataset.
3.3.3. Service Department Workload
The service department workload is measured on two granularities: (1) workload in an hour and (2)
workload in a day and is measured per service department. Our measure of workload is the number HCO
staff available for each of patient admitted in the service department. To obtain the number of HCO staff
present in a day or an hour, we simply count the number of unique user IDs (UID) that made accesses to
EHR records of patients that were admitted to a particular service department. Note that our data set is
extracted from an HCO where all staff members user the EHR system to retrieve and input patient
information and we also expect this number to be proportional to the total number of actual staff present in
the HCO. To measure the number of patients admitted in a service department, we simply count to the total
patients who have their inpatient stay overlapping with a particular hour or a particular day. To get the
measure of workload in an hour or a day in a service department, we divide the total number of unique EHR
users (in an hour or day) by the total number of patients admitted.
3.3.4. Staff Collaboration
In this section, we describe and define the process of user network construction from the Chart Access logs.
This user network represents the user collaborations extracted from the audit logs. While user collaborations
on per patient bases is not recorded in EHR systems, the access patterns in the patient access sequences can
give us an understanding of which users collaborate for patient’s flow. This type of method of creating a
network of users from EHR audit logs has previously been used for learning relational policies in HCOs
(Malin et al. 2011).
We construct the network in a similar fashion as Malin et al. (2011) where we define the user
network, 𝒢, as a set of nodes, 𝑈𝐼𝐷, which represent the users in the network, the edges (weighted &
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directed), ℰ𝑈𝐼𝐷𝑖, 𝑈𝐼𝐷𝑗 , which represent the strength and direction of collaboration between two users with
weight, 𝒲𝑈𝐼𝐷𝑖, 𝑈𝐼𝐷𝑗 . Here, the proximity refers to the time frame in which two user’s access a patient’s
charts which is less than a heuristically defined maximum time frame defined by 𝑀𝑎𝑥𝑇𝑖𝑚𝑒 or a maximum
of 3 user access apart from each other defined by 𝑀𝑎𝑥𝑊𝑖𝑛𝑑𝑜𝑤 = 3.
The window size, 𝑀𝑎𝑥𝑊𝑖𝑛𝑑𝑜𝑤 , is a useful parameter as collaboration process in the HCO might
not happen face to face (Malin et al. 2011) and there may be other noisy access in between actual
collaboration access. Given enough patient access sequences and instances of individuals user access, the
sequences of access related to actual collaborations (direct and indirect) will emerge with a higher weight
in the network.
To give more weight to users that have accesses closer to each other than further apart, we decay
the edge weight contribution of observed access proximity between users as the number of accesses between
them increases. Thus, we define weight of edges as:

𝑁

𝒲𝑈𝐼𝐷𝑖, 𝑈𝐼𝐷𝑗 = ∑
𝑛=1

1
(𝑇𝑖,𝑗

𝑛 𝑊𝑖𝑛𝑑𝑜𝑤
)

where, 𝑇𝑖,𝑗 < 𝑀𝑎𝑥𝑇𝑖𝑚𝑒 is defined in seconds and 𝑊𝑖𝑛𝑑𝑜𝑤 is the order of the transition. For first order
transition, i.e. 𝑈𝐼𝐷𝑖 to 𝑈𝐼𝐷𝑖+1 , 𝑊𝑖𝑛𝑑𝑜𝑤 will be equal to 1 and will increment by 1 for every successive
increase in the order to a maximum of 𝑀𝑎𝑥𝑊𝑖𝑛𝑑𝑜𝑤 .
We heuristically estimate 𝑀𝑎𝑥𝑇𝑖𝑚𝑒 as the median of all (unweighted) time differences between all
pairs of users for a maximum of 3 user access apart from each other defined by 𝑀𝑎𝑥𝑊𝑖𝑛𝑑𝑜𝑤 . For example,
given a PCP sequence (𝑈𝐼𝐷1 , 𝑈𝐼𝐷2 , … , 𝑈𝐼𝐷𝑁 ), we define a network where we will have 1 ≤ 𝑛 ≤ 𝑁 nodes
representing the users and the edges between them will represent access proximity. If the access time stamps
corresponding to 𝑈𝐼𝐷1 and 𝑈𝐼𝐷2 was under the heuristically defined maximum threshold then we would
have an edge representing the different between them in seconds. Similarly, if the time difference between
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𝑈𝐼𝐷1 and 𝑈𝐼𝐷5 is under the maximum threshold, we would also have an edge representing their difference
in seconds. The mined graph will be a directed weighted graph.
3.3.5. Staff Experience
Our measure of experience of an HCO staff member signifies the experience gained by both working in the
HCO and using the EHR system. Kc and Staats (2012) note that the ideal point to estimate experience and
learning curve is at the start of the learning curve where we would expect to find the greatest amount of
learning and we adopt this strategy in measuring the experience in this study. To calculate the experience
of the HCO staff working on PCPs, we first subset the entire EHR user base of the HCO by new staff
members and old staff members. As our data spans 3 months of EHR access logs, we mark all new user
IDs (UID) that had their first access after 30 days of the start of the recording period of our dataset. We
chose 30 days as this gives enough time for users that went on leave at the start of the recording period to
return to the HCO. After marking new and old user IDs, we increment each new user ID’s experience by 1
for each day they have been in the HCO. As we don’t know the start date of employment for old user IDs,
we simply record the metric for only new users.
3.4. Data
3.4.1. Research Setting
Our data set consists of EHR access logs from multiple inpatient patient service departments from
Northwestern Memorial Hospital, a large teaching HCO in the United States of America. The access logs
are from PowerChart® EMR system from Cerner Corporation. The access logs contain information on the
patient, the user ID (UID) of the HCO staff who accessed the patient’s EHR record, the timestamps of the
access and the service department where the access took place. At NMH, all staff members including
physicians, nurses, residents and other staff user the EHR system to retrieve and input patient information.
This is a typical type of access logs dataset found in all HIPAA security compliant HCOs in USA. Using
such data makes the findings and methods from our study also generalizable and readily usable by many
HCOs. The dataset is of 19 weeks in length and was recorded in between 2010 and 2011. In summary, there

87

are a total of 8,337 distinct EHR users, 25,373 distinct patients and a total of 6,855,391 accesses to EHR
records for patient information. Table 3.2 presents the attribute descriptions of the EHR access logs dataset.

Table. 3.2: EHR Access Logs Dataset
Attribute
Patient Pseudonym
Patient Age
Patient Gender
Service
Encounter Start Timestamp
Encounter End Timestamp
User Pseudonym
User Chart Access Timestamp
User Role

Description
Deidentified unique ID given to each patient
Age of the patient
Gender of the patient
The service department of the patients specified by the doctors caring for patient
Timestamp of when the patient was admitted
Timestamp of when the patient was discharged
Unique user ID (deidentified)
The timestamp of the patient chat access
The role assigned to the EHR user

3.4.2. Variables
In this section, we describe the dependent and independent variables used in our study. The variables are
also briefly described in Table 3.3.
3.4.2.1. Dependent Variables
LOS Analysis: For analyzing the impacts of inefficiencies and delays on a patient’s LOS, we use the
difference between the admission day and discharge day for a patient as his/her LOS in the HCO.
Additionally, we calculate the risk adjusted length of stay for each patient which accounts for prior
conditions of the patient. Here, a patient with higher risk factor indicated by prior conditions will have a
greater LOS after adjusting for this risk and a patient with a lower risk factor will have a lower LOS after
adjusting for the low risk.
Inefficiency and Delay Analysis: For analyzing the impacts factors such as collaboration, workload and
experience on the probability of experiencing inefficiencies and delays, we use an indicator variable for the
flagged transitions as the dependent variable. As inefficient and delayed transitions are calculated by only
using the 𝑆 2 , 𝑈𝐼𝐷𝑖−1 and 𝑈𝐼𝐷𝑖 , this indicator is an appropriate dependent variable for the analysis because
the independent variables in the analysis are calculated with no information on 𝑆 2 , 𝑈𝐼𝐷𝑖−1 or 𝑈𝐼𝐷𝑖 .
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3.4.2.2. Independent Variables
LOS Analysis: Our main variable of interest is the amount of delay or inefficiency experienced in minutes
in the PCP. In addition, we also study the amount of delay or inefficiency experienced in minutes in the
first day of admission. Additionally, we record the day of admission, the day of discharge and patient
demographics such as age and gender. In addition, we use multiple variables as instruments, discussed in
§3.6.1.
Delay Analysis: We use multiple independent variables that may lead to delays and inefficiencies. We use
collaboration between staff, workload in the hour, workload in the day, experience of EHR user, the day of
access and the role of the EHR user as the independent variables.

Table 3.3: Variable Descriptions
Variables
PCP Level
LOS
RiskAdj.LOS

Description
The length of stay of the patient.

Workload

The risk adjusted length of stay of the patient.
The total minutes of delay and inefficiencies for each access on a PCP divided by the total
number of accesses on a PCP.
The total minutes of delay and inefficiencies for each access on first day of a patient’s
admission divided by the total number of accesses on first day of a patient’s admission.
The daily workload for all days in a PCP divided by the LOS

Experience

The average experience of all the users working on a PCP

Collaboration

The average collaboration between all the users working on a PCP

Adm:Weekend

Indicator variable for the admission being on a weekend

Disc:Weekend

Indicator variable for the discharge being on a weekend

Age

The age of the patient

Gender:Male

Indicator variable for the patient’s gender being a male

DelayPCP
DelayDay1

User Access Level
Delay

Indicator variable for access being flagged as an inefficient or delayed access

UserRole

Indicator for the role of the user being either Nurse, Resident, Physician or Other

WorkloadHour

The workload in the hour of the access

WorkloadDay

The workload in the day of the access

Experience

The experience (in days) of the user making the access

Collaboration

The average collaboration between the user making the access and the previous two users

Weekday

Indicator variable for the access being made on a weekday
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Table 3.4: Summary Statistics
Variable

N

Mean
Neurosurgery

Std. Dev.

Min.

Max.

PCP Level
LOS

690

4.716

5.454

1

48

RiskAdj.LOS

678

4.616

5.176

-8.097

47.880

DelayPCP

692

4.018

12.965

0

243.163

DelayDay1

692

3.114

12.555

0

314.681

Workload

690

302.776

115.110

21.237

939.089

Experience

692

57.561

31.872

0.533

119.632

Collaboration

692

0.038

0.016

0.003

0.162

Age

692

53.819

16.663

19

89

Gender:Male

692

0.496

-

-

-

Adm:Weekend

692

0.084

-

-

-

Disc:Weekend

692

0.230

-

-

-

Delay
UserRole:Nurse

99443

0.098

-

-

-

99443

0.379

-

-

-

UserRole:Physician

99443

0.054

-

-

-

UserRole:Resident

99443

0.226

-

-

-

WorkloadHour

99443

0.838

0.316

0.022

2.933

WorkloadDay

99443

5.055

0.978

0.714

16

Experience

99443

58.34

34.001

0

124

Collaboration

98861

0.0904

0.172

0

2.985

Weekday

User Access Level

99443

0.836

-

-

-

i

559

-

-

-

-

t

99443

134

105.405

1

499

9.938

1

63

Hematology
PCP Level
LOS

439

9.269

RiskAdj.LOS

434

8.816

9.244

-5.619

62.931

DelayPCP

440

6.002

24.949

0

298.384

DelayDay1

440

5.750

32.032

0

361.202

Workload

439

355.486

152.156

23.222

1,441.375

Experience

440

54.487

31.411

0.606

115.196

Collaboration

440

0.044

0.016

0.005

0.193

Age

437

56.178

14.817

21

89

Gender:Male

440

0.470

-

-

-

Adm:Weekend

440

0.186

-

-

-

Disc:Weekend

440

0.257

-

-

-

120441

0.084

-

-

-

User Access Level
Delay
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Table 3.4. (Continued)
UserRole:Nurse

120441

0.383

-

-

-

UserRole:Physician

120441

0.105

-

-

-

UserRole:Resident

120441

0.149

-

-

-

WorkloadHour

120441

1.037

0.421

0.031

2.75

WorkloadDay

120441

5.94

1.518

2.227

15.438

Experience

120441

52.61

33.471

0

123

Collaboration

120238

0.115

0.183

0

203

Weekday

120441

0.788

-

-

-

i

354

-

-

-

-

t

120441

268.5

220.515

1

995

4.554

1

40

General Medicine
PCP Level
LOS

1,572

4.056

RiskAdj.LOS

1,532

4.099

4.040

-3.795

35.043

DelayPCP

1,572

59.285

100.917

0.000

1,369.448

DelayDay1

1,572

45.430

143.307

0.000

1,739.463

Workload

1,572

375.519

152.019

35.549

1,573.995

Experience

1,572

53.097

32.500

0.205

120.062

Collaboration

1,572

0.056

0.026

0.003

0.298

Age

1,497

56.178

18.116

17

89

Gender:Male

1,572

0.465

-

-

-

Adm:Weekend

1,572

0.228

-

-

-

Disc:Weekend

1,572

0.207

-

-

-

341751

0.035

-

-

-

0.339

-

-

-

UserRole:Physician

341751
341751

0.089

-

-

-

UserRole:Resident

341751

0.211

-

-

-

WorkloadHour

341751

0.865

0.334

0.0117

2.914

WorkloadDay

341751

5.039

1.03

3.176

12.286

Experience

341751

52.77

33.53

0

125

Collaboration

340347

0.132

0.227

0

4.88

Weekday

341751

0.783

-

-

-

i

1446

-

-

-

-

t

341751

204.1

184.429

1

989

User Access Level
Delay
UserRole:Nurse
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3.5. Descriptive Analysis
3.5.1. Summary Statistics
Table 3.4 reports the summary statistics split by neurosurgery, hematology and general medicine for the
variables used in the empirical analysis.
Table 3.5 reports the correlations between the variables for PCP level analysis and Table 3.6 reports
the correlations between variables for the user access level analysis. From these tables, we can see that the
correlations between the variables used in the empirical analysis are not high and denote low issues due to
multicollinearity.

Table 3.5: Correlation Matrix – Length of Stay Analysis
Neurosurgery
(1) LOS

(1)

(2)

(3)

(4)

(5)

(6)

1

(2) RiskAdj.LOS

0.931

1

(3) DelayPCP

-0.071

-0.064

1

(4) DelayDay1

-0.070

-0.065

0.921

1

(5) Workload

0.007

0.055

-0.138

-0.119

1

(6) Experience

-0.054

-0.059

-0.016

-0.022

-0.158

1

(7) Collaboration

-0.341

-0.320

-0.052

-0.065

0.016

0.117

(1)

(2)

(3)

(4)

(5)

(6)

Hematology
(1) LOS

1

(2) RiskAdj.LOS

0.952

1

(3) DelayPCP

-0.095

-0.081

1

(4) DelayDay1

-0.005

-0.022

0.694

1

(5) Workload

-0.204

-0.173

-0.158

-0.112

1

(6) Experience

-0.004

-0.027

0.0002

0.017

-0.224

1

(7) Collaboration

-0.291

-0.263

0.012

-0.008

-0.126

0.018

(1)

(2)

(3)

(4)

(5)

(6)

General Medicine
(1) LOS

1

(2) RiskAdj.LOS

0.872

1

(3) DelayPCP

-0.278

-0.238

1

(4) DelayDay1

-0.140

-0.118

0.807

1

(5) Workload

-0.153

-0.086

-0.303

-0.315

1

(6) Experience

0.010

-0.018

-0.013

-0.008

-0.080

1

(7) Collaboration

-0.255

-0.248

-0.038

-0.121

0.120

0.029
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Figure 3.3 presents the log(workload) in the neurosurgery service department for each hour of the
day. We can observe from Figure 3.3 that the workload in a service department varies by the time of day
with the workload increasing between 5-7 am where the workload reaches its peak and then remaining
constant until 3 pm after which it starts to drop. As workload in our study is the ratio between the number
of active users in the service department normalized by the number of patients, this suggests that workload
by the hour of day is indicative of congestion in the department which has been found to have a nonlinear
influence on LOS of patients (Kc and Terwiesch 2009).

Table 3.6: Correlation Matrix – Inefficient and Delayed Access Analysis
Neurosurgery

(1)

(2)

(3)

(1) WorkloadHour

1

(2) WorkloadDay

0.330

1

(3) Experience

-0.164

-0.458

1

(4) Collaboration

-0.020

-0.025

0.017

(1)

(2)

(3)

Hematology
(1) WorkloadHour

1

(2) WorkloadDay

0.442

1

(3) Experience

-0.128

-0.304

1

(4) Collaboration

-0.066

-0.055

0.02

General Medicine

(1)

(2)

(3)

(1) WorkloadHour

1

(2) WorkloadDay

0.425

1

(3) Experience

-0.068

-0.144

1

(4) Collaboration

-0.026

-0.014

0.013
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Figure 3.3: Workload by Hour of Day for Neurosurgery Service Department

3.5.2. Latent Processes (𝑺𝟏 ) Driving Workflows in PCPs
Before moving to the empirical analysis section, we explore the estimated latent transition state 𝑆 1
for the processes that may drive the observed workflows between users working on PCPs. We explore the
latent workflow dynamics driving factors that were captured by the latest state 𝑆 1 which may shed light on
the processes that may drive the workflows in the PCPs. We first study the transition probabilities from one
state to another. Figure 3.4 presents this transition matrix as a graph where the nodes represent the 10 states
of 𝑆 1 and the edges represent the transition probability of the next state where probabilities below 0.2 have
been removed. Here, we can see that the transition between states has a clear structure.
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Figure 3.4: Transition Probabilities between different States of 𝑺𝟏

Next, we study the association of user roles and time of day with the latest state 𝑆 1 . To study this,
we use standardized residuals (Pearson’s residuals) of a chi-squared test on a two-way frequency table of
user roles (or time of day) with their 𝑆 1 states for each access in PCPs (for neurology service department).
A score of ±2 would tell us that a role or time of day is significantly associated with a latent state 𝒮 1 . Figure
3.5 presents the standardized residuals (Pearson’s residuals) of a chi-squared test of user roles and latent
state 𝑆 1 . We can see that nurses are strongly associated with 𝑆 1 ∈ (4, 5, 6, 7, 8) while residents are strongly
associated with 𝑆 1 ∈ (1, 10). We also find that physicians and other staff show strong association with 𝑆 ∈
(2, 3, 10) and 𝑆 1 ∈ (2, 3, 9, 10) with state 9 being the only differentiator. This could be because of the fact
that many support staff also are specialized staff which may exhibit similar working styles as physicians.
Similar to hour of day, we study the association of states with day of week (Figure 3.7). We find
that some states are highly associated with weekdays while other states are highly associated with
weekdays. Intestinally, we find that the states that physicians are negatively associated to are states that are
associated to weekends while residents in 𝑆 1 = 1 are positively associated with weekends. This could signal
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that the quality of care provided on weekends compared to weekdays may differ depending of the
differences in the staffing in the HCO.
In summary, we find that the user’s role and user’s shift in the HCO are captured by 𝑆 1 and may
play a significant role in governing the observed workflows in the PCP. This also indicates that roles, hour
of day, weekday/weekend may be factors that can impact the delays and inefficiencies in user accesses.

User Role

𝑺𝟏 = 1

2

3

4

5

6

7

8

9

10

Nurse

-65.06

-15.23

-18.92

13.53

63.89

82.86

56.89

27.36

2.66

-79.96

Physician

-1.49

12.19

15.42

-4.64

-25.86

-16.71

-4.59

2.66

-17.76

23.34

Resident

92.93

-24.45

-28.2

-5.04

-31.33

-32.78

-27.51

-0.11

-5.8

15.67

Other

-16.07

29.59

34.75

-6.44

-21.98

-43.58

-29.06

-27.62

11.21

52.14

Figure 3.5: Relationship between User’s Roles and Latent State 𝑺𝟏

Figure 3.6 presents the standardized residuals (Pearson’s residuals) of a chi-squared test of access hour of
day and latent state 𝑆 1 . We can easily see that the states also represent the HCO shifts of the users. For
example, 𝑆 1 = 1 represents the shift from 9 pm to 6 am (night shift) while 𝑆 1 = 2 represents the shift from
8 am to 6 pm (long day shift). As we have residents that have the highest association to 𝑆 1 = 1, we can
assume that residents in this state usually are on the night shift. On the other hand, can expect to not see
any physicians in this shift as physicians are not associated with this state. Physicians are also negatively
associated with 𝑆 1 ∈ (5, 6, 9) which are all night shifts.
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Hour

𝑺𝟏 = 1

2

3

4

5

6

7

8

9

10

0

11.13

-18.86

-21.9

-4.27

19.65

15.55

20.11

-6.18

14.16

-13.29

1

8.24

-20.54

-24.21

-4.48

25.85

18.05

13.38

-8.48

27.46

-15.07

2

6.2

-20.4

-24.01

-5.65

35.06

21.69

14

-7.97

15.27

-14.59

3

10.87

-17.47

-20.73

-4.39

21.16

15.92

17.06

-4.6

8.55

-12.91

4

16.42

-19.57

-22.96

-5.42

17

12.87

17.84

-3.43

13.19

-14.61

5

14.85

-27.63

-31.78

-4.53

23.82

18.28

12.68

-0.56

30.87

-17.06

6

10.22

-36.19

-42.21

-5.96

39.14

26.98

3.71

5.12

30.66

-7.31

7

-3.7

-28.65

-24.49

4.19

38.7

19.55

-5.39

4.09

17.08

2.05

8

-4.04

8.42

26.43

4.93

-14.48

-10.09

-11.35

5.51

-13.17

-7.81

9

-2.77

19.44

26.42

-4.95

-33.5

-20.65

-12.25

16

-20.97

2.81

10

-4.89

17.48

28.98

-4.35

-32.96

-19.62

-11.67

8.72

-19.59

11.29

11

-6.99

19.81

29.2

-0.45

-33.14

-21.65

-13.29

2.22

-21.23

22.73

12

-4.63

16.02

24.27

-1.67

-29.89

-20.49

-8.65

0.68

-20.2

24.74

13

-5.99

19.2

26.23

-2.05

-31.47

-22.45

-9.13

0.5

-21.94

25.73

14

-9.54

30.96

29.01

0.12

-32.75

-22.35

-8.86

-2.69

-21.19

16.2

15

-7.06

25.65

26.25

3.63

-30.74

-18.92

-5.35

-0.98

-18.69

8.95

16

-0.84

21.32

16.45

6.82

-27.99

-17.11

-4.21

2.26

-16.06

5.1

17

-2.06

24.4

7.13

9.95

-23.49

-10.02

-2.96

-0.78

-9.99

1.81

18

1.45

14.35

-2.28

10.29

-14.11

-3.7

-1.12

1.49

-0.88

-5.26

19

-2.83

-23.06

-33.25

5.21

57.31

24.11

5.75

-4.81

26.34

-21.34

20

2.79

-29.45

-33.85

-3.36

52.56

33.87

15.07

-12.73

25.73

-16.93

21

6.34

-24.84

-29.34

-4.85

31.7

24.93

17.22

-9.33

29.59

-14.93

22

5.18

-23.68

-27.8

-4.56

32.17

27.21

19.55

-8.67

21.36

-14.88

23

5.93

-21.57

-24.79

0.05

37.37

19.63

16.04

-7.94

11.77

-13.43

Figure 3.6: Relationship between Hour of Day and Latent State 𝑺𝟏

Day

𝑺𝟏 = 1

2

3

4

5

6

7

8

9

10

Mon

-6.41

-1.79

22.27

-18.76

-6.82

-11.4

-1.06

-2.98

-10.17

20.64

Tue

-8.65

9.82

8.31

-6.01

1.92

-9.31

-6.88

-2.77

-9.64

16.16

Wed

-0.82

2.72

6.55

12.26

-2.74

-13.77

-0.27

0.57

-12.77

8.14

Thu

2.59

4.57

6.07

-12.98

-6.56

-11.95

0.04

4.87

-13.26

10.27

Fri

0.32

10.18

9.29

-3.44

-4.13

-7.27

-2.94

-3.53

-8.24

0.21

Sat

7.59

-14.44

-31.44

6.81

13.7

34.07

4.09

5.21

35.16

-37.46

Sun

9.15

-19.46

-36.82

31.37

10.14

36.34

10.67

-0.56

35.81

-34.62

Figure 3.7: Relationship between Day of Week and Latent State 𝑺𝟏
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3.6. Empirical Analysis
In this section, we first present our empirical models and discuss the estimation strategy for each model in
§3.6.1. We then present the estimation results and robustness checks in §3.6.2 and §3.6.3.
3.6.1. Empirical Models, Estimation Strategies and Instruments
In our study, we can potentially run into econometric problem of endogenous regressors when estimating
the impact of delays on LOS. As we want to estimate the relationship between LOS and delay, there can be
unobserved variables that may impact both LOS and delay. The patient condition such as severity can
induce longer LOS. Severity can also impact the access delays as a more severe case may require more time
for EHR users to do their jobs than usual. If this indeed is the case, then, the error term will be correlated
with both delay and LOS and make the estimate of the coefficient of delay biased. To overcome such issues,
we use instrumental variable approach for estimating models with endogenous regressors (Wooldridge
2002) . Similar techniques have been previously been used by researchers studying the impact of boarding
delay on patient LOS (Chan et al. 2016; Kc and Terwiesch 2009; Kc and Terwiesch 2012; Kim et al. 2015;
McClellan et al. 1994). In particular, Chan et al. (2016) and Kim et al. (2015) use congestion in the service
department of the patients first inpatient unit as an instrument for admission delay. In a similar strategy, we
use average workload in the first two days of admission and collaboration between EHR users as
instruments. As previous research (Berry Jaeker and Tucker 2017) has also found that workload (or high
occupancy levels) can show a curvilinear impact on LOS, we also use squared terms for workload in the
first two days of admission as instruments. Additionally, we introduce other instruments such as average
experience of EHR users in the last day of PCP for robustness which do not impact the results by much.
This analysis will be at a PCP level.

𝑅𝑖𝑠𝑘 𝐴𝑑𝑗. 𝐿𝑂𝑆𝑝 = 𝛼1 𝐷𝑒𝑙𝑎𝑦𝑃𝐶𝑃(𝑀𝑖𝑛𝑠)𝑝 + 𝝁𝒁𝟐 + 𝜀
(1)
𝐷𝑒𝑙𝑎𝑦𝑃𝐶𝑃(𝑀𝑖𝑛𝑠)𝑝 = 𝝑𝒁𝟏 + 𝜔
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𝑅𝑖𝑠𝑘 𝐴𝑑𝑗. 𝐿𝑂𝑆𝑝 = 𝛼1 𝐷𝑒𝑙𝑎𝑦𝐷𝑎𝑦1(𝑀𝑖𝑛𝑠)𝑝 + 𝝁𝒁𝟐 + 𝜀
(2)
𝐷𝑒𝑙𝑎𝑦𝐷𝑎𝑦1(𝑀𝑖𝑛𝑠)𝑝 = 𝝑𝒁𝟏 + 𝜔

In addition to studying the impact of delays on LOS, an important question is how workload,
collaboration and experience of different EHR users impact the probability of experiencing a delayed access
in a PCP. Equation (3) will help us study the more granular impacts of the above instruments on delays.
For estimating Equation (3), we will use fixed-effects (FE) logit estimator (Allison 2009) as our dependent
variable, delay, is binary in nature. This strategy will also control for unobserved time invariant patient
level variables that our model does not account for.

𝐷𝑒𝑙𝑎𝑦𝑝,𝑖 = 𝛼1 (𝐷𝑒𝑙𝑎𝑦𝑝,𝑖−1 ) + 𝛼2 (𝐷𝑒𝑙𝑎𝑦𝑝,𝑖−2 ) + 𝛼3 log(𝐶𝑜𝑙𝑙𝑎𝑏𝑜𝑟𝑎𝑡𝑖𝑜𝑛𝑝,𝑖:𝑖−2 )
+ 𝛼4 log(𝐸𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒𝑝,𝑖 ) + 𝛼5 log(𝐸𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒𝑝,𝑖−1 )
+ 𝛼6 log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐻𝑜𝑢𝑟𝑝,𝑖 ) + 𝛼7 log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐷𝑎𝑦𝑝,𝑖 )
+ 𝛼8 log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐷𝑎𝑦𝑝,𝑖−1 ) + 𝛼9 (𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖 )
+ 𝛼10 (𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖−1 ) + 𝛼11 (𝑊𝑒𝑒𝑘𝑑𝑎𝑦|𝑊𝑒𝑒𝑘𝑒𝑛𝑑𝑝,𝑖 )

(3)

+ β1 (log(𝐸𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒𝑝,𝑖 ) ∗ 𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖 )
+ β2 (log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐻𝑜𝑢𝑟𝑝,𝑖 ) ∗ 𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖 )
+ β3 (log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐷𝑎𝑦𝑝,𝑖 ) ∗ 𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖 )
+ β4 (log(𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑 𝑖𝑛 𝐷𝑎𝑦𝑝,𝑖−1 ) ∗ 𝑈𝑠𝑒𝑟 𝑅𝑜𝑙𝑒𝑝,𝑖 ) + 𝛾𝑝 + 𝜀𝑝,𝑖

where, 𝑝 and 𝑖 represent the 𝑖’th access by an EHR user in the 𝑝’th PCP.
3.6.2. Impacts of Delays in Workflows on Length of Stay
The estimation results for Equations (1) and (2) using OLS and two stage least-squares (2SLS) approach
on data from neurosurgery, hematology and general medicine service departments are reported in Table
3.7, Table 3.8 and Table 3.9. In all three tables, we find that the results of OLS estimation are quite different
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from two stage least-squares approach. This was expected as OLS results will be inconsistent due to
endogenous variables measuring delay. On running the weak instruments F-test on IV models, we reject
the null hypothesis of weak instruments in first stage (p<0.05). The Wu-Hausman test statistic suggests that
endogeneity was present and that OLS estimates differ (p<0.01). The Sargan test statistic for instrument
exogeneity null hypothesis is not rejected, suggesting that the instruments are valid.
On investigating the impacts of the average amount of delay per EHR user access in the entire PCP
and the first day of admission in the neurosurgery service department (Table 3.7), we find that the
relationship is curvilinear and U-shaped. As we used workload of the service department as instruments,
this is an extension to the results of Kc and Terwiesch (2012) who found the relationship between
occupancy levels (workload) and LOS to be linear and negative. Additionally, this result contrasts with the
results of Chan et al. (2017) who found the relationship between boarding delays and LOS to be positive
(where ED boarding delay was instrumented in a similar way as our study). We also find that the impact
size of average delay and inefficiency in the entire PCP is larger than delay and inefficiency on the day of
admission suggesting that delays right after the admission of a patient also play a significant role in
impacting the LOS of patients admitted in neurosurgery service department. These results suggest that an
increase in the average amount of delays and inefficiencies (measured in minutes) per EHR user access (the
ratio of total inefficiencies and delays in minutes and total accesses of EHR users) during a patients LOS
in the neurosurgery service department can result in lower LOS, where the delay and inefficiency is being
instrumented by the service department workload on first and second day of admission and user
collaboration. However, this decrease in the LOS is decreasing at a decreasing pace (U-Shaped).
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Table 3.7: Impact of Access Delays on Risk Adjusted LOS - Neurosurgery

Risk Adj.
LOS

Dependent variable:
Risk Adj.
LOS
LOS

Risk Adj.
LOS

LOS

(6)

(7)

(8)

-0.602***

-0.543***

-0.601***

-0.542***

(0.951)

(0.126)

(0.184)

(0.125)

(0.182)

0.003

0.011

-0.008

-0.005

-0.006

-0.003

(0.024)

(0.025)

(0.515)

(0.661)

(0.630)

(0.805)

***

***

***

3.462***

Risk Adj. LOS

LOS

(1)

(2)

(3)

(4)

(5)

-0.743

-0.999

-0.184

-0.154

(2.010)

(2.290)

(0.902)

-0.098

-0.094

(0.068)

(0.071)

LOS

2SLS

Gender:Male
Age
Adm:Weekend
Disc:Weekend
DelayPCP
DelayPCP^2

-1.353

-0.673

1.371

2.303

(2.922)

(3.213)

(1.568)

(1.702)

(0.0004)

2.518

3.478

(0.000)

(0.0004)

(0.000)

-0.447

-0.710***

-0.433

(0.127)

(0.372)

1.965

2.644

0.544

0.931

-0.724***

(3.063)

(3.370)

(1.472)

(1.561)

(0.122)

(0.359)

-7.671*

-8.524*

-0.135***

-0.153***

(4.294)

(4.658)

(0.011)

(0.006)

0.031*

0.034*

0.0005

0.001

(0.016)

(0.018)

(0.036)

(0.023)

DelayDay1
DelayDay1^2
Constant

OLS

2.504

-3.462***

-3.679***

-0.209***

-0.231***

(1.087)

(1.114)

(0.0002)

(0.0001)

0.013***

0.014***

0.001

0.001

(0.004)

(0.004)

(0.001)

(0.0004)

34.150***

34.920**

12.581***

12.833***

5.725***

5.483***

5.709***

5.492***

(10.346)

(16.249)

(3.111)

(2.920)

(0.000)

(0.000)

(0.000)

(0.000)

642

652

677

689

677

689

Observations
642
652
Note:
*p<0.1; **p<0.05; ***p<0.01
Robust Standard Errors for 2SLS Models

Next, we study the results from hematology service department reported in Table 3.8. We can see
that delays and inefficiencies in accesses (the ratio of total inefficiencies and delays in minutes and total
accesses by EHR users) during a patients LOS in the hematology service department has a curvilinear
impact on LOS, similar to neurosurgery. However, unlike neurosurgery, the delays and inefficiencies in the
first day of admission don’t have a curvilinear impact. In fact, the delays on the admission day increase the
LOS instead. Chan et al. (2017) also found that boarding delays to ICU from ED (instrumented in a similar
way as our study) increases the LOS of patients while this impact varied by patient’s service. We also find
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that the admission day being a weekend decreases the LOS of patients suggesting heterogenous impacts of
admission conditions by service departments.

Table 3.8: Impact of Access Delays on Risk Adjusted LOS - Hematology

Risk Adj.
LOS

Dependent variable:
Risk Adj.
LOS
LOS

Risk Adj.
LOS

LOS

Risk Adj.
LOS

LOS

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

1.132

1.733

-4.115

-4.192

0.604

1.032***

0.613

0.992***

(2.219)

(2.479)

(3.147)

(3.671)

(0.503)

(0.283)

(0.497)

(0.304)

0.087

0.103

0.018

0.007

-0.049

-0.057

-0.052

-0.059

(0.058)
-4.789***

(0.065)

(0.101)

(0.115)

(0.109)

(0.081)

(0.088)

(0.069)

-5.231***

-4.289**

-4.475*

-2.497***

-2.562***

-2.414***

-2.411***

(1.790)

(1.927)

(2.072)

(2.423)

(0.030)

(0.037)

(0.036)

(0.050)

-2.582

-2.878

2.921

3.759

0.368

0.589

0.483

0.824*

(1.803)

(1.982)

(2.087)

(2.286)

(0.718)

(0.589)

(0.638)

(0.453)

-4.104***

-4.559***

-0.115

-0.141

(1.411)

(1.629)

(0.139)

(0.092)

0.013**

0.014**

0.0003

0.0004

(0.006)

(0.007)

(0.279)

(0.227)

LOS

2SLS

Gender:Male
Age
Adm:Weekend
Disc:Weekend
DelayPCP
DelayPCP^2
DelayDay1
DelayDay1^2
Constant

OLS

3.812*

4.473*

0.014

0.064

(2.070)

(2.378)

(0.806)

(0.284)

-0.015

-0.017

-0.0001

-0.0002

(0.009)

(0.011)

(0.698)

(0.210)

19.790***

21.011***

2.303

1.819

12.187***

12.910***

11.845***

12.289***

(4.484)

(4.930)

(6.437)

(7.155)

(0.000)

(0.000)

(0.000)

(0.000)

422

424

431

436

431

436

Observations
422
424
Note:
*p<0.1; **p<0.05; ***p<0.01
Robust Standard Errors for 2SLS Models

Lastly, we study the results from general medicine service department reported in Table 3.9. We
can see that delays and inefficiencies in accesses (the ratio of total inefficiencies and delays in minutes and
total accesses by EHR users) during a patients LOS in the general medicine service department has a
curvilinear impact on LOS, similar to neurosurgery and hematology. However, unlike neurosurgery and

102

hematology, the delays and inefficiencies in the first day of admission don’t have any impact of LOS. This
suggests that general service departments like general medicine are not impacted by delays on day 1.

Table 3.9: Impact of Access Delays on Risk Adjusted LOS – General Medicine

Risk Adj.
LOS

Dependent variable:
Risk Adj.
LOS
LOS

Risk Adj.
LOS

LOS

Risk Adj.
LOS

LOS

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

-0.301

-0.372

-0.109

-0.025

0.007

0.091

0.104

0.216

(0.727)

(0.920)

(0.675)

(0.776)

(0.972)

(0.671)

(0.622)

(0.352)

LOS

2SLS

Gender:Male
Age
Adm:Weekend

OLS

0.058

0.071

0.031

0.034

-0.005

-0.006

-0.005

-0.006

(0.053)

(0.067)

(0.027)

(0.030)

(0.329)

(0.282)

(0.406)

(0.381)

-0.116

-0.507

0.669

0.454

-0.792***

-1.186***

-0.702***

-1.070***

(1.084)

(1.373)

(0.585)

(0.639)

(0.001)

(0.00000)

(0.005)

(0.0001)

-0.391

-0.570

1.229

1.486

-0.278

-0.254

-0.135

-0.058

(1.690)

(2.165)

(0.948)

(1.043)

(0.253)

(0.334)

(0.599)

(0.840)

DelayPCP

-0.191***

-0.265***

-0.029***

-0.039***

(0.057)

(0.072)

(0.000)

(0.000)

DelayPCP^2

0.0003**

0.0005**

0.00003***

0.00003***

(0.0002)

(0.0002)

(0.000)

(0.000)

Disc:Weekend

DelayDay1
DelayDay1^2
Constant

-0.027

-0.035

-0.006***

-0.009***

(0.067)

(0.078)

(0.0001)

(0.00000)

0.0001

0.0001

0.00000

0.00000

(0.0001)

(0.0001)

(0.056)

(0.006)

7.529*

9.689*

1.357

1.126

5.993***

6.498***

4.719***

4.807***

(3.946)

(4.960)

(2.276)

(2.574)

(0.000)

(0.000)

(0.000)

(0.000)

1,428

1,462

1,428

1,462

1,462

1,497

1,462

1,497

Observations
Note:
*p<0.1; **p<0.05; ***p<0.01
Robust Standard Errors for 2SLS Models

Next, we study the impacts of workload, user collaboration and user experience on access delays
to gain a better understanding of when and how delays occur during a PCP and how they can be potentially
curbed (§3.6.3.).
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3.6.3. Factors Impacting Delays in Workflows
We estimate Equation (3) using fixed effects logit estimator (see §3.6.1.) on data from neurosurgery,
hematology and general medicine service departments. The results from the estimations are reported in
Table 3.10, Table 3.11 and Table 3.12. We can see that the coefficients are quite similar in strength,
directionality and significance.
In the results from estimation on neurosurgery service department (Table 3.10), we find strong
evidence for delays in previous user accesses increasing the probability of new delays (p<0.01). Next, we
find evidence that the presence of higher collaboration between the current user and previous two users
decreases the probability of delays (p<0.01). More experienced users also decrease the probability of delays
(p<0.05), however, the effect is not moderated by the role of the user. We also find evidence for a reduction
in delays when the workload in the hour or the day increases (p<0.01 & p<0.05), however, having high
workload in the previous day increases the probability of delays (p<0.01) indicative of overwork.
Interestingly, we find this effect is moderated by residents showing a higher reduction in the probability of
delays when the workload in the day increases (p<0.05) and a higher increase in delays when workload in
previous day was higher (p<0.1). We find evidence that users having accesses in proximity of physician
accesses have a decreased probability of delays (p<0.05) while users having accesses in proximity of
resident increase the probability of delays (p<0.05). Lastly, there is evidence for access on weekends having
an increased probability of increasing delayed accesses (p<0.01).
Next, we investigate the results from estimation on hematology service department (Table 3.11).
Contrary to results from neurosurgery, we find no evidence of previous delays increasing or decreasing the
probability of new delays (p<0.01). We find evidence that the presence of higher collaboration between the
current user and previous two users decreases the probability of delays (p<0.01) like in neurology service
department. Interestingly, more experienced nurses increased the probability of delays (p<0.01). In contrast
to results from neurology service department, we find evidence for a reduction in delays when the workload
in the hour increases (p<0.01), however, having high workload in the previous day increases the probability
of delays (p<0.01) only for nurses. This suggests that the probability of delays is highly influenced by the
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nurses and their working conditions in the hematology department while neurosurgery is more influenced
by residents and physicians. Lastly, like neurosurgery, there is evidence for access on weekends having an
increased probability of increasing delayed accesses (p<0.01).

Table 3.10: Impacts of Collaboration, Experience, Workload and User Roles on Delays Neurosurgery
Dependent Variable: Delay
(1)

FE-Logit
(3)

(2)

Delay-Lag1

0.0546 (0.0976)

0.0474 (0.0977)

0.0506 (0.098)

Delay-Lag2

0.1829*** (0.065)

0.1844*** (0.0651)

0.1893*** (0.0653)

Role:Nurse

-0.0243 (0.0228)

-0.0264 (0.0229)

0.083 (0.3334)

Role:Physician

0.0008 (0.043)

0.00367 (0.0431)

-0.9773 (0.6579)

Role:Resident

0.0329 (0.0249)

0.0338 (0.025)

0.6535* (0.3626)

Role-Lag1:Nurse

0.00591 (0.0232)

0.00545 (0.0232)

Role-Lag1:Physician

-0.0974** (0.0446)

-0.098** (0.0446)

Role-Lag1:Resident

0.0591** (0.0253)

0.06** (0.0253)

Log(Collaboration)

-0.0382*** (0.00768)

-0.0377*** (0.00778)

-0.0378*** (0.00779)

Log(Experience)

-0.0806*** (0.0311)

-0.0729** (0.0315)

-0.0447 (0.0369)

-0.0321 (0.0323)

-0.0332 (0.0323)

Log(Experience-Lag1)
Log(WorkloadHour)

-0.0796*** (0.0254)

-0.0825*** (0.0255)

-0.1033** (0.0414)

Log(WorkloadDay)

0.0803 (0.1302)

-1.1948** (0.5332)

-0.9888 (0.8343)

1.3062** (0.5292)

1.2032 (0.8316)

-0.1205*** (0.0206)

-0.1216*** (0.0208)

-0.119*** (0.0209)

Log(WorkloadDay-Lag1)
Weekday
Log(Experience)* Role:Nurse

0.0063 (0.0306)

Log(Experience)* Role:Physician

0.0658 (0.0605)

Log(Experience)* Role:Resident

-0.0349 (0.0327)

Log(WorkloadHour)* Role:Nurse

0.0805 (0.0498)

Log(WorkloadHour)* Role:Physician

-0.0372 (0.1096)

Log(WorkloadHour)* Role:Resident

-0.0342 (0.0562)

Log(WorkloadDay)* Role:Nurse

-0.5479 (0.9947)

Log(WorkloadDay)* Role:Physician

1.2226 (2.2129)

Log(WorkloadDay)* Role:Resident

-2.396** (1.1335)

Log(WorkloadDay-Lag1)* Role:Nurse

0.4837 (0.9957)

Log(WorkloadDay-Lag1)* Role:Physician

-0.776 (2.2124)

Log(WorkloadDay-Lag1)* Role:Resident

2.0839* (1.1352)

Observations
Note: *p<0.1; **p<0.05; ***p<0.01

84299
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83717

83717

Table 3.11: Impacts of Collaboration, Experience, Workload and User Roles on Delays Hematology
Dependent Variable: Delay
FE-Logit

Delay-Lag1

(1)

(2)

(3)

0.0103 (0.092)

-0.0041 (0.0933)

-0.00533 (0.0934)

Delay-Lag2

0.0285 (0.0649)

0.04 (0.0665)

0.0428 (0.0667)

Role:Nurse

-0.0544*** (0.0176)

-0.0559*** (0.0177)

-0.2589 (0.1963)

Role:Physician

0.0263 (0.026)

0.028 (0.026)

0.0224 (0.2949)

Role:Resident

0.0111 (0.0231)

0.0116 (0.0232)

0.3066 (0.2646)

Role-Lag1:Nurse

-0.0145 (0.0176)

-0.0141 (0.0176)

Role-Lag1:Physician

-0.00012 (0.0263)

-0.00107 (0.0263)

Role-Lag1:Resident

0.0259 (0.0232)

0.0255 (0.0232)

-0.024*** (0.00688)

-0.0235*** (0.00694)

-0.0235*** (0.00694)

-0.0405 (0.0297)

-0.0405 (0.0315)

-0.0622* (0.0324)

-0.0208 (0.0318)

-0.0196 (0.0318)

Log(Collaboration)
Log(Experience)
Log(Experience-Lag1)
Log(WorkloadHour)

-0.119*** (0.0218)

-0.12*** (0.022)

-0.0974*** (0.0267)

Log(WorkloadDay)

0.4226*** (0.1012)

0.588 (0.3682)

0.5535 (0.454)

-0.1272 (0.3575)

-0.0974 (0.445)

-0.1616*** (0.0212)

-0.1614*** (0.0213)

Log(WorkloadDay-Lag1)
Weekday

-0.1539*** (0.0208)

Log(Experience) * Role:Nurse

0.0564*** (0.0201)

Log(Experience) * Role:Physician

-0.0345 (0.0297)

Log(Experience) * Role:Resident

-0.0393 (0.0274)

Log(WorkloadHour) * Role:Nurse

-0.0399 (0.0352)

Log(WorkloadHour) * Role:Physician

0.0274 (0.0549)

Log(WorkloadHour) * Role:Resident

0.0465 (0.0523)

Log(WorkloadDay) * Role:Nurse

-1.1489** (0.575)

Log(WorkloadDay) * Role:Physician

-1.0901 (0.8838)

Log(WorkloadDay) * Role:Resident

0.7633 (0.9447)

Log(WorkloadDay-Lag1) * Role:Nurse

1.1442** (0.5753)

Log(WorkloadDay-Lag1) * Role:Physician

1.1693 (0.8843)

Log(WorkloadDay-Lag1) * Role:Resident
Observations
Note:

-0.8502 (0.944)
118566

*p<0.1; **p<0.05; ***p<0.01
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117559

117559

Table 3.12: Impacts of Collaboration, Experience, Workload and User Roles on Delays – General
Medicine
Dependent Variable: Delay
FE-Logit
(1)

(2)

(3)

Delay-Lag1

1.6899*** (0.068)

1.7147*** (0.0688)

1.7162*** (0.0688)

Delay-Lag2

1.4767*** (0.0523)

1.4708*** (0.0523)

1.4705*** (0.0523)

Role:Nurse

0.0301 (0.0196)

0.028 (0.0197)

0.1184 (0.2462)

Role:Physician

-0.0166 (0.0309)

-0.0133 (0.031)

0.0765 (0.3842)

Role:Resident

-0.00256 (0.0227)

-0.00396 (0.0229)

-0.1203 (0.2842)

-0.0269 (0.0196)

-0.0276 (0.0197)

Role-Lag1:Physician

0.0448 (0.03)

0.0448 (0.03)

Role-Lag1:Resident

0.00153 (0.0226)

0.00119 (0.0226)

Role-Lag1:Nurse

Log(Collaboration)
Log(Experience)

0.00643 (0.00718)

0.00931 (0.00726)

0.00964 (0.00727)

-0.1017*** (0.0295)

-0.0898*** (0.03)

-0.0891*** (0.0303)

-0.1177*** (0.0294)

-0.1177*** (0.0294)

Log(Experience-Lag1)
Log(WorkloadHour)

-0.0184 (0.0258)

-0.0208 (0.026)

-0.0506 (0.0318)

Log(WorkloadDay)

0.7347*** (0.1831)

0.317 (0.2389)

0.3503 (0.255)

0.3676* (0.1891)

0.343 (0.2094)

-0.0535** (0.0249)

-0.0539** (0.0249)

Log(WorkloadDay-Lag1)
Weekday

-0.0677*** (0.0244)

Log(Experience) * Role:Nurse

-0.00779 (0.0208)

Log(Experience) * Role:Physician

-0.0175 (0.0305)

Log(Experience) * Role:Resident

0.0141 (0.024)

Log(WorkloadHour) * Role:Nurse

0.0886** (0.042)

Log(WorkloadHour) * Role:Physician

-0.019 (0.0721)

Log(WorkloadHour) * Role:Resident

-0.108** (0.0526)

Log(WorkloadDay) * Role:Nurse

0.0108 (0.3071)

Log(WorkloadDay) * Role:Physician

0.2116 (0.4494)

Log(WorkloadDay) * Role:Resident

-0.257 (0.3462)

Log(WorkloadDay-Lag1) * Role:Nurse

-0.0346 (0.3049)

Log(WorkloadDay-Lag1) * Role:Physician

-0.233 (0.446)

Log(WorkloadDay-Lag1) * Role:Resident
Observations
Note:

0.2832 (0.3451)
336421

333733

333733

*p<0.1; **p<0.05; ***p<0.01

Next, we investigate the results from estimation on hematology service department (Table 3.12).
Contrary to results from specialized service departments (i.e. neurosurgery and hematology), we find very
strong evidence of previous delays increasing or decreasing the probability of new delays (p<0.01). We
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find no evidence that the presence of higher collaboration between the current user and previous two users
increases or decreases the probability of delays, unlike specialized service departments. In contrast to results
from specialized service departments, we find no evidence for a reduction in the probability of inefficiencies
and delays when the workload in the hour increases (p<0.01), however, having high workload in the
previous day still increases the probability of delays (p<0.01). Lastly, like neurosurgery and hematology,
there is evidence for access on weekends having an increased probability of increasing delayed accesses
(p<0.01).
3.7. Discussion and Future Research Directions
To summarize, this research investigates the sparsely studied topic of

the impacts of delays and

inefficiencies in care provided during an inpatient stay on the length of stay of the patient. Additionally,
this research explores the impacts of staff collaboration, experience, workload and roles on the probability
of experiencing delays and inefficiencies in care provided during as inpatient stay.
We find that (1) an increase in delays and inefficiencies in care provided during an inpatient stay
decreases the length of stay of patients. However, (2) the decrease in LOS is decreasing at a decreasing
pace (U-shaped relationship). This suggests that delays and inefficiencies during a patient’s stay can lead
to early discharge which previous research has found to have negative impacts on mortality and
readmission. Additionally, we find that (3) the impacts of delays and inefficiencies in the first day of
admission are moderated by the patient’s service department suggesting heterogeneity in how delays and
inefficiencies are handled in specialized and general service departments. Specialized service departments
are impacted by first day delays and inefficiencies while general service departments don’t show this effect.
We also find several important insights when studying the impacts of user collaboration, user
experience in the HCO, workload in the service department and user roles in the service department on
increasing or decreasing delays and inefficiencies. We find that (4) for specialized departments, the
collaboration between the hospital staff plays a significant role in decreasing the probability of experiencing
inefficiencies and delays. This suggests that EHR users who have worked together on an inpatient case in
the past and have worked closely with each other multiple times decrease the probability of experiencing
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delays and inefficiencies. General service departments don’t show this impact suggesting that a
collaborative environment between hospital staff may only benefit specialized services. (5) We also find
that increases in a user’s experience in working in the HCO (as well as their experience in using the EHR
system) decreases the probability of experiencing inefficiencies and delays. This effect is most prominent
in general service departments which suggests that highly experienced staff are more likely to increase
efficiency in general service departments. (6) Additionally, for specialized service departments, we find
that high workload during the hour (or the same day) decreases the probability of inefficiencies and delays
suggesting increased efficiency under higher workload. This effect is not prominent in general service
departments. (7) However, the impact of having a high workload in the previous day has heterogonous
impacts as it either increases the probability of experiencing inefficiencies and delays for specialized service
departments or has no impact on general service departments. We find that (8) not all staff members in
different service departments handle high workload in the say way with the role of the staff member being
resident or nurse moderating this effect. Lastly, (9) we find that experiencing delays in the past increases
the chances of experiencing newer delays. This is prominent in general service departments and suggests a
cascading effect of inefficiencies and delays.
3.7.1. Contributions
Our study adds to prior literature studying the impacts of delays on patient’s length of stay (Chalfin et al.
2007; Chan et al. 2016; Luca et al. 2004; Yankovic et al. 2010). To the best of our knowledge, this study is
first to investigate the impacts of delays and inefficiencies in care provided during an inpatient stay on
hospital quality of care metric – LOS. Our findings extend previous research that found that delays during
the admission of a patient lead to longer LOS. We extend literature by finding that delays and inefficiencies
taking place while a patient is admitted also play an important role in impacting the LOS of the patient,
however, the impact of such delays and inefficiencies is heterogonous and not the same as delays before
the admission. We find the existence of speeding up effect more delays and inefficiencies take place during
an inpatient stay, however, the speeding up effect slows down as the amount of delays and inefficiencies
increase. Additionally, the speedup-slowdown effect on the day of admission is contingent on the hospital
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service department the patient is admitted in. Specialized departments dealing with surgical cases show
resilience to delays and inefficiencies up to a certain point after which additional delays and inefficiencies
results in longer LOS. On the other hand, departments that are dealing with patients that are non-surgical
care patients are not resilient to first day delays and inefficiencies, increasing the LOS of the patients,
however, can cope with delays and inefficiencies on average up to a point by showing the speedupslowdown effect. Additionally, general service departments don’t show any impact of first day delays. This
indicates that the speedup effect can be a managerial response to experiencing inefficiencies while the
slowdown effect can be an individual’s behavioral response. These findings show how delays during an
inpatient stay may impact the LOS of patents admitted for specialized or general reasons differently than
delays in boarding from ED to ICU (Chan et al. 2016).
This study takes the first steps in investigating the potential causes of delays and inefficiencies at
the level of an individual staff member and in doing so, makes several contributions to literature. This study
makes contributions to literature studying collaboration between hospital staff and efficiency (Alert 2008;
Benike and Clark 2013). Our study finds that the staff that have worked on more patient cases together
decrease the possibility of producing inefficiencies and delays during an inpatient stay. This is to say that
reduction in inefficiencies in workflows can be contingent on how well the staff know each other’s working
styles and preferences. However, this is only true for specialized services and general services don’t show
any benefit from collaboration between staff. This study also contributes to literature on workload in HCOs
(Berry Jaeker and Tucker 2017; Kim et al. 2015; Powell et al. 2012). We show that inefficiencies and delays
can be a product of exhaustion of staff from high workload in the previous day. While HCO staff can
increase their efficiency when workload is high in the hour or the day, sustained high workload for even
two days may increase inefficiencies and delays in an HCO. In addition, this study makes contributions to
literature studying experience of HCO staff (Ibanez et al. 2017) by finding that experience in not only
physicians but also nurses, residents and other HCO staff can play a role in increasing or decreasing
efficiency.
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Lastly, this study contributes to literature modeling dynamic processes in HCOs using audit logs
data (Aalst 2016; Chen et al. 2015b; Malin et al. 2011; Zhang et al. 2013). The dynamic Bayesian Network
model presented in this study can be used to study audit logs trails in other HCOs as the data used by the
model is available from most modern EHR systems. Additionally, the model can be easily modified to
include additional variables that may be important to studying different dynamic process patterns. The
model can also be used for studying dynamic process patterns and labeling inefficiencies and delays in
other processes such as logistics.
3.7.2. Limitations and Future Research Directions
The study has several limitations which can inform future research. First, the inefficient and delayed
accesses that were flagged using the DBN model are inefficiencies based on the previously observed data
and are not necessarily be considered as inefficiencies if a human studies them. Yet, it would also make it
nearly impossible for a human to flag each and every transition between users as efficient or inefficient.
Second, the data that we use only represent the subset of EHR users that accessed a patient’s record. There
can be unobserved users that were working on a PCP in an hour but didn’t access the records. However, all
accesses are recorded when a user retrieves or inputs information in the patient’s record. This is appropriate
amount of information for our study. As the time difference between accesses represent two distinct users
extracting or inputting information, our study investigates inefficiencies and delays in extraction and input
of information in a patient’s record which the next user may use in the PCP. Third, the DBN model doesn’t
consider 2nd order transitions which limits the model’s ability to learn processes and workflows that may
be occurring in parallel.
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APPENDIX A:
DEFINITIONS OF SOME COMMON MEDICAL CODING SCHEMES USED IN EHR
SYSTEMS

Table A.1: Definitions of Some Common Medical Coding Schemes Used in EHR Systems
Medical Coding
Scheme
ICD-9-CM and ICD10-CM
SNOMED-CT

RxNorm

LOINC

Definition
International Classification of Diseases, 9th and 10th revisions, clinical modification, are used to
code medical diagnosis and procedures from physician offices and inpatient/outpatient records.
These codes are commonly used for billing, reporting and morbidity statistics.
Systematized Nomenclature of Medicine, Clinical Terms, is the most comprehensive and precise
multilingual medical coding terminology and can be mapped to a variety of other coding systems
such as ICD-9-/10CM.
RxNorm is a standardized nomenclature for clinical drugs and is intended to cover all human use
approved drugs in the United States with certain exceptions for inclusion of international drugs as
well. RxNorm provides standardized names for clinical drugs and dosages.
The Logical Observation Identifiers Names and Codes terminology is used for the recording of
laboratory results for clinical care, reporting and research. LOINC provides standardized names and
structured codes for laboratory and clinical observations.
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APPENDIX B:
CASE STUDY

B.1. Introduction
In this study, the objective is to show the effectiveness of the collaborative intelligence model to perform
an unstructured task of studying a group of potential ADRs that have previously not been examined in
literature or by the FDA. The study follows the sequential interaction of two physicians with an algorithm
designed for the task of ADR detection. The sequential actions in the collaborative framework are
dominated by inputs and guidance from the physicians as the algorithm is designed to mark potential ADRs
from the available data in the EHR system.
The study is split into several phases where each phase is a collection of sequential interactions
between the physicians and the algorithm outputs. Prior to phase 1, the need for data preprocessing was
recognized by the physicians from the experiences on working with the EHR dataset to reduce the amount
of noise in the dataset. Phase 1 describes the data preprocessing efforts put in by the physicians to reduce
the amount of noise in the dataset. Phase 2 describes a series of actions taken by the physicians in order to
obtain accurate ADR signals from the algorithm. Phase 3 describes an in-depth ADR signal validation
analysis of detected potential ADR signals which correspond to the physicians own expertise. Phase 4
describes the final confounding checks performed by the physicians.
B.2. Phase 1: Data Preprocessing
In this phase, a number of steps were taken between the physicians and the algorithm to transform the input
data into a coherent format with as little issues as possible. These steps can be broadly categorized into two
sets of actions. First, the data manipulation steps performed on the patient diagnosis information recorded
in the EHR and second, the data manipulation steps performed on the prescription information.
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Figure B.1: Sequential Actions Taken by Two Physicians and the Algorithm in Phase 1

Most of the data cleaning process was performed on the patient medical history table that contained
the diagnosis information and associated timestamps. First, the algorithm was underreporting the number
of patients with a certain diagnosis. On investigation by the physicians, the cause of the underreporting was
found to be the existence of two separate diagnosis coding schemes in the dataset. In the EHR system, the
diagnosis of patients was recorded in Concept Unique Identifier for internal purposes and ICD9 for claims
purposes and in certain records, one or the other was missing mainly because the EHR system was rolled
out in phases. For tackling this problem, the CUI codes related to patient diagnosis were converted to ICD9
codes. For the conversion, the physicians imported the UMLS Metathesaurus1 that the algorithm could use
for mapping. Second, some CUI codes that could not be mapped to ICD9 codes were either procedure codes
or were CUI codes that identify diagnosis information outside the scope of ICD9 and the corresponding
records were removed from use by the ADR detection algorithm. Third, the patient medical history table
also suffered from missing timestamps which posed a problem as the algorithm requires the date of

1

https://www.nlm.nih.gov/research/umls/knowledge_sources/metathesaurus/
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diagnosis of a disease to accurately detect ADRs and reduce noise in the results. When a timestamp was
absent, this information could be obtained from text mining as described in the ADR Validation step
delineated below.
The prescriptions table contained information for all drugs in the EHR system at a very granular
level with brand names, generic names and dosage information. The physicians found many instances of
under reporting of prescriptions as the same drug was being treated as separate drugs where the name of
the drug differed slightly were essentially the same drug. To introduce a hierarchy that would group similar
drugs together, drug names were condensed into a new drug name that combined the drugs with matching
first names. For example, the drug names Toprol XL and Toprol were combined in the Drug Name V2 and
named Toprol. This procedure was necessary to reduce computation requirements of the ADR detection
algorithm. After the above transformation steps, the cleansed dataset was ready to be used by analyzed
again by the ADR detection algorithm to obtain updated potential ADR signals.
B.3. Phase 2: ADR Detection
This phase describes the algorithm for detecting ADR signals in the EHR database and the sequential
remedial actions taken by the physician to obtain potential ADR signals. These signals will later be
validated as strong or weak signals in the third phase.
The ADR detection algorithm and remedial actions taken by the physician are split into several
sub-processes. First, all the diagnoses and prescriptions are retrieved for all patients. The only criteria here
is that these should have associated time stamps. This step didn’t require any physician intervention.
Second, a table is built for all patients which includes all prescriptions that occur before a diagnosis. Here,
the physician added an additional criterion to further reduce noise and retrieve ADRs related to long term
diseases. To meet this criterion, the drug must be prescribed more than 4 times before the diagnosis of the
disease for a given patient. Aggregation yielded the total number of patients that had a prescription and
subsequently had the disease diagnosis. Then, another criterion was placed by the physicians on the
maximum time gap between the fifth prescription and diagnosis. This criterion is a minimum time gap
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range deemed appropriately by the physicians as it reduced the noise created in terms of false signals, and
reduced the number of observations the model had to deal with. One of the reasons behind this criterion is
that the physicians were more interested in looking for serious ADRs that are chronic in nature. Thus, for
the ADR detection algorithm, the maximum time gap was set to the prescription being in the year before
the diagnosis.

Figure B.2: Sequential Actions Taken by Two Physicians and the Algorithm in Phase 2

Third, through the intervention of the physician, drug-diagnosis pairs in which the drugs general
category corresponded to the treatment for a paired diagnosis were removed from the analysis. This step
greatly reduced the number of noisy signals in the final outputs and sped up the validation methodology.
Fourth, Odds Ratios were generated by the algorithm for each prescription and diagnosis pair. This is shown
in Table 2. The odds ratio measure of the relationship between the exposure to a specific medication and
the subsequent diagnosis of a specific disease. If the Odds Ratio is higher than 1, it implies that the
population that was prescribed the medication (Rx) had a higher incidence of subsequent diagnosis of the
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disease (Dx) than that of the population that was not prescribed the medication and was subsequently
diagnosed with the disease.

Table B.1: A Contingency Table of Patients Who Were Prescribed a Medication (or Not) and Later
Developed a Disease (or Not)

Exposed: Prescribed
Medication (RX)

Yes
No
Totals

Case: Developed Disease (DX)
Yes
No
Rx – Dx
Rx – No Dx
No Rx - Dx
No Rx – No Dx
Dx

No Dx

Totals
Rx
No Rx
Total Patients

Rx − Dx
(
)
Rx
− No Dx
𝑂𝑑𝑑𝑠 𝑅𝑎𝑡𝑖𝑜 =
No Rx − Dx
(
)
No Rx − No Dx

Fifth, some more noise reduction measures were employed by the physicians in the form of filters
on the results. The prescription and disease pairs with an odds ratio of less than or close to one were removed
from the table as they showed no sign of an ADR. The minimum number of patients for a prescriptiondiagnosis pair was set to 4 as the obtained odds ratios that were unusually inflated if the minimum threshold
was not set. Similarly, the minimum number of patients that were prescribed a drug was set to 200 patients
to reduce false signals (noise).
B.4. Phase 3: ADR Validation
The design of the final validation phase resembled that of a Retrospective Cohort Study, also known as a
Non-Concurrent Prospective Cohort Study or Historic Cohort Study. A retrospective cohort study is one in
which the relevant information about the cohort members is obtained from past records, as are some and
perhaps all of the outcomes of interest (Doll, 2001).

120

Figure B.3: Sequential Actions Taken by Two Physicians and the Algorithm in Phase 3

In this phase, the detected ADRs from phase 2 were analyzed by the physicians. To validate the
detected ADR signals, the physicians choose to study a selected class of diseases (ICD9 Level 2). This
selection was made according to the physicians own expertise. As another benefit of this selection apart
from expert opinion, the total number of potential ADRs that are to be analyzed by the physician were
considerably lowered.
A weak signal would correspond to either a low odds ratio or the drug being a known treatment
medication for the specific disease which was not removed in the last phase. The treatment medications
that were removed in the last phase were by no means complete and was implemented to reduce noise at a
higher hierarchy. The strong ADR signals were studied in detail to validate them.
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In this step, the physicians asked for text mining to be performed on the clinical notes in the EHR
system to retrieve more information regarding the prescriptions and diagnosis that might not be present in
the patients’ medical history table. For this, clinical notes for patients were analyzed with text mining for
occurrence of diagnosis information related to the specific diseases associated with the strong signals. Text
mining was not performed until the validation phase because it employed text analysis techniques that were
more computationally demanding, and it required the domain expertise of physicians to validate the
Adverse Drug Reactions found in the detection phase. Table 3 provides an overview of the study design for
the validation phase and is like the table obtained in Table 2 with some extra information obtained from
Clinical Notes table using text analysis. Table 3 has more restrictions on what can and cannot count as a
case falling in each of the four cells.

Table B.2: A New Contingency Table with Extra Criteria Placed for Observations Falling in Each
Cell
Yes

Exposed:
Prescribed
Medication
(RX)

Case: Developed Disease (DX)
No

Totals

Yes

Rx the year before Dx

Rx and No Dx

Rx

No

Rx after Dx OR
No Rx and Dx

No Rx and No Dx OR
No Rx and Dx before observation period
OR
Rx and Dx before observation period

No Rx

Totals

Dx

No Dx

Total
Patients

After the complete contingency table was retrieved by the algorithm, a battery of statistical tests
was conducted on the retrieved contingency tables to validate whether the ADR signals are statistically
strong or weak. The first series of tests are conducted to estimate the difference between the two groups,
exposed and not exposed, by using the difference between the two proportions. The second series of tests
are conducted to compare the population proportion odds. The second test is very useful when the
proportions are close to 0 and 1. The third test is to check the probabilities involved in the random allocation
of the subjects to treatment groups. This is conducted by using Fishers Exact Test. The fourth test is to
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check if there is a statistically significant dependence between the Prescription (Rx) and the Diagnosis (Dx).
This is done by conducting a Chi-squared test of independence.
B.5. Phase 4: Confounding Checks
In phase 4, additional tests were asked to be performed by the physicians to check for potential confounders
utilizing the patient demographic information available in the EHR data set If all five tests reject the null
hypothesis, the Dx and Rx ADR combination is marked as a strong ADR signal. Next, the detected strong
ADR signal was checked against spontaneous reporting systems like FARES for external validity.
B.5.1. Results: Degenerative Diseases of the Central Nervous System and Lipophilic Beta-Blockers
This section explains the results obtained from the ADR detection, validation and confounding analysis
phases.
B.5.1.1. Disease Category Selection
In the ADR detection phase, several strong ADR signals were detected in several disease categories which
had the potential to be strong ADR signals. Of these signals, only the category of Hereditary and
Degenerative Diseases of the Central Nervous System (ICD9 330 to 337) was studied in detail per the
expertise of the physicians involved in the study. Table 4 lists the diseases that fall within this group of
diseases. The detected ADRs in this category were related to Alzheimer’s disease, Parkinson’s disease and
Essential Tremor

Table B.3: Diseases and Their ICD9 Codes Belonging to Category of Degenerative Diseases of the
Central Nervous System
ICD9 Code
330
331
332
333
334
335
336
337

Disease
Cerebral degenerations usually manifest in childhood
Other cerebral degenerations
Parkinson's disease
Other extrapyramidal disease and abnormal movement disorders
Spinocerebellar disease
Anterior horn cell disease
Other diseases of spinal cord
Disorders of the autonomic nervous system
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B.5.1.2. Detected ADRs Associated with Alzheimer’s Disease
The top 5 ADRs related to Alzheimer’s disease per Odds Ratio are listed in Table 5. On investigation of
Alzheimer’s disease (AD), it was recognized that the diagnosis of AD is used interchangeably in the clinical
setting with Dementia which has an ICD9 of 290. Therefore, to capture the true number of cases of AD,
both AD and Dementia must be studied together. For this reason, the total number of AD cases in our
dataset (0.4%) was much lower than the reported national average for adults (2.2%). It was thus decided
that because of the complication of combining two ICD9’s for the 331.0 cases, we decided to evaluate it in
a future study.

Table B.4: Top 5 Potential Adverse Drug Reactions Found Related to Alzheimer’s Disease
Drug Name V2

ICD9

Y-Y

Y-_

_-Y

Total

N-_

_-N

Y-N

N-Y

N-N

Odds Ratio

Coumadin

331.0

6

385

39

20777

20392

20738

379

33

20359

9.77

Metoprolol

331.0

7

486

39

20777

20291

20738

479

32

20259

9.25

Zocor
Hydrochlorothiazide

331.0
331.0

6
6

533
574

39
39

20777
20777

20244
20203

20738
20738

527
568

33
33

20211
20170

6.97
6.46

Diovan

331.0

6

641

39

20777

20136

20738

635

33

20103

5.76

B.5.1.3. ADRs Associated with Parkinson’s Disease
Next, we studied all the ADRs related to ICD9 332: Parkinson’s disease. The top five ADRs for Parkinson’s
disease are listed in Table 6. There were nine potential ADRs (Odds Ratio > 1) related to ICD9 332
(Parkinson’s disease) detected prior to text mining. Coumadin fell into the Blood Thinners category of
medications. Pravachol, Zocor and Lipitor fell into the Statin category of medications. Metoprolol, Toprol
and Atenolol fell into the Beta-Blockers category of medications, but more specifically Metoprolol and
Toprol into the Lipophilic Beta Blockers (LBB) category and Atenolol into the Hydrophilic Beta Blockers
(HBB) category. Norvasc fell into the Calcium Channel Blocker (CCB) category of medications and Diovan
into the Angiotensin II Receptor Antagonist category of medications.
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Table B.5: Top 8 Potential Adverse Drug Reactions Found Related to Parkinson’s Disease
Drug Name V2
Coumadin
Pravachol
Metoprolol
Toprol
Zocor
Norvasc
Atenolol
Diovan

ICD9
332.00
332.00
332.00
332.00
332.00
332.00
332.00
332.00

Y-Y
5
5
6
6
6
5
5
5

Y-_
385
387
486
501
533
515
606
641

_-Y
76
76
76
76
76
76
76
76

Total
20777
20777
20777
20777
20777
20777
20777
20777

N-_
20392
20390
20291
20276
20244
20262
20171
20136

_-N
20701
20701
20701
20701
20701
20701
20701
20701

Y-N
380
382
480
495
527
510
601
636

N-Y
71
71
70
70
70
71
71
71

N-N
20321
20319
20221
20206
20174
20191
20100
20065

Odds Ratio
3.76
3.74
3.61
3.50
3.28
2.79
2.35
2.22

There have been many recent studies looking at Statin use and subsequent diagnosis of PD and they
have yielded conflicting results (Huang et al., 2015; Ritz et al., 2010; Simon, Chen, Schwarzschild, &
Ascherio, 2007) with the most recent and comprehensive study indicating that the reported benefits of
statins on PD went away when taking cholesterol levels into account (Bykov, Yoshida, Weisskopf, &
Gagne, 2017). Due to the contrasting results from these studies, the ADR regarding the association of the
use of Statins and subsequent diagnosis of PD was not analyzed further as it was evident that additional
clinical trials were necessary to provide substantial evidence of the true relationship between Statins and
PD. To offset the potential effects of Statins on other ADRs that were detected, the odds ratios of remaining
ADRs detected for PD were recalculated by excluding patients that were on Statins. While this further
reduced the available data set, it was a conservative approach ensuring more accurate results.
Coumadin has been well documented to have serious interactions with other medications. For
example, several studies (Andersson, Eliasson, & Lindh, 2012; Schelleman et al., 2010) found interactions
when Statins are used with Warfarin. Considering the evidence of high adverse drug-drug interactions with
Coumadin (Warfarin), we didn’t study this ADR in this second phase of the ADR detection method in order
to eliminate confounding results.
Investigating the Calcium Channel and Angiotensin II Receptor Antagonist groups, the odds ratios
became close to 1 when we removed the patients who were also on Statins. This is in line with previous
studies that found that current long-term use of calcium channel blockers was associated with a significantly
reduced risk of a Parkinson disease diagnosis (Becker, Jick, & Meier, 2008) and suggested that centrally125

acting dihydropyridine calcium channel blockers (CCBs) use and high cumulative doses of angiotensin
converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers may be associated with a
decreased incidence of PD in hypertensive patients (Lee et al., 2014). For this reason, we did not further
investigate Norvasc which is a Calcium Channel Blocker and Diovan which is an Angiotensin II Receptor
Antagonist.
Analyzing LBB’s, we found that five out of the 8 patients who developed PD subsequent to using
LBBs were not on Statins. The odds ratio for the patients on an LBB and no Statin was 2.1514. In the
Hydrophilic Beta Blockers (HBB) group, we found only one patient who was not on a Statin. The new odds
ratios for patients on an HBB and no Statin was 0.7685.
B.5.1.4. ADRs Associated with Essential Tremor
The third and last type of ADR that was detected in the 330 to 337 group was related to Essential Tremor
(ICD9 – 333.1). Essential Tremor is one of the most common of the movement disorders. However, in the
general community, the diagnosis is commonly applied indiscriminately to all tremors and therefore carries
a high misdiagnosis rate (Jain, Lo, & Louis, 2006; Meara, Bhowmick, & Hobson, 1999). We therefore
chose not to study it further in the second phase of the methodology. None of the cases of the use of LBBs
regarding PD examined in this study, were used to treat Essential Tremor.
Studies on beta blockers have largely ignored the lipophilicity of the medication, which is
surprising considering that both in animals and man lipophilic beta-blockers readily cross the blood-brain
barrier and hydrophilic beta-blockers do not (McAinsh & Cruickshank, 1990). That study found that the
incidence of CNS side effects was lowest with atenolol (hydrophilic) and generally highest with propranolol
(highly lipophilic) and pindolol and metoprolol (moderately lipophilic) occupied an intermediate position.
The results agreed with the pharmacokinetic observation that the more lipophilic the molecule, the more is
found in the brain. It is for this reason that we decided to further study the ADR that concerned the use of
Lipophilic Beta Blockers and a subsequent diagnosis of Parkinson’s disease.
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Note, a study (Louis, Benito-León, & Bermejo-Pareja, 2009) on the neuro-protective effect of
antihypertensive agents, including Beta Blockers, found that antihypertensive medication use was not
associated with prevalence or incidence of PD. However, the study did not differentiate between lipophilic
and hydrophilic beta-blockers.
B.5.2. Parkinson’s Disease and Lipophilic Beta-Blockers
For the methodology of this study, all LBB medications were combined and treated as one type of drug.
Combining the results from the phase one analysis and using text mining techniques on physician notes to
retrieve patient diagnosis information, a contingency table was created. To negate the potential impact of
Statins on the association between LBBs and PD, we analyzed the results but only considered patients who
were prescribed LBBs and not Statins in the exposed group. The noise reduction mechanism for phase one
which was the restriction on minimum time between last prescription and diagnosis of one year was
removed for this case study.

Table B.6: Contingency Table of Patients who were Prescribed Lipophilic Beta-Blockers and Not
Statins and Later were Diagnosed with Parkinson’s Disease
Case: Developed Parkinson’s Disease after Start of Observation Period
Totals
Yes
No
Exposed: Prescribed Lipophilic
Beta Blockers and Not Prescribed
Statins Prior to Development of
PD

Yes

7

1,146

1,153

No

49

19,575

19,624

56

20,721

20,777

Totals

The confusion matrix used to identify a correlation between prescription of LBBs and no Statins
and PD is shown in Table 6. The odds of developing Parkinson’s disease when prescribed LBBs and no
Statins are estimated to be 2.44 times as large as the odds of developing Parkinson’s disease when not
prescribed LBBs nor Statins (P<0.05, 95% CI = 1.10 to 5.40). The risk of PD among the patients who
were prescribed LBBs and no Statins was 2.26 times as high as the risk of PD among patients who were
neither prescribed LBBs nor Statins (prescription count >= 5). The data are consistent with the hypothesis
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of non-equal proportions of development of Parkinson’s disease in the populations of exposed and nonexposed patients (one-sided p-value < 0.05). There is substantial evidence (p-value < 0.05) that the
observed division of Development of Parkinson’s disease was not the result of random allocation. The
one-sided p-value from Fisher’s Exact Test is <0.05. There is also convincing evidence (chi-squared test
of independence p-value < 0.05) that Exposure to Lipophilic Beta Blockers (row) and the development of
Parkinson’s disease (column) are not independent.
B.5.2.1. Confounding Checks
Patient Gender: Stratified analysis was performed to check if patient gender was a confounder in the study.
The Mantel-Haenszel Chi-Square Test results show that the odds ratio for the first stratum (Men) was 1.93,
the odds ratio for the second stratum (Women) was 1.71 but both were not significant at P<0.05.
Patient Age: Patient ages were compared using t-Tests. Patients age in the group who were prescribed
LBBs and later developed PD were not significantly different (p = 0.0509) from the group who were not
prescribed LBBs and developed PD at a significance 0.05 level.
External Validity using FARES: Using the FARES database, the odds ratios were calculated for each
type of LBB medication and Parkinson’s disease. In the FARES database, the odds for prescriptions of
metoprolol and diagnosis of Parkinson’s disease was 1.12 which strengthen the results obtained from the
EHR database.
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